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Abstract 
Based on the "Human in vitro dermal absorption datasets" published as supporting information to the 
revised EFSA Guidance on Dermal Absorption, in silico models for prediction of absorption across the 
skin have been evaluated. For this evaluation, a systematic literature search and review was 
performed, identifying 288 publications describing mathematical models for prediction of dermal 
absorption. Eleven models potentially relevant to the regulatory assessment of pesticides and which 
cover a range of approaches were selected for in depth evaluation. This included three mixture 
models taking into account physicochemical properties of the co-formulants such as polar surface 
area, hydrogen bonding or octanol-water partition coefficients. Additional data on the pesticidal active 
substances and information on the composition of some of the formulations covered in the dermal 
absorption dataset were gathered, as these were required as input parameters for the selected 
models. The models were implemented with settings reflecting as much as possible realistic exposure 
scenarios and the experimental conditions under which the measured data were obtained. As the 
majority of the models predicted either maximum flux or the permeation coefficient, further 
combination with a model achieving translation into percentage absorption was required. This was 
done with and without consideration of the lag time. Only one model directly predicted percentage 
dermal absorption, which was a spreadsheet-based single substance model taking into consideration 
several skin parameters, experimental conditions, various physicochemical properties of the active 
substance and the type of vehicle. Statistical analysis of model predictions revealed overall low 
concordance with measured values, thereby limiting regulatory acceptance. Additional analysis was 
performed on the results of two mixture models and the above mentioned complex single substance 
model which showed moderate correlation between predicted and measured data. Options to improve 
model performance were discussed and Bayesian random effects modelling was explored to adjust 
predicted percentage dermal absorption to measured data as was model combination. When taking 
into account observed uncertainties of predictions, one of the models may provide a Tier 2 tool to 
estimate dermal absorption value in the absence of adequate experimental data when the predicted 
values are in the range of 10 to 70%. However, further work is needed to better understand the 
effect of co-formulants on dermal absorption of pesticides and to improve model predicitivity. 
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Summary 
A search protocol to retrieve papers on models predicting dermal absorption from public literature for 
application in Scopus, PubMed and ToxLine was developed in cooperation with EFSA. In addition, an 
internet search using Google was performed. The records retrieved were unduplicated and transferred 
into the TNO Literature Review Tool (LRT) for relevance check. The 2212 records collected yielded 
288 papers considered relevant based on their title and abstract and copies of these papers were 
obtained for further scrutiny.  
Subsequently, a first review of the scientific quality and of the relevance for the regulatory framework 
of pesticide risk assessment of the models described in the selected papers was executed according to 
a protocol refined in cooperation with EFSA. Issues considered were the descriptors and algorithms 
used, the provision of details on the training sets employed for model development and of actual input 
values, the statistical parameters provided to illustrate the goodness-of-fit, robustness and predictivity 
of the models and the extent to which the models offered a mechanistic interpretation of the dermal 
absorption process.  
Based on the first stage of the scientific review, 103 out of the 288 papers originally regarded as 
relevant were excluded from further consideration as they proved not to be relevant when the full 
publication was assessed. Only the publications describing original work were entered for the second 
stage of the scientific review, as the review papers were not expected to contribute additions to the 
pool of models extracted from the original studies. The 142 original papers described a total of 233 
models, 188 predicting absorption of single substances and 45 predicting absorption of substances 
from mixtures. Most models were algorithm based: 141 out of 188 single substance models and 37 
out of 45 mixture models; the remainder were machine learning models.  
In the second stage of the scientific review, models were screened for their potential usefulnes 
regarding the prediction of dermal absorption of pesticides and their dilutions in water or of pesticides 
from mixtures (including solutions in vehicles other than water). Of the 111 models identified as 
possibly useful, 95 models predict the permeation contstant (kp), 15 provide estimates for either 
maximum or steady state flux (Jmax and JSS, respectively), whereas only one predicted percentage 
absorption.  
A selection of models for prediction of dermal absorption was made for comparison of predicted 
versus measured data provided in the "EFSA Human in vitro dermal absorption dataset". A selection 
proposal was presented to and agreed with EFSA. In accordance with the specifications, eleven 
models including at three models taking into account physicochemical properties of the co-formulants 
such as polar surface area, hydrogen bonding or octanol-water partition coefficients (hereafter called 
"mixture models") were selected for implementation and statistical evaluation. Models predicting 
either flux (Jmax or Jss) or the permeability coefficient (kp) were combined with another model for 
estimation of percentage dermal absorption. Simple physicochemical descriptor models with MW and 
LogPow as input parameters, complex physico-chemical descriptor models with many input parameters 
as well as those with quantum-chemical descriptors were included in this project. The descriptors for 
selected models were collected from EFSA conclusions, assessment reports and public databases or 
calculated with several software tools for the active substances and the co-formulants, respectively. 
Prediction models for dermal absorption could be successfully implemented covering two artificial 
neural network (ANN) models, one random walk model and one complex spreadsheet model as well 
as 7 algorithm-based models. The reconstruction of ANNs was realised in MATLAB 2016b using Neural 
Network Toolbox. All other predictions with the remaining dermal absorption models could be 
computed with Microsoft Excel. Multiple scenarios were accounted for during the implementation of 
the models: different definitions of lag-time, discrimination between experimental and computed 
model parameters, combination of experimental and computed parameters. This was done to 
generate a reasonable number of model implementation alternatives and facilitate a useful 
subsequent statistical analysis. Implementation of mixture models required information on the 
composition of the formulation which was made available by EFSA from respective sections of 
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registration reports (RRs) and Draft / Renewal Assessment Reports (DARs/RARs). However, suitable 
information could be retrieved only for a subset of mixtures covered in the EFSA dermal absorption 
dataset. In addition, information frequently related to co-formulant mixtures rather than the exact 
chemical composition requiring some assumptions to be made when calculating mixture descriptors.  
A statistical analysis was performed addressing the relationships between predicted and measured 
values, as well as questions that derive from regulatory considerations. As most of the examined 
models yielded kp/Jmax values that needed to be further translated to the relevant endpoint, %DA, the 
DAME model (Buist 2010) was additionally applied. For the implementation of this model, information 
on the lag-time (tlag) is required. The lag-time was either taken as 0 or was calculated; this way two 
sub-versions were generated for each model (except for model 7). No major variation was detected 
between the predicted %DA for each model sub-version, thus all further representations and analyses 
were performed with calculated lag-time. Another methodological issue that was addressed here is the 
use of information from individual replicates or from the same experimental block (blocks of 
replicates) for %DA predictions. In the present study, the computed %DA values were preferably 
derived by using, when available, as "applied concentration" the concentration that was introduced on 
each individual replicate (Franz cell) in one experimental block. In cases where this information was 
not available, the concentration means from many replicates of the same experimental block (blocks 
of replicates) were used. Thus, it was expected that the predictions for a set of replicates would not 
always be identical to one another. For this reason, the relationship between predictions for pairs of 
replicates from within the same block of replicates was examined, as a measure of how closely related 
the single replicate values are to their averaged ones. 
To explore the association between measured and computed values, graphical representations with a 
variety of axes’ scales were generated including linear, log, adjusted logit, ranks. Plots depicting the 
relationship between predicted and measured %DA, did not reveal any correlations between the two 
variables for most models. Weak to moderate associations between predicted and measured 
absorption, as demonstrated by the respective graphical representations and confirmed by Spearman 
rho and Kendall tau rank correlations analyses, were detected only for model 7 (single substance 
model) and for models 9 & 10 (mixture models). This finding suggested that models 7, 9 and 10 were 
worthy of further investigation and that the other models are less likely to be useful predictively. 
For models 7, 9 and 10, a systematic search was made for subsets of the data, defined by values of 
covariates expected to have potential to be relevant, for which there would be a stronger correlation 
within the subset than for the whole data. A small number of subsets were found which had slightly 
stronger correlations but no subset was found which had a substantially stronger correlation. 
The rate and magnitude of over- and under-prediction of absorption, and their dependence on the 
predicted level of absorption, were explored empirically for models 7, 9 and 10 and reported 
graphically and in tables.  
A Bayesian random effects (BREM) statistical model of the relation between measured and predicted 
absorption, and incorporating random effects per active substance and block of replicate 
measurements was developed and used to further quantify the predictive properties of model 7. The 
model was used to plot the probability of a given level of over- or under-prediction as a function of 
the predicted level of absorption. The BREM statistical model was also used to make an adjustment to 
the output of model 7 to reduce the level of over- or under-prediction, depending on the predicted 
level of absorption. 
A "Questionnaire on the practical applicability and potential regulatory implementation of in silico tools 
for the prediction of pesticides dermal absorption" was prepared considering also feedback by EFSA 
and the European Crop Protection Association (ECPA). The purpose of this questionnaire was to 
receive feedback from Member State Competent Authorities (MSCAs) on regulatory needs and raise 
technical questions that should be considered and addressed in the statistical review of model 
predictions. Thirteen (13) experts from ten (10) Member State Competent Authorities involved in the 
mammalian toxicology evaluation and risk assessment of active substances and their products, 
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responded to the questionnaire. In general, it was concluded that the use of in silico tools is currently 
driven by the regulatory needs as described in current legislation and related guidelines. Since in silico 
tools are currently not recommended for the prediction of dermal absorption of pesticides (EFSA, 
2017), none of the experts is using them routinely. Furthermore, there is a general scepticism on the 
use of in silico tools for dermal absorption of pesticides for several reasons. Firstly, very few of the 
experts have the technical knowledge on how to use the available tools reliably, highlighting the need 
for training on the topic. In addition, the multifactorial nature of dermal absorption is recognised as a 
parameter limiting the in silico tools reliability. However, several experts would be willing to use in 
silico tools for the prediction of pesticide dermal absorption if validated methods are available and are 
recommended by regulatory bodies (e.g. EFSA).  
Considering the result from model implementation and statistical analysis, it is recommended to 
further discuss the possibility of using the adjusted model 7 (NIOSH model) as a Tier 2 tool to 
estimate the dermal absorption value in the absence of adequate experimental data when the 
predicted values are in the range of 10 to 70%, with a defined level of uncertainty.  
It is also recommended to further investigate the influence of physicochemical properties defined as 
optional by Dancik et al. (2013) such as pKa, water solubility, density, vehicle solubility, non-ionised 
unbound fractions, on the predictivity of model 7. These additional actions could be considered for 
potential improvement of model 7 outcome and increase predictivity.  
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1 Introduction 
1.1 Terms of Reference as provided by the requestor 
This contract was awarded by EFSA to a consortium with BfR in the lead. 
Members of the consortium are: 
Federal Institute for Risk Assessment (BfR), Berlin, Germany 
TNO innovation for life (TNO), Zeist, The Netherlands 
BENAKI Phytopathological Institute (BPI), Kifissia, Athens, Greece 
Durham University (DU), Department of Mathematical Sciences, Durham, United Kingdom 
The Danish EPA (DK-EPA), Copenhagen, Denmark, was engaged as a sub-contractor of the 
consortium. 
Contract title: Applicability of in silico tools for the prediction of dermal absorption for pesticides 
Contract number: OC/EFSA/PRAS/2016/02 
 
1.2 Interpretation of the Terms of Reference 
Background as provided by EFSA 
Dermal absorption is a critical element in the risk assessment of plant protection products (PPPs) for 
operators, workers, bystanders and residents being dermal the primary route for occupational 
exposure to PPPs. 
Internationally agreed test guidelines exist for the performance of dermal absorption studies both in 
vivo and in vitro, for testing formulated product or in-use dilution. However, there is growing interest 
in the potential to use in silico (computational) tools for prediction of dermal absorption and reduce 
the need for testing, in particular for ethical reason. 
In the last decades, non-testing approaches have been developed to predict skin absorption of 
chemicals. These include quantitative structure-activity relationships (QSARs), theoretical models that 
connect structural or physicochemical properties (descriptors) of substances to their ability to diffuse 
through the skin layers. In addition, more mechanistically based mathematical models of skin 
penetration and transport processes have been developed. A few attempts to develop models for 
multicomponent mixtures have been done. 
Main challenges for the use of developed models based on an initial (often not homogeneous) training 
set of substances are their applicability to the PPPs under investigation in occupationally relevant 
conditions, taking into consideration also the mixture effect of formulations, and their regulatory 
acceptance. 
From EFSA guidance on dermal absorption, the extrapolation of dermal absorption is possible only 
under specific circumstances (closely related formulations of the same active substance). Based on the 
analysis of the available approaches for predicting dermal absorption of active substances for pesticide 
products, QSAR models were not recommended and the need to conduct further research in the area 
was evidenced. Furthermore, the need for a revision of last enhancements of the in silico prediction 
tools and the evaluation of their performances using homogeneous data on PPPs has been identified 
by the EFSA Working Group on Dermal Absorption. The robust EFSA dataset of human in vitro dermal 
absorption studies with PPPs has been indicated as appropriate for assessing predictivity of existing in 
silico tools. 
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1.3 Additional information 
The overall objectives of the contract were defined as described below. 
 
"Objective 1: provide a comprehensive and critical review of existing in silico models developed to 
predict skin absorption. The review should cover existing available models for the period from 1990 till 
present. The search strategy should be documented, following the criteria described in the EFSA 
Systematic Review Guidance, if possible. References shall be collected into EndNoteTM Library or in a 
format that is compatible with EndNoteTM. In the review the following information on the in silico 
models should be included: descriptors, algorithm, and training sets used for the development of the 
model, information on applicability domain, assessment of goodness-of-fit, robustness and predictivity, 
mechanistic interpretation, additional information. In addition a critical appraisal on advantages and 
limitations of existing in silico models should be provided, as well as their applicability in the 
regulatory context. The review should include also models for multicomponent mixtures to include 
vehicle effect in the prediction. 
• Objective 2: compile a list of identified in silico models (including models for mixtures) for skin 
absorption prediction to be critically evaluated. The EFSA dermal absorption dataset of human in vitro 
studies with PPPs should be implemented with the descriptors to be used for testing the selected 
models. This information should be retrieved from available published scientific literature, chemicals 
databases, or calculated using software tools. In addition, to evaluate the vehicle effect, data on 
formulations composition of PPPs in the EFSA dermal absorption dataset will be extracted from the 
relevant sources (e.g. Draft Assessment Reports (DARs), Draft Registration Reports (DRRs). The 
evaluation should include a minimum of 10 models (at least 3 should be models for mixtures) covering 
skin penetration as endpoint. Moreover, a different combination of models should be also investigated 
as a possibility for improvement of the prediction performance. 
• Objective 3: test the predictability and reliability of predictions for the identified in silico models 
against the dermal absorption dataset and provide the analysis of the outcomes including a proposal 
for refinement of existing models. Special attention should be given to the evaluation of the reliability 
and of the uncertainties of the prediction. A list of recommended models for dermal absorption 
prediction for pesticides should be provided. In addition, the possibility of incorporating such models 
into the tiered approach for the dermal exposure assessment of PPPs has to be evaluated." 
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2 Data and Methodologies 
2.1 Literature Search 
A search was performed in Scopus, PubMed, ToxLine and Google in order to identify publications 
describing mathematical/statistical models for prediction of dermal absorption across mammalian skin 
since 1990. The development of the search strategy is described in detail in Appendix A. In short, 
relevant search terms and subject areas were selected and reviewed by experts in the field. For 
refinement, it was investigated whether a draft search strategy developed for Scopus would reveal all 
27 papers that are listed in Scopus and were reviewed in a recent publication by Buist (2016). 
Following revision of the initial search strategy, 26 out of 27 publications were retrieved. This was 
considered acceptable and the search strategy was then translated into PubMed and ToxLine search 
protocols. It was able to find all publications relating to dermal absorption modelling that were quoted 
in the recent EFSA Guidance on Dermal Absorption (2017) with the exception of two papers. One of 
these was not listed in the literature databases, the other was an overview paper by Mitragotri et al. 
(2011). To increase coverage, additional searches were performed including the search term 
"permeability", and now also the Mitragroti paper was hit. In addition, an internet search using Google 
was performed resulting in seven webpages containing 3 relevant hits. All search results were 
exported into the TNO-Literature Review Tool (TNO-LRT) and unduplicated. The Endnote™ file 
containing all references is available upon request at EFSA. 
2.2 Literature Relevance Assessment 
An initial evaluation of relevance was based on publication title. In the context of this check, "relevant 
papers" were defined as "papers addressing mathematical models of dermal absorption". Records 
considered irrelevant based on their abstract were excluded from the next selection phase. The 
reasons for exclusion were documented and included the following: "No mathematical model of 
dermal absorption", "Refers to models, but does not describe them", "PBPK model for a single 
substance", "Mixed model with in silico and experimental input" and "Other". Details of the relevance 
assessment and documentation are provided in Appendix B. Results of the relevance assessment for 
all individual references are available upon request at EFSA. 
2.3 Systematic Literature Appraisal 
A systematic evaluation of the scientific quality and relevance for the regulatory framework for 
pesticide risk assessment of the models described in the papers retrieved from public literature was 
performed. Proprietary in silico models were not excluded from the start, but evaluated along-side the 
non-proprietary models. Only well-defined and explicit algorithm models and reconstructable machine 
learning models were evaluated further. It was evaluated whether the publications provided details on 
the training sets used for model development and the model’s applicability domain. Statistical 
parameters provided in the papers to illustrate the goodness-of-fit, robustness and predictivity of the 
models were included. This included external validations described in the original paper, not those in 
secondary literature. Finally, it was assessed to which extent the models offer a mechanistic 
interpretation of the dermal absorption process. 
The first stage of the scientific review was based on answering the following questions: 
1. Relevant based on complete paper? 
2. Prediction for single chemical or mixture? 
3. Original paper, review paper or other, non-relevant, type of paper? 
Only relevant original papers were considered in the second stage of the assessment. At the second 
stage of the scientific review the following questions were addressed: 
1. Algorithm based model? 
2. Addresses a clearly defined need in pesticide RA? 
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3. Are there more recent similar models by the same research group? 
4. Details of the training set provided? 
5. Can the model be reproduced based the materials and methods of the paper? 
6. Internal validation performed? 
7. External validation performed? 
8. Can the model be interpreted mechanistically? 
9. Proprietary model? 
As soon as for a specific model either question 2 or 5 of the second stage of the scientific review was 
answered with "No" or question 3 with "Yes", it was not further considered in the assessment. 
Quality control of the results of the systematic literature appraisal was performed by the internal 
reviewer. In total 26 of 129 publications describing single substance models and 5 papers describing 
mixture models (approx. 20% of all scientifically assessed papers) were evaluated regarding questions 
1-2 and 4-9 of the second stage of scientific review. The concordance between assessor and reviewer 
was evaluated in a blinded manner. It was foreseen that if the percentage of publications with 
deviating evaluation was higher than 10%, a set of additional 20% of the papers would be evaluated 
by the reviewer. Any other errors would be corrected. A deviation rate of 3.2% between the internal 
reviewer and the initial assessor was recognized, which was regarded as acceptable according to the 
established protocol. Minor deviations as detected by the reviewer were adjusted after discussion with 
the assessor. 
Further information on the methodology is provided in Appendix C. 
2.4 Selection of Models for Implementation 
The literature review resulted in the identification of 111 relevant single substance and mixture 
models, which are reconstructable, suitable for pesticide risk assessment and represent the most 
recent version. 
A total minimum of 11 models including 3 mixture models were selected for implementation and 
statistical evaluation. Models predicting either maximum flux (Jmax) or the permeability coefficient (kp) 
require combination with another model for estimation of percentage dermal absorption. One of the 
selected models predicted percentage dermal absorption and further output parameters with 
corresponding entries in the EFSA dataset (also refer to section 2.7). The model selection approach 
can be described as follows. 
In a first step, a scoring scheme based on the input parameter availability was developed to allow a 
ranking of single substance models (SSM) and mixture models (MM). The highest score was taken 
forward when more than one availability category was applicable. 
In a further stage, a selection was made with the objective to ensure best possible representativeness 
regarding input and output parameters as well as modelling approaches, taking into account available 
information on existing validation efforts and training / test data set sizes.  
2.5 Combination of Models 
2.5.1 Sequential combination (DAME) 
Since the pesticide absorption data published by EFSA only report percentage absorption and not flux 
or kp as absorption parameters (EFSA, 2017), the output of all but one model needs to be converted 
to percentage absorption (%DA), as they predict flux or kp. In vitro dermal absorption measurements 
of pesticides are usually executed under finite dose conditions, implying a mathematical model 
addressing finite dose conditions is needed for this conversion. Two publicly available finite dose 
models discussed by Buist, one of the authors of this report, in his 2016 thesis, were considered for 
this purpose: the Dermal Absorption Model for Extrapolation (DAME) (Buist et al., 2010; Buist, 2016) 
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and the Finite Dose Skin Permeation (FDSP) model made available on the internet by the US Centers 
for Disease Control and Prevention (CDC)1. The searches performed, which were not specifically 
targeted at such models, had not provided other alternatives. 
DAME basically models the Franz diffusion cell and predicts in vitro dermal absorption from aqueous 
solutions, defined as the sum of the amounts of a chemical encountered in the epidermis and the 
receptor fluid. Chemical-specific inputs needed by DAME are the measured permeation constant (kp), 
lag time and stratum corneum/water partition coefficient (KSC,W). The permeation constant and lag 
time should be measured in an infinite dose in vitro absorption experiment. Usually, a measured KSC,W 
is not available, in which case the model uses a QSAR to calculate it. For this QSAR two additional 
chemical-specific parameters are needed: its MW and logPow. DAME can be used to convert a 
predicted kp into percentage absorption by using this kp as input instead of a measured kp, and setting 
lag time to zero. The introduction of this worst case assumption (that absorption starts immediately at 
t = 0) is offset by also ignoring a potential skin reservoir. Alternatively, a predicted lag time can be 
used using the fixed relationship between lag time (tlag), KSC,W, kp for the stratum corneum (kpSC) and 
thickness of the stratum corneum (LSC), derived by Shah et al. (1994): tlag = KSC,W × LSC/6kpSC. 
The FDSP model was developed by Fedorowicz et al. (2011) and published in peer-reviewed literature 
(Dancik et al., 2013; Kasting and Miller, 2006; Kasting et al., 2008; Miller and Kasting, 2010; Wang et 
al., 2007). Besides predicting skin permeation under finite conditions, the FDSP model also facilitates 
predictions based on user specified kp’s. FDSP needs quite a number of physicochemical parameters of 
the penetrant as input: MW, LogPow, water solubility, melting point, boiling point, vapour pressure, 
pKa, number of rings and number of double bonds. 
Table 2.1: Parameters used in DAME. 
Parameter Description Value Unit 
MW molecular weight a.i. g/mol 
LogPow logarithm of octanol/water partitioning coefficient a.i. -- 
Alkanol?  yes/no 
(a.i.) 
-- 
kp predicted permeation coefficient or predicted Jmax 
(mg/cm2/h)/solubility of a.i. in the vehicle used (mg/cm3) 
0.003 cm/h 
      volume of Parameters used in DAME, set to a default 
value 
0.002 mL/cm2 
KSC,W  stratum corneum/water partitioning coefficient, predicted: 
= 0.514 LogPow+ 0.104 (alkanols) 
= 0.078 (LogPow
2 + 0.868 LogMW - 2.04 (non-alkanols)) 
a.i. -- 
       volume of the donor cell in the predicted experiment sp.e mL/cm2 
tlag  lag time, predicted using tlag = KSC,W × LSC/6kpSC 0 or a.i. h 
LSC thickness of the stratum corneum, set to a default value 0.002 cm 
kpSC permeation coefficient of the stratum corneum, 
approximated by using the predicted overall k(p) 
 cm/h 
  fraction of not-penetrated dose in donor cell: 
V(don) / (V(SC) x KSC,W  + V(don)) 
a.i.  
         applied dose at start of experiment sp.e mg/cm2 
*a.i. = specific of active ingredient, sp.e = specific for the experiment 
The performance of DAME and the FDSP model was compared by Buist (2016) using a dataset of 15 
chemicals with MW varying between 60 and 391 g/mol and LogPow between 0.17 and 7.7.  
                                               
1 http://www.cdc.gov/niosh/topics/skin/finiteSkinPermCalc.html 
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In general, the predictions by the FDSP model did not correlate well with the measured absorption 
values (R2 = 0.12) and were outperformed by the DAME predictions (R2 = 0.64). Therefore, and 
because it needs less parameters as input, DAME was preferred above the FDSP model for the 
conversion of kp or Jmax in absorption percentages. 
The parameters used in the DAME model to convert predicted kp or Jmax into percentage absorbed are 
listed in Table 2.1 above. 
The percentage of the applied dose that had penetrated into the receptor fluid (%M(rec)) was 
calculated using the following formula: 
            
 
     
      
                
      
Equation 2.5.1 
in which          exposure time in hours. 
The percentage of the dose that had remained in the stratum corneum at the end of the experiment 
       was calculated using the following formula: 
                            
Equation 2.5.2 
The predicted (potential) absorption was subsequently calculated by adding         and       . 
2.5.2 Combinations to improve predictivity 
One of the objectives of the present study was to explore the possibility to combine independent 
models in order to improve predictions. Accordingly, the three models showing the best individual 
correlation were combined in groups of two or three and predicted percentage of absorption was 
calculated either as the average of the two/three individual model predictions, the minimum or the 
maximum2. Predictions were made for the subset of data for which all models were applicable to avoid 
selection bias. Spearman rank correlations were calculated as described below.  
2.6 Input Parameters related to the active substances 
2.6.1 The EFSA dataset 
An Excel file identified as "Human in vitro PPPs Dataset_CONFIDENTIAL.xlsx" was received from EFSA, 
which was essentially identical with the “Human in vitro dermal absorption PPPs dataset” published as 
supporting  information  to the EFSA (2017) Guidance on dermal absorption3. 
The dataset file contains information on in vitro dermal absorption studies performed according to 
OECD test guideline 428 on plant protection products and dilutions thereof. The file is composed of 
6842 records/lines, with each line representing one single replicate of an experimental block. For each 
replicate, information on the identity and basic properties of the active substance, the origin of the 
data, experimental conditions and measured data is provided in the columns. The dataset provides 
experimental information on the dermal absorption of 193 different active substances comprising 29 
different types of formulations, such as SE (Suspoemulsion, 8% of the records), WG (Water-
                                               
2 Combination of single substance model with mixture models is allowed, since the given mixture models reflect the absorption 
of the a.s. and not of each single mixture component (see also 2.7.2.4). 
3 http://onlinelibrary.wiley.com/store/10.2903/j.efsa.2017.4873/asset/supinfo/efs24873-sup-0003-
SupInfo_3.xlsx?v=1&s=a89137554518e850f69d836c219c853f89bd5e6c  (date accessed 19/01/2018), also available at 
http://s3.amazonaws.com/objects.readcube.com/publishers/wiley/original_supplements/2f777ded3499aa2ccd6e3e1cabd5440ab
160b9efff1ae65bf46099fc75a5dee0/efs24873-sup-0003-SupInfo_3.xlsx (date accessed 07/09/2018) 
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dispersible granules, 13% of the records), EC (Emulsifiable concentrate 23%) and SC (Suspension 
concentrate, 30% of the records). 
For the present analysis, the experimental %DA was taken as the sum of the amount directly 
absorbed into the receptor fluid and present in the whole skin by subtracting tape strips 1 and 2. In 
analogy to the statistical evaluation described in EFSA (2017) and in the interest in homogeneity of 
data, completion of absorption indicated by t0.5 above 75% was not considered. An extensive 
description of this dataset is provided in Annex A of the revised EFSA Guidance on Dermal Absorption 
(2017).  
2.6.2 Parameters related to the active substances 
For implementation of the models selected for evaluation as described in section 2.7, additional 
structural, quantum-chemical, and physical-chemical parameters had to be collected or calculated for 
the active substances listed in the EFSA dataset. A summary of the parameter values sources is 
provided in Table 2.2. It was noted that the same descriptor may be calculated with various tools, 
while the method for parameter calculation was not always clearly described in the publication and 
application of different methods would not necessarily result in the same parameter value.  
Table 2.2: Overview of collecting source with descriptors. "Regulatory documents" refers to published 
EFSA conclusions, draft Registration Reports ((d)RR), DAR, Renewal Assessment Reports (RAR) and 
Risk Assessment Committee (RAC) opinions. "N.A." refers to not applicable. 
Parameter 
Experimental values 
source 
Computed values source 
MW: molecular weight EFSA dataset N.A. 
Pow: octanol-water partition coefficient EFSA dataset N.A. 
mLogPow: mixture octanol-water partition 
coefficient (co-formulants) 
Pubchem EPI Suite 
HA/mHA: hydrogen bond acceptor counts 
(also applies to co-formulants) 
Pubchem Molinspiration 
HD: hydrogen bond donor counts Pubchem Molinspiration 
double bonds counts N.A. Instant JChem (IJC) 
triple bonds counts N.A. Instant JChem (IJC) 
aromatic and non-aromatic rings counts N.A. Instant JChem (IJC) 
TPSA/mTPSA: Topological Polar Surface 
Area (also applies to co-formulants) 
Pubchem Molinspiration 
VP: vapour pressure Regulatory documents EPI Suite 
MP: melting point Regulatory documents EPI Suite 
BP: boiling point Regulatory documents EPI Suite 
Saq: water solubility Regulatory documents Instant JChem (IJC) 
Soct: olubility in octanol Regulatory documents N.A. 
pKa Regulatory documents Instant JChem (IJC) 
MV: molecular volume  N.A. Molinspiration 
Ve: Van der Waals volume N.A. Instant JChem (IJC) 
EHOMO: the energy of the highest 
occupied molecular orbital (eV) 
N.A. MOPAC 
ELUMO: the energy of the lowest 
unoccupied molecular orbital (eV) 
N.A. MOPAC 
Qh: the sum of the net atomic charges of 
the hydrogen atoms bound to nitrogen or 
oxygen atoms 
N.A. Instant JChem (IJC) 
QO.N: the sum of the absolute values of 
the net atomic charges of oxygen and 
N.A. Instant JChem (IJC) 
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Parameter 
Experimental values 
source 
Computed values source 
nitrogen atoms which were hydrogen-
bond acceptors 
MR: molar refractivity N.A. Instant JChem (IJC) 
Hα or B: Hydrogen bond acceptor activity 
(summation) 
N.A. 
Abraham Descriptor 
Prediction 
Hd or A: Hydrogen bond donor activity 
(summation) 
N.A. 
Abraham Descriptor 
Prediction 
 
Experimental data on water solubility, solubility in octanol, melting point, boiling point, vapour 
pressure and pka values were collected, when available, from published EFSA conclusions, draft 
Registration Reports ((d)RR), DAR, Renewal Assessment Reports (RAR) and Risk Assessment 
Committee (RAC) opinions. Even though experimental conditions in in vitro dermal absorption studies 
are 32°C, data availability and comparability required to collect most physico-chemical values for 
(20)25 °C and pH7. 
The SMILES codes of the active substances were retrieved from the internal BfR database. The 
SMILES codes were identified by the given active substance name and identity was furthermore 
verified by the given molecular weight. A cross-check was additionally conducted against displayed 
structures from SMILES codes listed in Pubchem public database for a few substances. If no entry was 
found in the internal BfR database for active substance name, a search by name was performed in 
Pubchem public database. In cases where no information was available in Pubchem either, the 
structure of those substances was clarified by google search. Initially, 198 different substance names 
relating to 193 active substances were provided by EFSA in the dataset within the scope of the 
project. During data curation, substance names were harmonized and two substances, for which the 
structure could not be identified unambiguously, were excluded from further analysis (refer to 
Appendix E for further detail). Thus, the final number of structures included in the study was reduced 
to 191.. 
The water solubility (Saq) was calculated using the proprietary software ChemAxon Instant JChem 
(IJC; version 17.22.0)4 with the Solubility Calculator Plugin (version 2017). IJC calculates the intrinsic 
aqueous solubility of the respective substance. The calculation method is based on the article of Hou, 
Xia et al. (2004). This method uses a fragment-based method to estimate the parameter, meaning the 
molecule is divided into fragments and the contribution of these structural fragments to water 
solubility results in the estimated parameter water solubility. The function logS (logS("7.0", "mg/ml")) 
at pH 7.0 was used to calculate water solubility. In cases where two molecules or active substances as 
salt represent the active substance, water solubility was calculated for the active molecule. For 
example, for Aminopyralid-TIPA with SMILES code 
"CC(CN(CC(C)O)CC(C)O)O.C1=C(C(=C(N=C1Cl)C(=O)O)Cl)N", the water solubility was calculated only 
for Aminopyralid (SMILES: C1=C(C(=C(N=C1Cl)C(=O)O)Cl)N) and not for triisopropanolammonium or 
Aminopyralid-TIPA, representing the active substance of interest. This approach was also adopted for 
other active substances listed in the dataset, which consist of two molecules. Unrealistic water 
solubility values were obtained for some active substances, e.g. Aminoethoxyvinylglycine (Aviglycine), 
Trinexapac, Propamocarb HCl, Ethephon and Glyphosate reaching values of 49920.40, 5168.73, 
18137.5, 143720.0 and 1931460.00 mg/L, respectively. Overall, calculated water solubility values 
were higher than the experimental ones. Figure 2.1 illustrates the relationship between predicted and 
reported Saq, which can be described mathematically by a Kendall tau value of 0.534 and Spearman 
rho correlation coefficient of 0.702. Even though a correlation was established, quantitative 
concordance between the experimental (reported) and predicted values was regarded as insufficient 
for the purpose of this study. It was concluded that computed water solubility should be considered of 
                                               
4 2017, ChemAxon http://www.chemaxon.com 
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limited reliability and experimentally values for water solubility should be preferably used for model 
implementation. 
 
 
Figure 2.1: Comparison of the logarithms of the reported water solubility values to those predicted 
using IJC software. 
The calculation of pKa values was performed with the Protonation Plugin (version 2017) in IJC and the 
chemical term pka ("1") for the first strongest pKa value (acidic or basic). 
Where no information on melting point (MP), boiling point (BP) or vapour pressure (VP) were available 
in accessible EFSA conclusions, (d)RR, DAR, RAR, RAC opinions, these parameters were predicted with 
EPI Suite5 using the module MPBPWIN. 
The topological polar surface area (TpSA) is a descriptor associated with the polarity of the molecule, 
specified as the contribution of polar atoms at the surface of a molecule. TpSA values were collected 
from the Pubchem database, when available, and were additionally calculated with Molinspiration6  
based on SMILES codes. The calculation is in both cases based on the method described by Ertl, 
Rohde et al. (2000), where the total polar surface area is the sum of polar surface contributions of 3D 
generated structures of molecules. 
The molecular volume (MV) was calculated with Molinspiration. SMILES codes were entered in the 
command line and the three dimensional volume was calculated based on a group contribution 
method. Geometries were optimised by semi empirical AM1 method. 
The Van der Waals volume (Ve) values were calculated based on the active substances’ SMILES codes 
and 3D geometrical conformers by using the Geometrical Descriptor Plugin of the Structural 
Calculations Plugin (version 2017) in IJC.  
The molar refractivity (MR) was estimated based on SMILES codes by using the Refractivity Plugin of 
the Structural Calculations Plugin (version 2017) in IJC. The computation relies on the atomic method 
published by Viswanadhan, Ghose et al. (1989). 
The number of rings was counted with the Topological Analysis Plugin of the Structural Calculations 
Plugin (version 2017) of IJC. Here ring count means the number of rings per molecule, which is based 
on the Smallest Set of Smallest Rings (SSSR) and is taken from the structure. The number of rings as 
required for the selected model comprises all aromatic and non-aromatic ring systems. This was 
covered by using the ring count function of IJC.  
The number of double bonds per active substance was determined manually from structures 
generated from SMILES codes in IJC. All kinds of double bonds (in conjugated systems and others) 
                                               
5 US EPA. [2018]. Estimation Programs Interface Suite™ for Microsoft® Windows, v 4.11. United States Environmental 
Protection Agency, Washington, DC, USA. 
6 free online Molinspiration property calculation service, available at: http://www.molinspiration.com/cgi-bin/properties 
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were counted as required for the respective model. A potential limitation of this procedure arises from 
the fact that SMILES codes represent only one mesomeric resonance structure. This may be of 
relevance for example for nitro groups occurring in several active substances. For such sub-structures, 
one double bond was counted (SMILES code: [N+](=O)[O-]). 
Hydrogen bond donor HD and acceptor HA counts were registered as reported in the Pubchem public 
database according to the classification published by Wang, Fu et al. (1997). In addition, HA and HD 
values were also calculated with Molinspiration, where the underlying method is based on counting 
oxygen and nitrogen atoms for HA (nON) and OH and NH groups for HD (nOHNH).  
For the implementation of one single substance model the quantum chemical descriptors Qh and 
QO.N were required. Qh is defined as the sum of the net atomic charges of the hydrogen atoms 
bound to nitrogen or oxygen atoms. QO.N relates to the sum of the absolute values of the net atomic 
charges of oxygen and nitrogen atoms which are hydrogen-bond acceptors. Calculation was 
performed using IJC including the usage of the Structural Calculations Plugin (version 2017). In a first 
step, SMILES codes were entered in a new substance field and hydrogen bond acceptors were 
afterwards indicated. Following this, the displaying of partial charges for the input molecule was 
selected. The descriptors were then manually calculated by summation of the respective partial 
charges indicated for the single atoms in the molecule. The reproduction of calculated values by Fu et 
al. (2002) was assessed for three selected substances as shown in Table 2.3. It was observed that 
there can be substantial deviations between Qh and QO.N values calculated in this project and those 
reported by Fu et al. (2002). 
Table 2.3: Comparison of calculated and reported Qh and QO.N values for three selected substances. 
Substance Qh QO.N 
calculated reported calculated reported 
17-Oxo Dexamethasone 0.21 0.6426 1.07 1.5276 
Methyl 4-hydroxybenzoate 0.29 0.2238 0.62 0.8831 
3-Nitrophenol 0.29 0.2277 0.83 0.9531 
 
The hydrogen bond donor/ acceptor activities (Hd or A and Hα or B, respectively) were estimated with 
a free online tool named Abraham Descriptor Prediction7. This model is based on the publication of 
Bradley et.al (2015) "Predicting Abraham model solvent coefficients". The descriptor values were 
predicted using a model derived from the Open Notebook Science Abraham Descriptor data. The 
model returned all the Abraham descriptors including the desired hydrogen bond donor activity and 
hydrogen bond acceptor activity. For each active substance, SMILES codes were needed for 
computation as well as molar volume MV      and molar refractivity      
  
   
  are required input 
parameters and were calculated as described above. For further information on the computation of 
the hydrogen bond donor/ acceptor activities please refer to Appendix F. 
For implementation of single substance models published by Fu, Ma and Liang (2002), EHOMO and 
ELUMO values were needed as input variables. For the training set used by the authors, the AM1 
method was employed for calculation of these values. Accordingly, the AM1 method was also chosen 
to predict EHOMO and ELUMO values for the pesticidal active substances evaluated in this project. 
The software solution MOPAC20168 was preferred for this purpose as this tool is available free of 
charge for non-commercial purposes. SMILES were translated into MOPAC Cartesian format (MOP 
files) using OpenBabel software version 2.4.1 (O’Boyle et al., 2011). During conversion, hydrogens 
were added and the 3D structure was created with coordinated centers. The AM1 Hamiltonian method 
was applied following geometry optimization with symmetry imposed using MOPAC2016 (32 bit-
version 17.279W). In a first step, it was checked whether MOPAC2016 can reproduce the EHOMO and 
ELUMO values calculated by Fu, Ma and Liang (2002) to a satisfactory degree. SMILES codes were 
                                               
7 http://showme.physics.drexel.edu/onsc/models/AbrahamDescriptorsModel001.php 
8 MOPAC2016, James J. P. Stewart, Stewart Computational Chemistry, Colorado Springs, CO, USA, HTTP://OpenMOPAC.net 
(2016) 
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obtained for 12 substances selected from the training set used by Fu et al. (2002) from PubChem 
public database. HOMO/LUMO energies as reported by Fu et al. (2002) and those calculated by the 
method described above were not fully identical (see Appendix F). Nevertheless, for the purpose of 
this project, the level of reproduction was considered sufficient. The same procedure as described 
above was followed for predicting EHOMO and ELUMO for active substances listed in the dataset. 
The collected data is provided within the respective Supporting Information (file name: “Human in 
vitro PPP EFSA dataset with add parameters and predictions.xlsx”). 
2.6.3 Parameters related to test item formulation 
The first step to collect information on the composition of the tested formulations in the characterised 
study reports in the provided EFSA dataset was to collect the identifiers for the tested formulations 
(formulation codes) from the study reports, as far as available. Altogether, 414 different study 
identifiers could be found in the dataset relating to 294 study reports submitted by ECPA and 120 
dermal absorption study reports evaluated by BfR. Two internal databases were searched to support 
the identification of the actually tested formulations in those studies. One database links the study 
identifier to the registration number (in Germany), while the second one links registration number to 
formulation codes. This allowed the collection of 142 formulation codes related to studies (study 
identifiers) reported by ECPA and BfR.  
In some dermal absorption studies, two or more pesticide products were tested and summarised in 
one study report. This resulted in more formulation codes than studies. Study identifiers could be, in 
part, directly linked to national registration numbers for which the study was submitted. To identify 
the actual formulation tested from the registration number (or the product name), all listed 
registration numbers for a given study report were cross-checked in the database whether they match 
to the description of the tested formulation as in the study report. 
In general, formulation codes were specific, e.g. AKD 2023, while in some reports only a universal 
formulation code or trade name was reported, such as Azafenidin 80 WG. Clear linking of the study 
report and tested formulation to the registration number or the product name was rather challenging 
for universal formulation codes and therefore exact matching was not possible in most cases. 
The concentration of active substance in the tested product, as stated in the original study reports, 
was additionally entered to the extended dataset. This information helped identifying the product 
name. Only if the tested formulation in the dermal absorption study could be clearly matched to one 
registration number and product name, the information was added to the EFSA dermal absorption 
dataset file. Overall, it should be noted that a certain degree of uncertainty exists in identifying the 
tested formulation identity. 
As a next step, the formulation composition was collected based on the available formulation codes. 
This included identity and concentration of up to ten co-formulants for each product. Considering the 
available information on a case-by-case basis, the main steps of the search strategy followed are 
summarized below: 
- Search using the formulation code names available ( in CIRCABC, Post Annex I data) for any 
relevant Registration Report (RR) available.  
- If no RR was identified as relevant based on the code name provided in the EFSA dermal 
absorption dataset, while there is a Registration number available, a google search was 
conducted to obtain any other useful information (e.g. any synonymous trade names of the 
formulation). 
- If still no RR was identified as relevant, the EFSA dms database (Active Substance 
Assessments Workspace) was visited to check the availability of a relevant Draft Assessment 
Report (DAR) or Renewal Assessment Report (RAR) and whether the formulation of interest 
has been evaluated in the remit of a.s. assessment. 
- Finally, the BPI archive was checked. 
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In cases where a report (RR or DAR/RAR) was identified as relevant, a further search was conducted 
for the "Study identifier" in the detailed evaluation of the dermal absorption for the specific 
formulation. This aimed to further confirm that the composition retrieved as relevant was indeed the 
one of the formulation used in the dermal absorption study. It is noted, however, that in most cases 
the coding used for the study references was different that the one in the EFSA dataset.  
When no RR was identified for the specific code name, the availability of evaluations for similar 
formulations was further checked. In some cases, it was found that the dermal absorption study of 
interest has been used for the assessment of a different formulation and thus the detailed composition 
of the formulation used was included in the RR of another product. 
Following the search strategy described above, it has frequently not been possible to identify the 
formulation used in the study recorded in the database. This affected 4881 records out of 6842 in 
total. Records without formulation data concerned about 288 studies (140 active substances). 
Excluding the above studies, it was concluded that a detailed search was possible only for 140 
formulations (corresponding to 1961 of 6842 records in the EFSA dermal absorption dataset 
provided). 
Overall, the exact composition for 75 formulations was retrievable: 
- for 68 formulations a relevant Registration Report (RR) – Part C has been identified in the 
CIRCABC,  
- for 4 formulations although no relevant RR was identified in the CIRCABC it was found that 
the required formulation composition was included in the RAR (Volume 4) for the a.s. 
available in EFSA dms. 
- For 3 formulations, no RR was available in any of the above data sources, but the composition 
details were retrieved from the relevant dossier available in BPI. 
For the remaining 65 formulations, no RR/DAR/RAR was available in CIRCABC/EFSA dms which 
included information for the specific code. It was not possible to conclude whether any other product 
could be considered as relevant/similar. Detailed information on the outcome of the search for 140 
formulations is available upon request at EFSA. 
The final step towards the full characterization of the tested formulations was the collection or 
computation of physical-chemical descriptors associated with the identified co-formulants. In analogy 
to the active substances, SMILES codes were required for all co-formulants/co-formulant substances 
to further calculate physical-chemical descriptors. Notably, co-formulants frequently represented 
mixtures of two or more chemical substances. In addition, different co-formulant names were used 
across the product range to identify the same or similar (mixture of) chemical substance(s). 
Therefore, the following approach was chosen: 
1. One CAS / SMILES / set of parameters was used when more than one chemical names were 
used to identify the same co-formulant having one structure and one CAS. 
2. One CAS / SMILES / set of parameters was used when different CAS numbers were used for 
co-formulants with the same name (and identical SMILES). 
3. Co-formulant entries were split into different components and information was collected for 
each of these components when the co-formulant name described a mixture of different 
components. 
Grouping of co-formulants that are essentially identical reduced the number to 201 structural 
representations. In some cases, co-formulant codes as provided in RR and RARs did not allow to 
unambugiously identify the exact chemical composition. In these cases, assumptions were made 
based on experience and similarity to related co-formulants. 
For the implementation of the selected "mixture models", information on the topological polar surface 
area (TpSA), hydrogen bond acceptor count (HA) and octanol-water partition coefficient (LogPow) 
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were needed. Publicly available information on these three descriptors was collected from the 
Pubchem database. Whenever the co-formulants were not directly found in Pubchem with the 
reported names, an additional ChemIDplus search was performed with CAS to find other systematic 
names or synonyms. Additionally, all three descriptors were calculated with EPI Suite (LogPow) and 
Molinspiration (TpSA, HA) by using the respective SMILES codes. Further details on the computation 
of the physical-chemical descriptors are provided in 2.6.2. 
It is to be noted that during a quality control of the database, the information on the concentration of 
the a.s. in the product was occasionally not identical to the information on concentration of the 
concentrate that was tested. This may be related to pre-application modification or experimental 
variability rather than data entry error. 
2.7 Implementation of Models 
In this chapter, short descriptions of the selected models and their corresponding implementation in 
the remit of the present study are outlined. It needs to be noted, that the models were not applicable 
for all the records/replicates provided in the EFSA dataset. This is due to restricted availability of 
experimental data for some records as provided in the dataset, or due to violation of models’ 
fundamental assumptions in some cases. For example, the kp-%DA-transformation model, DAME, is 
by definition not applicable to non-liquids. For more thorough explanations on the applicable records 
and the derived model sub-versions, please refer to Appendix G. 
Predicted %DA was taken as the sum of % predicted in the receptor fluid and the stratum corneum, 
except for model 7, where the model allowed reporting of the predicted %DA as the sum of % 
absorbed systemically, in the stratum corneum, viable epidermis, and dermis.  
Predicted values as well as mixture factors computed based on the information on the composition are 
provided within the Supporting Information (file name: “Human in vitro PPP EFSA dataset with add 
parameters and predictions.xlsx”). 
2.7.1 Single Substance Models 
2.7.1.1 Model 1 – Frasch 2002 
Model description 
The Frasch model is a so called random walk model, taking into account the heterogeneous nature of 
the stratum corneum. It considers two distinct layers: the proteinaceous corneocytes and the lipid 
layer in between them (Frasch 2002). 
Model implementation 
The following formulas derived from (Frasch 2002) are used to predict kp, expressed in cm/h: 
                      
Equation 2.7.1 
in which      permeation constant of the epidermis, set to 0.1151 cm/h, as postulated by Frasch 
(2002) and      permeation constant of the stratum corneum, expressed in cm/h, which is predicted 
using the following formulas: 
         
 
  
 
Equation 2.7.2 
in which      membrane (skin)/vehicle partition coefficient,   diffusivity of the stratum corneum, 
expressed in cm2/h, and     the effective path length of diffusion in the stratum corneum, in cm. 
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    is predicted using the following QSAR: 
                            
Equation 2.7.3 
in which     is the octanol/water partition coefficient of the active substance. 
  is calculated using the following formula: 
      
            
    
 
                                         
                           
                
Equation 2.7.4 
in which      = the diffusivity of the corneocytes, in cm
2/h;      = the diffusivity of the lipid layer of 
the stratum corneum, in cm2/h. 
         is the corneocyte/lipid layer partition coefficient, which is predicted using the following QSAR: 
                                    
Equation 2.7.5 
Also              is predicted with a QSAR: 
                        
Equation 2.7.6 
in which MW is the molecular weight of the active substance. 
To conclude, the effective path length (  ) is calculated using the following formula: 
                                                        
                          
 
  
Equation 2.7.7 
For lipophilicity (LogPow) and molecular weight (MW) experimental values were used, as provided by 
the EFSA dataset. The permeability coefficient kp was then transformed to %DA by feeding the 
predicted kp values to the DAME model (Buist et al. 2010 and Buist 2016). For implementation of the 
DAME model please refer to section 2.5.1. 
2.7.1.2 Model 2 – Potts & Guy 1992 
Model Description 
The classical kp prediction model of Potts and Guy (Potts & Guy, 1992) was developed based on 
measured kp values collected by Flynn (1990).  
Model Implementation 
The model was used by implementing the formula provided in the original publication: 
      
  
 
                             
 
   
  
Equation 2.7.8 
The algorithm described in Equation 2.7.8 was implemented in a separate Excel sheet. For lipophilicity 
(LogPow) and molecular weight (MW) experimental values were used, as provided by the EFSA dataset 
described in section 2.6.1. The permeability coefficient kp was converted to cm/h by multiplying it with 
3600 and then transformed to %DA by feeding the predicted kp values to the DAME model (Buist et 
al. 2010 and Buist 2016). For implementation of the DAME model please refer to section 2.5.1. This 
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additional computation step yielded two results since two different      scenarios were considered 
(    =0;     = calculated). 
2.7.1.3 Model 3 – Magnusson 2004 
Model Description 
A collection of published data for human skin epidermal permeation was used to define the 
relationship between the solute      and solute physical-chemical properties. First, an algorithm was 
developed with training data on experimental maximum flux from aqueous solutions and it was 
validated with experimental data for full- and split-thickness skin, ionized solutes, pure solutes and 
solutes in propylene glycol vehicle. Linear regression revealed that the molecular weight (MW) was 
the dominant determinant for the training set under consideration (n=87). Stepwise inclusion of 
additional parameters such as solubility in octanol, melting point, and hydrogen bond acceptor 
capability (also known as hydrogen bond acceptor activity    or B) only marginally improved the 
regression. After validating the initially derived equation with the subsets described above (r² ranging 
from 0.282 to 0.784), linear regression was performed with the training and validation datasets 
merged together (n=278) to derive the final equation:  
         
   
     
                    
 
   
            
Equation 2.7.9 
Model Implementation 
In the present study, Equation 2.7.9 was used to calculate the maximum flux     . In order to obtain 
%DA values, the maximum flux      needed to be transformed to   . This was done by dividing the 
         by the water solubility     according to the following formula referenced in the paper: 
   
    
   
 
Equation 2.7.10 
Where    is expressed in cm/h ,      in 
   
     
 ,     in mol/l.  
Since     is captured in the database in mg/l , it needs to be converted to     in       according to 
the following calculation: 
            
          
          
      
Equation 2.7.11 
Consequently, the following formula was used for the final calculation of   : 
   
       
   
  
       
            
  
       
   
  
      
          
  
       
   
      
  
 
  
Equation 2.7.12 
With      corresponding to the one in the database expressed in mg/l. 
Experimental values were used for molecular weight (  ) throughout all calculation steps. For water 
solubility (          ) experimental data from publicly available regulatory documents - EFSA 
conclusion, draft Registration Report ((d)RR), Draft Assessment Report (DAR), Renewal Assessment 
Report (RAR) and Risk Assessment Committee (RAC) Opinion - were used, where available. It was 
noticed that the retrieved experimental data on the water solubility are not covering all substances in 
the scope of the study. For that reason, the whole simulation was rerun with solely computed data 
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derived from Instant JChem (for methodology see section 2.6.2). This way, two different    values 
were computed for each record, one solely based on experimental input parameters (  ,     ) and 
one with experimental    and computed    . The rationale behind this decision is that this way 
evaluation of the model is possible under two scenarios: when experimental physical chemical values 
are readily available and when not. 
By translating    into %DA, the two different     values were fed into a model where two different 
     scenarios were considered (    =0;     = calculated), which in turn yielded four different %DA 
values. For more detailed explanation of the   -%DA transformation please refer to the description of 
the DAME model in section 2.5.1. 
2.7.1.4 Model 4 – Fu 2002 Algorithmic solution 
Model Description 
The Abraham dataset (Abraham et al., 1997) was used to construct two skin permeability models: an 
algorithm and an Artificial Neural Network (ANN) model (ANN explained in 2.7.1.5). Both models are 
based on the same input parameters: 
i. MV , which is the molecular volume and is given in                     
ii.    , which is the sum of net atomic charges of hydrogen atoms attached to oxygen or 
nitrogen atoms  
iii.     , which is the sum of the absolute values of the net atomic charges of oxygen and 
nitrogen atoms which were hydrogen bond acceptors 
iv.       , which is the energy of the highest occupied molecular orbital and is expressed in eV 
v.       , which is the energy of the lowest unoccupied molecular orbital and is expressed in eV. 
The algorithmic model was developed by simple linear regression and is defined as follows: 
      
  
 
                                                               
       
Equation 2.7.13 
Model Implementation 
In the present study, the algorithmic model was implemented according to Equation 2.7.13 in a 
separate Excel sheet added to the EFSA dataset file. For the description of the computation of the 
necessary parameters for model implementation please refer to section 2.6.2. 
Similarly to the other models, the calculated    was translated to %DA using DAME as described in 
section 2.5.1, yielding two different %DA values, since two different      scenarios were considered 
(    =0;     = calculated). 
2.7.1.5 Model 5 – Fu 2002 Artificial Neural Network (ANN) 
Model Description 
The Fu et al. (2002) Artificial Neural Network (ANN) model is a four layer network that includes an 
input layer, two hidden layers, and an output layer. The description of the input layer (input 
parameters) is provided in section 2.7.1.4. The two hidden layers both consist of 4 neurons and the 
output layer of a single neuron, the permeability coefficient      . The ANN was initially trained with 
45 input-output datasets for 100000 cycles and was validated by prediction of the       values of 8 
additional compounds outside of the training set (mean prediction error 2.6%). In comparison to the 
respective algorithmic regression model (see 2.7.1.4) the ANN showed better predictive capacity. 
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Model Reconstruction and Implementation 
The feedforward artificial neural network (ANN) model was reconstructed on the basis of the training 
set published in the paper. The reconstruction was realized in MATLAB 2016b using Neural Network 
Toolbox, with 5 inputs, 20 hidden layers, and an output. The inputs and outputs correspond to the 
same variables used in the Fu ANN model. The correlation between observed and calculated kp using 
the original and the reconstructed ANN model is high (r2 = 0.99 in both cases) and the concordance is 
good (RMSE for log kp = 0.12 and 0.10, respectively). Also the concordance between the predictions 
by Fu et al. and the reconstructed model is good (RMSE = 0.12). While the Fu et al. model provides a 
good prediction of the test set (r2= 0.98, RMSE = 0.16), the reconstructed model performs less well 
(r2= 0.79, RMSE = 0.69). This is mainly due to one outlier (corticosterone) (see Figure 2.2). 
 
Figure 2.2: Prediction of the test data set by Fu et al. (2002) and the reconstructed ANN.  
 
This trained ANN model was further used to estimate the value of       given the input values: MV, 
Qh, QO.N, EHOMO, and ELUMO for 190 sets of a.s. data from the EFSA dataset. Aminopyralid-
Olamine corresponding to 24 individual records was excluded. For molecular volume, the van der 
Waals volume was used. 
Similarly to the other models, the calculated    was translated to %DA using DAME as described in 
section 2.5.1, yielding two different %DA values, since two different      scenarios were considered 
(    =0;     = calculated). 
2.7.1.6 Model 6 – Milewski 2012 
Model Description 
The starting point for the development of the Milewski et. al (2012) model was Fick’s first law of 
diffusion, where, for aqueous formulations, the maximum transdermal flux          can be expressed 
as: 
                        
Equation 2.7.14 
By using the "classical" Potts & Guy (1992) algorithm for estimation of      
9 and the general 
solubility equation by Yalkowsky and Valvani (1980)10, a generic algorithm that relates          with 
lipophilicity       , molecular weight   , and melting point    was derived:  
                                               
9
                                         , see also Equation 2.7.8 (transformed) 
10
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Equation 2.7.15 
Equation 2.7.15 served as a basis for multiple linear regression with the training set (n=87) described 
in Magnusson et al. (2004) (see also 2.7.1.3). The training dataset comprised compounds spanning 
over a broad range of physical-chemical properties:        (-4.67 to 4.52),    (18 to 477) and    
(for liquids to 293 °C). The derived model (r²=0.90) was validated with the validation set (n=121) 
described by Magnusson et al. (2004) (see also 2.7.1.3). The training and validation datasets were 
merged and were used to derive the final algorithm by linear regression analysis: 
         
    
     
                               
 
   
                         
Equation 2.7.16 
Model Implementation 
Equation 2.7.16 was applied to derive values for the maximum flux, where, by definition of the model, 
   is to be set at 25°C for liquid permeants. Differentiation between liquid and non-liquid permeants 
was made by consulting the definitions in Table B.2 of the EFSA (2017) Guidance on dermal 
absorption. For WP, WG, WDG, SG, SP, GEL, a differentiation between liquid and non-liquid was done 
by relating the formulation type to the tested concentration (concentrate/dilution). For these 
formulation types the concentrate was taken as non-liquid and the dilutions thereof as liquid. For all 
other formulation types that are identified in the table as non-liquids (RB, Pellet Bait, Wax Block, Pasta 
Bait, Pellets, PS, DS) no such differentiation was made, since these are not to be further diluted. This 
resulted into the identification of 6249 cases as liquids and 517 as non-liquids and 42 as "not-clear". 
Setting the melting point at 25°C for liquid permeants results into not taking this parameter into 
consideration for the calculation of         , meaning that Equation 2.7.16 above remains as it is for 
non-liquids and becomes for liquids: 
         
    
     
                               
 
   
  
Equation 2.7.17 
Experimental values, as registered in the EFSA dataset, were used for molecular weight    and 
lipophilicity        throughout all calculation steps. Experimental values were used for the melting 
point   , when available, as retrieved from publicly available regulatory documents - EFSA 
conclusion, draft Registration Report ((d)RR), Draft Assessment Report (DAR), Renewal Assessment 
Report (RAR) and Risk Assessment Committee (RAC) Opinion. In the absence of experimental data for 
the melting point – corresponding to 2.3% of the total data under evaluation, computed data from EPI 
Suite were considered (see Table 2.4). 
Similarly to the Magnusson model,          had to be converted into    by dividing the          by 
the water solubility     (see section 2.7.1.3), and consequently    had to be transformed to %DA via 
the DAME model. This, as also described in section 2.7.1.3, yielded in total four different %DA values: 
two different    values for each record, one solely based on experimental input values for      and 
one on computed    , combined with two scenarios for      in DAME (refer to section 2.5.1 for 
description of DAME model). 
Considering the fact that, by definition, DAME is applicable only to liquid permeants, all non-liquid 
         (and therefore   ) values that were calculated by Equation 2.7.16 were not accounted for in 
the final calculations of %DA. Thus, the absorption values presented for this model combination 
(Milewski-DAME) are based on          /    values that are derived by Equation 2.7.17, so that in the 
end the contributions of the melting point are not taken into account for the predictions. To explore 
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the role of the melting point for the predictions on the EFSA dataset, the model was rerun based on 
Equation 2.7.16 without distinguishing between liquids and non-liquids. 
 
Table 2.4: List of a.s. for which no experimental information were available on the Melting Point and 
computed values form EPI Suite were used. 
Active substance name 
Melting Point [°C] 
(experimental, public source) 
Melting Point [°C] 
(EPI Suite) 
2,4-D EHE (2-ethylhexyl 2-(2,4-
dichlorophenoxy)acetate) 
NA 121.30 
Flupyrsulfuron methyl NA 248.61 
Indaziflam NA 177.65 
Iofensulfuron-sodium NA 330.76 
Metosulam NA 232.08 
Quinoxyfen NA 148.09 
Triclopyr (TEA) NA 135.20 
 
2.7.1.7 Model 7 – Dancik / NIOSH model 
Model Description 
The NIOSH model described by Dancik et al. (2013) is a transient model simulating bioavailability of 
chemicals from dermal exposure. The skin is treated as a slab of three different components, for 
which various kinetic parameters are estimated: the stratum corneum (SC), the viable epidermis (VE) 
and the dermis. The SC can be either partially or fully hydrated. The SC follows the two dimensional 
brick and mortar structure, which is composed of lipid and aqueous phases, along with corneocytes, 
which are composed of proteinic and aqueous phases.  
The model is a spreadsheet-based model developed by the University of Cincinnati and The National 
Institute for Occupational Safety and Health (NIOSH) of the U.S. Centers for Disease Control and 
Prevention (CDC). In addition, a Java tool was created and made available as "The Finite Dose Skin 
Permeation Calculator"11. 
Model Implementation 
It was not possible to execute the java applet provided on the website. However, the original Excel™ 
spreadsheet and associated add-ins identified as "Finite Dose Skin Permeation Calculator"12, along 
with all the necessary ﬁles and an instruction sheet to run the code in the Excel/VB format was 
provided by the University of Cincinnati. The batch version of the Calculator13 was also provided by 
the model creators and used for final predictions. 
Subset selection 
Implementation of this model proved far more time consuming than for the other models. Therefore, 
it was decided to apply the model only on a subset consisting of 48 out of the 191 available pesticide 
active substances within the EFSA dataset. The selected subset is the result of the integration of three 
smaller subsets which were derived based on the following criteria: 
SUBSET 1 (14 active substances): Priority was given to substances for which experimental data were 
retrievable for all the model input parameters (see chapter 2.6.2). This applies to the following 
physical-chemical descriptors: No. of rings, No. of double bonds, Molecular Weight (g/Mol), LogPo/w, 
                                               
11 https://www.cdc.gov/niosh/topics/skin/finiteskinpermcalc.html 
12 4-Case 3-Layer (4C3L) Diffusion Model Parameters, Version: 2.1, Spreadsheet update: 20/8/2014 
13 4C3L M.A. Miller/G.B. Kasting, Spreadsheet update: 22/7/2015 
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Melting Point [°C], Boiling Point [°C], Vapour Pressure [Pa at 25°C], pKa at 20 °C, Water solubility 
[mg/L at pH 7 and 20/25 °C], Solubility in octanol [g/L at 20/25 °C]. This criterion was set in order to 
minimise the use of calculated values and therefore the risk of introducing additional uncertainty in 
the computation.  
SUBSET 2 (9 active substances): Another criterion for the selection of substances was the availability 
of data on formulation composition, as retrieved during the data collection process on co-formulants. 
The idea behind this approach was to allow comparison of the predicted values from the NIOSH model 
(single substance model accounting for some vehicle effects) to the predictions made using mixture 
models. Note that two of such substances (cyflufenamid and cyprodinil) were already included in 
SUBSET 1. 
SUBSET 3 (25 active substances): From the remaining 170 a.s.14, another 25 a.s. were selected after 
considering the upper and lowest extremes (minimum/maximum) and medians of all relevant input 
parameters. 
Adequate representativeness of the final combined subset (SUBSET 1 & SUBSET 2 & SUBSET 3) in 
comparison to the total EFSA dataset (191 a.s.) was verified graphically (histograms) and via 
descriptive statistics. 
Implementation 
For efficiency reasons, the batch version of the Calculator was used when a group of substances was 
tested simultaneously. Input data were added for each compound in the following spreadsheets: 
"Phys", "struct", "dose", "environ", "misc". 
 
The "Phys" spreadsheet contained information on the Physical Properties of each substance: 
 
 
Figure 2.3: Example of completion of the "phys" spreadsheet. 
 
  
                                               
14 Total - SUBSET 1 - SUBSET 2 + 2 common a.s. from SUBSET 1 & SUBSET 2 = 191-14-9+2 = 170 a.s. 
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The "struct" spreadsheet contained information on the Structural Properties of each substance:  
 
Figure 2.4: Example of completion of the "struct" spreadsheet.  
 
The "dose" spreadsheet contained information on the Dose / Regimen of each substance: 
 
Figure 2.5: Example of completion of the "dose" spreadsheet.  
 
4-Case 3-Layer Diffusion Model Parameters
Structural Properties C11 H10 O3
Compound MW Ring
Name Abbrev g/mol C H N O S Br Cl F I P = ≡ Systems
Amisulbrom 271 466.3 13 13 5 4 2 1 1 10 0 3 FALSE FALSE
Amisulbrom 272 466.3 13 13 5 4 2 1 1 10 0 3 FALSE FALSE
Amisulbrom 273 466.3 13 13 5 4 2 1 1 10 0 3 FALSE FALSE
Amisulbrom 274 466.3 13 13 5 4 2 1 1 10 0 3 FALSE FALSE
Amisulbrom 275 466.3 13 13 5 4 2 1 1 10 0 3 FALSE FALSE
Amisulbrom 276 466.3 13 13 5 4 2 1 1 10 0 3 FALSE FALSE
Amisulbrom 277 466.3 13 13 5 4 2 1 1 10 0 3 FALSE FALSE
Amisulbrom 278 466.3 13 13 5 4 2 1 1 10 0 3 FALSE FALSE
Amisulbrom 279 466.3 13 13 5 4 2 1 1 10 0 3 FALSE FALSE
Amisulbrom 280 466.3 13 13 5 4 2 1 1 10 0 3 FALSE FALSE
Amisulbrom 281 466.3 13 13 5 4 2 1 1 10 0 3 FALSE FALSE
Amisulbrom 282 466.3 13 13 5 4 2 1 1 10 0 3 FALSE FALSE
Amisulbrom 283 466.3 13 13 5 4 2 1 1 10 0 3 FALSE FALSE
Amisulbrom 284 466.3 13 13 5 4 2 1 1 10 0 3 FALSE FALSE
Amisulbrom 285 466.3 13 13 5 4 2 1 1 10 0 3 FALSE FALSE
Amisulbrom 286 466.3 13 13 5 4 2 1 1 10 0 3 FALSE FALSE
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4-Case 3-Layer Diffusion Model Parameters
Dose/Regimen Amount of Immobile 
Compound Vehicle
Compound Applied Applied
Name Abbrev µg/cm2 mg/cm2
Boscalid 470 11.3 9.99
Boscalid 471 11.3 9.99
Boscalid 472 11.3 9.99
Boscalid 473 11.3 9.99
Boscalid 474 11.3 9.99
Bromoxynil phenol 511 2507 7.52
Bromoxynil phenol 512 2507 7.52
Bromoxynil phenol 513 2507 7.52
Bromoxynil phenol 514 2507 7.52
Bromoxynil phenol 515 2507 7.52
Bromoxynil phenol 516 4.72 10.04
Bromoxynil phenol 517 4.72 10.04
Bromoxynil phenol 518 4.72 10.04
Bromoxynil phenol 519 4.72 10.04
Chlorantraniliprole 585 1862 7.45
Chlorantraniliprole 586 1862 7.45
Chlorantraniliprole 587 1862 7.45
Chlorantraniliprole 588 1862 7.45
Chlorantraniliprole 589 1862 7.45
Chlorantraniliprole 590 1862 7.45
Chlorantraniliprole 591 4.48 5.97
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The "environ" spreadsheet contained information on the Skin Properties: 
 
Figure 2.6: Example of completion of the "environ" spreadsheet. 
 
The "misc" spreadsheet contained Miscellaneous information on each substance: 
 
Figure 2.7: Example of completion of the "misc" spreadsheet.  
  
4-Case 3-Layer Diffusion Model Parameters M.A. Miller/G.B. Kasting 22/7/2015 version
Skin Properties
Species: Output Parameters
maximum duration of simulation 24 hours  
Hydration State: set concentration enter on "misc" sheet
pH
43.4 µm 5.0
100 µm 7.4
300 µm 7.4 minimum output step size 10 minutes  
in vivo  or in vitro  ? maximum step size 5 hours
Environmental Parameters  
For variable SC diffusivity, see the SC sheet. Surface Temperature 32 ˚C  
Wind Velocity 0.17 m/s
occlusion not active yet
Click here for 
default 
thicknesses
viable epidermis
dermis
Flux Plot
Cumulative Amount Plot
Concentration Profiles
4-Case 3-Layer Diffusion Model Parameters
Compounds CAS number Formula Class SMILEs
Amisulbrom 348635-87-0 C13 H13 N5 O4 S2 Br F Pesticide CN(C)S(=O)(=O)n1cnc(n1)S(=O)(=O)n1c(C)c(Br)c2ccc(F)cc12
Amisulbrom 348635-87-0 C13 H13 N5 O4 S2 Br F Pesticide CN(C)S(=O)(=O)n1cnc(n1)S(=O)(=O)n1c(C)c(Br)c2ccc(F)cc12
Amisulbrom 348635-87-0 C13 H13 N5 O4 S2 Br F Pesticide CN(C)S(=O)(=O)n1cnc(n1)S(=O)(=O)n1c(C)c(Br)c2ccc(F)cc12
Amisulbrom 348635-87-0 C13 H13 N5 O4 S2 Br F Pesticide CN(C)S(=O)(=O)n1cnc(n1)S(=O)(=O)n1c(C)c(Br)c2ccc(F)cc12
Amisulbrom 348635-87-0 C13 H13 N5 O4 S2 Br F Pesticide CN(C)S(=O)(=O)n1cnc(n1)S(=O)(=O)n1c(C)c(Br)c2ccc(F)cc12
Amisulbrom 348635-87-0 C13 H13 N5 O4 S2 Br F Pesticide CN(C)S(=O)(=O)n1cnc(n1)S(=O)(=O)n1c(C)c(Br)c2ccc(F)cc12
Amisulbrom 348635-87-0 C13 H13 N5 O4 S2 Br F Pesticide CN(C)S(=O)(=O)n1cnc(n1)S(=O)(=O)n1c(C)c(Br)c2ccc(F)cc12
Amisulbrom 348635-87-0 C13 H13 N5 O4 S2 Br F Pesticide CN(C)S(=O)(=O)n1cnc(n1)S(=O)(=O)n1c(C)c(Br)c2ccc(F)cc12
Azoxystrobin 131860-33-36 C22 H17 N3 O5 Pesticide CO\C=C(/C(=O)OC)c1ccccc1Oc1cc(Oc2ccccc2C#N)ncn1
Azoxystrobin 131860-33-36 C22 H17 N3 O5 Pesticide CO\C=C(/C(=O)OC)c1ccccc1Oc1cc(Oc2ccccc2C#N)ncn1
Azoxystrobin 131860-33-36 C22 H17 N3 O5 Pesticide CO\C=C(/C(=O)OC)c1ccccc1Oc1cc(Oc2ccccc2C#N)ncn1
Azoxystrobin 131860-33-36 C22 H17 N3 O5 Pesticide CO\C=C(/C(=O)OC)c1ccccc1Oc1cc(Oc2ccccc2C#N)ncn1
Azoxystrobin 131860-33-36 C22 H17 N3 O5 Pesticide CO\C=C(/C(=O)OC)c1ccccc1Oc1cc(Oc2ccccc2C#N)ncn1
Azoxystrobin 131860-33-36 C22 H17 N3 O5 Pesticide CO\C=C(/C(=O)OC)c1ccccc1Oc1cc(Oc2ccccc2C#N)ncn1
Azoxystrobin 131860-33-36 C22 H17 N3 O5 Pesticide CO\C=C(/C(=O)OC)c1ccccc1Oc1cc(Oc2ccccc2C#N)ncn1
Azoxystrobin 131860-33-36 C22 H17 N3 O5 Pesticide CO\C=C(/C(=O)OC)c1ccccc1Oc1cc(Oc2ccccc2C#N)ncn1
Azoxystrobin 131860-33-36 C22 H17 N3 O5 Pesticide CO\C=C(/C(=O)OC)c1ccccc1Oc1cc(Oc2ccccc2C#N)ncn1
Azoxystrobin 131860-33-36 C22 H17 N3 O5 Pesticide CO\C=C(/C(=O)OC)c1ccccc1Oc1cc(Oc2ccccc2C#N)ncn1
Azoxystrobin 131860-33-36 C22 H17 N3 O5 Pesticide CO\C=C(/C(=O)OC)c1ccccc1Oc1cc(Oc2ccccc2C#N)ncn1
Azoxystrobin 131860-33-36 C22 H17 N3 O5 Pesticide CO\C=C(/C(=O)OC)c1ccccc1Oc1cc(Oc2ccccc2C#N)ncn1
Azoxystrobin 131860-33-36 C22 H17 N3 O5 Pesticide CO\C=C(/C(=O)OC)c1ccccc1Oc1cc(Oc2ccccc2C#N)ncn1
Azoxystrobin 131860-33-36 C22 H17 N3 O5 Pesticide CO\C=C(/C(=O)OC)c1ccccc1Oc1cc(Oc2ccccc2C#N)ncn1
Azoxystrobin 131860-33-36 C22 H17 N3 O5 Pesticide CO\C=C(/C(=O)OC)c1ccccc1Oc1cc(Oc2ccccc2C#N)ncn1
Boscalid 188425-85-20 C18 H12 N2 O Cl16 Pesticide Clc1ccc(cc1)-c1ccccc1NC(=O)c1cccnc1Cl
Boscalid 188425-85-20 C18 H12 N2 O Cl16 Pesticide Clc1ccc(cc1)-c1ccccc1NC(=O)c1cccnc1Cl
Boscalid 188425-85-20 C18 H12 N2 O Cl16 Pesticide Clc1ccc(cc1)-c1ccccc1NC(=O)c1cccnc1Cl
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Special considerations were made on the following areas: 
a) Vehicle settings 
Although the NIOSH model is a simple model, information on the vehicle is still required. For all 
dilutions, the vehicle was assumed to be water. For concentrates, vehicle selection was dependent on 
the formulation category. The different formulation types considered in this project were grouped into 
four broad categories (Table 2.5) as recommended in table B.2 of the EFSA Guidance on dermal 
absorption (EFSA, 2017): 
Table 2.5: Product formulation and selection of vehicle and vehicle properties for implementation of 
model 7. 
Formulation categories 
Formulation 
type* 
Vehicle Volatility 
Mobile / 
Immobile 
(1) organic solvent-based EC, EW, SE, OD, 
ME 
Octanol Non-volatile Immobile 
(2) water-based SL, SC, FS, FL Water Non-volatile Immobile 
(3) solid WP, WG, SG, SP Water Non-volatile Immobile 
(4) other CS Water Non-volatile Immobile 
CB, RB, WB, PB, P Neat NA NA 
Al, NS NA NA NA 
* Abbreviations as indicated in the EFSA Guidance on dermal absorption (EFSA, 2017): Emulsifiable concentrate, EW: 
Emulsion/oil in water, SE: Suspo-emulsion, OD: Oil-based suspension concentrate, ME: Microemulsion, SL: Soluble concentrate, 
FS: Flowable concentrate for seed treatment, FL: Flowable, WP: Wettable powder, WG/WDG: Water-dispersible granules, SG: 
Water-soluble granules, SP: Water-soluble powder, DS: Powder for dry seed treatment, CS: Capsule suspension. 
Additional abbreviations not included in the EFSA Guidance on dermal absorption (EFSA 2017): Al: Experimental solution of 
active substance in solvent CB: Bait concentrate, NS: Not specified, RB: Bait/ready for use, WB: Wax block, PB: Pasta Bait, P: 
Pellets. NA: not applicable.Additional formulation types that did not fit in Categories 1-3 were assigned in Category 4. 
 
For vehicle selection, it was considered that the vehicle could be either immobile or highly volatile 
according to the definitions described by Dancik et al. (2013): 
"A vehicle containing immobile components (i.e., none of it is depleted from the skin surface by either 
evaporation or penetration into the skin) or highly volatile components (which evaporate 
instantaneously) may be simulated. When deciding on whether a vehicle component is best modelled 
as immobile or highly volatile, the user should not only consider the physical and structural properties 
of the component, but also the degree to which the donor solution is occluded, the amount of airﬂow 
over it, and the volume of the headspace. Partial occlusion affects the evaporation of the permeant as 
well, and the wind velocity should be appropriately adjusted in that case." 
 
Considering these definitions, the following assumptions were made for vehicle selection: 
- Category 1 - organic solvent-based formulations 
Octanol was selected as an appropriate vehicle, since measured data for the solubility in octanol were 
available for the selected a.s.. Although octanol is ordinarily volatile (VP=8.7 Pa at 20°C), it was 
assumed to be an immobile vehicle, since evaporation is typically prevented by occlusion. In this case, 
as described by Dancik et al. (2013), the vehicle/water partition coefficient (Kv/w) is estimated by 
considering the ratio of solubility in octanol divided by the solubility in water. No correction for vehicle 
ionisation is performed in the model and thus no details on pH are required. Therefore, for organic 
solvent-based formulations an occluded system and fully hydrated skin conditions were considered. 
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- Category 2 - water-based formulations 
It is reasonable to assume that the vehicle is primarily water. Dancik et al. (2013) suggest that water 
can be either considered a volatile or non-volatile vehicle. Under occlusive conditions (immobile 
vehicle) water may be taken as non-volatile since evaporation is prevented by occlusion. In this case, 
the non-ionised permeant in the vehicle is estimated and the vehicle/water partition co-efficient (Kv/w) 
is corrected for ionisation (Dancik et al., 2013).  
In any case, under occlusive conditions, water volatility has low impact. As a trial, the NIOSH model 
was run for azoxystrobin SC formulation (concentrate) under occlusive conditions considering water to 
be (i) volatile and (ii) non-volatile. The results obtained were comparable with predictions for 
Maximum Absorptive Flux (µg/cm2 x h) of 0.00385 and 0.00383, and for Systemically Absorbed (%) of 
0.00673 and 0.00673, respectively. Thus, for water-based formulations an occluded system and fully 
hydrated skin conditions were considered. Water was assumed to be non-volatile.  
- Category 3 - solid formulations 
Dancik et al. (2013) state that "the permeant may be applied neat or dissolved in a vehicle". For solid 
formulations, three different options may apply: 
Option 1 - assume "neat" compound, without any vehicle, or  
Option 2 - assume that the water used for wetting of the solid formulation in accordance with OECD 
TG 428 can dissolve the permeant.  
Option 3 - treat as not applicable in results sheet (label NA).  
Although Option 3 would have been consistent with the approach taken in the implementation of 
some other models for solid formulations, it was considered more relevant to select between Options 
1 and 2. In order to make a justified decision, the EFSA Guidance on dermal absorption (EFSA, 2017) 
was consulted. In the Guidance, the following is recommended:  
"Solid material should be moistened with a minimal volume of vehicle (e.g. water or physiological 
saline) to make a paste. This is to mimic sweat on the skin or occlusive conditions under clothing. 
Since dermal exposure to granular products is usually in the form of dust, the granules should be 
ground and moistened before application to the skin. Organic solvents should not normally be used 
(see EFSA PPR Panel, 2011, section 3.2.) (If solids are not moistened then the validity of the study is 
questionable. If solids are not moistened but occlusive conditions are used then the study can be 
considered a reasonable match to actual exposures, except for granules.)" 
Considering the above, it is reasonable to assume that either (1) there is no vehicle (neat), but 
occlusive conditions apply, or (2) the vehicle is water which mimics occlusive conditions under 
clothing. Therefore, in case of solid formulations included in category 3, the vehicle was taken as 
water, since it is possible to make a paste with it. An occluded system and fully hydrated skin 
conditions were considered. 
- Category 4 - other formulations 
For CS formulations, the vehicle was water, an occluded system and fully hydrated skin conditions 
were considered. This assumption was based on the EFSA Guidance on dermal absorption (EFSA, 
2017), where a CS formulation is defined as "a stable suspension of microencapsulated active 
substance in an aqueous continuous phase, intended for dilution with water before use". 
When a vehicle could not be specified based on the formulation type (e.g. RB, WB, PB, P), the a.s. 
was assumed to be "neat". In the absence of a relevant vehicle, the model could not run for these 
mixtures and NA was indicated in the results spreadsheet. When there was limited or no information 
on the formulation type (e.g. NS, Al), it was not possible to select an appropriate vehicle and no 
predictions were made for these concentrates. These specific cases of a.s. in concentrates where 
implementation of the NIOSH model was not possible are summarised in Table 2.6. 
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Table 2.6: Active substances for which it was not possible to run the NIOSH model for concentrate 
formulations. N.A. refers to not applicable. 
Active substance 
name  
Formulation 
type 
Vehicle Reason for not running the NIOSH model 
Boscalid NS NA Unknown formulation type 
Cholecalciferol 
 
RB Neat "Neat" compound - RB formulation is 
designated to attract and be eaten by the 
target pests; vehicle is not relevant cannot be 
specified. 
Difenacoum Pellet Bait 
Wax Block  
Pasta Bait 
Neat Formulation types are designated to attract and 
be eaten by the target pests; vehicle is not 
relevant cannot be specified. 
Alpha-cypermethrin CB Neat CB is a bait concentrate and can be either a 
solid or a liquid intended for dilution before use 
as bait; the physical state of the formulation 
was not known and it was not possible to 
specify a vehicle. 
Metaldehyde RB 
Pellet Bait 
Neat Formulation types are designated to attract and 
be eaten by the target pests; vehicle is not 
relevant cannot be specified. 
Oxydemeton-methyl AI N.A.  Experimental solution of active substance in 
solvent; the vehicle can be organic or water-
based. These solutions are not comparable with 
organic or water-based formulations. 
 
 
b) Observations during data entry 
- Use of input parameters: The necessary input parameters for the implementation of the 
model are: LogPow, MW, VP, MP, BP, no. of double bonds, no. of triple bonds, no. of aromatic 
and non-aromatic rings. In Dancik et al. (2013) it is stated that use of some optional 
parameters is also possible ( , Saq, measured kp, pKa). Here, the number of input parameters 
was kept to the minimum necessary ones. It deemed more realistic that, in case the model is to 
be implementated in the future in the regulatory context, optional parameters would not be 
used consistently for a variety of reasons including lack of availability. Since there is no clear 
indication in the relevant publication that the inclusion of the optional parameters would lead to 
improved results, it seemed acceptable not to over-complicate the implementation with 
additional parameters. 
- Exposure time:The exposure time (8 or 10 or 12 or 24h) was indicated in a separate box in 
the "dose" sheet: 
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Figure 2.8: Example for setting time in the "dose" sheet. In this example, the test substance was 
fully removed (removal scenario 1) after 10 hours exposure.  
It is noted that there are 3 removal scenarios in the Calculator. In removal Scenario 1 all of the 
permeant and the vehicle are removed from the surface. In removal Scenarios 2 and 3 some of the 
permeant and the vehicle are removed from the surface, but none is reapplied; the amount removed 
should be indicated. For the purposes of this project, only Scenario 1 was considered relevant. 
- Skin properties. Regarding skin thickness, default values were selected in the "environ" sheet 
as follows: 
 species = human 
 hydration state = fully hydrated  
 in vivo or in vitro = in vitro 
 thickness and pH of stratum corneum = set to default 
 thickness and pH of viable epidermis = set to default 
 thickness and pH of dermis = based on the "Skin type" column of the dataset file as follows: 
when only epidermis was used (reporting "epiderm") = 0; when dermatomed skin was used 
(reporting "derm") = 300 default value; when full thickness skin was used (reporting "full 
thickness" or "scissors") = 900. 
 
- Wind velocity. Since all predictions were made assuming occlusive conditions (immobile 
vehicle) the wind velocity was set to the default indoor scenario (0.165 m/s, Figure 2.6). 
c) Observations during calculations 
- Batch run. Data were entered for 48 compounds under different solvent conditions and 
concentrations and for various skin types and durations of exposure, resulting in overall 1586 
entries. It was only possible to perform a batch run for up to 200 entries where the same skin 
type (dermis, epidermis, full thickness, scissors) and duration of exposure (6h, 8h, 10h, 24h) 
was selected. The data were grouped accordingly. 
- Solvent/water partition coefficient Ks/v. It was not possible to run the model for organic 
solvent-based concentrates of substances for which the solvent/water partition coefficient Ks/v 
was not specified. In these cases, predictions were only made for dilutions of these 
formulations, where water was assumed to be the appropriate solvent, as previously explained. 
- The specific case of Imidazole/BAS 590 02 F (Prochloraz-manganese): This was 
identified as a polymeric complex with a MW of 1632 g/mol, for which it was not possible to 
obtain a SMILES code and retrieve a CAS number in EPI Suite. It was considered reasonable to 
Compound Immobile 
Multiple Vehicle Explanation of
ApplicationApplicationTime, Removal Removal Scenario
Dose, µg/cm2Dose, mg/cm2hours Scenario numbers
Default Default Default 0 0
0 0.00 10 1 1
Default Default Default 0 2
Default Default Default 0 3
Default Default Default 0
Default Default Default 0
Default Default Default 0
Default Default Default 0
Default Default Default 0
Default Default Default 0
Default Default Default 0
Default Default Default 0
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assume that the polymer would be too large to be the absorbed species. Instead, it appears 
plausible that prochloraz monomer is released and becomes (in part) dermally absorbed. Thus, 
the released monomer (Prochloraz) was considered the relevant species of the active 
substance. It is noted that velocity and extent of release of prochloraz monomer is not known, 
however, and this needs to be taken into account when assessing predictivity of the model 
against the EFSA dataset. 
2.7.1.8 Model 8 – Potts & Guy 1995 
Model Description 
In addition to their classical model for predicting skin permeability (Potts & Guy, 1992), Potts and Guy 
later developed a partitioning-diffusion equation, based on free-energy relationships (Potts & Guy, 
1995). Following this approach, partitioning is related to molecular volume (MV), and hydrogen bond 
donor and acceptor activities (     , respectively). After consideration and rearrangement of formulas 
associated with the free-energy relationships approach and the assumption that transport through 
lipid membranes is achieved by free volume fluctuations within the lipid domain, the following 
(simplified) relationship was derived: 
                          
Equation 2.7.18 
Multiple regression analysis on Equation 2.7.18 with aqueous permeability coefficients of 37 non-
electrolytes yielded the following formula:  
      
  
 
                                 
Equation 2.7.19 
Where MV is the molecular volume and is given in   
 
        
             ,    is the sum of 
hydrogen donor activity (acidity), and    is the sum of hydrogen acceptor activity (basicity) (Abraham 
et al., 2002). 
Model Implementation 
Equation 2.7.19 was applied to calculate the permeability coefficient   . Hydrogen bond donor and 
acceptor activities (acidity/basicity) were calculated as described in section 2.6.2.  
In the derived acidity/basicity values it was noticed that some non-feasible negative values were 
predicted by the model. One solution to that could be to set all negative values equal to 0 and 
continue with the calculation of       with these "corrected" values. However, it was decided to keep 
the non-feasible acidity and basicity values as predicted by the model, by assuming that maybe 
negative basicity values would be derived by the model’s attempt to overcompensate for very high 
acidity values and vice versa. For the sake of good modelling application practices this assumption 
needs to be further elucidated. Similarly to the other models, the calculated    was converted to cm/h 
by multiplying it with 3600 and then translated to %DA as described in section 2.5.1 by combination 
with the DAME model yielding two different %DA values, since two different      scenarios were 
considered (    =0;     = calculated). 
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2.7.2 Mixture Models 
2.7.2.1 Model 9 – Riviere Brooks 2007 No. 1 
Model Description 
In order to develop algorithms that calculate permeability coefficients after exposure to mixtures, 
Riviere and Brooks (2007) elaborated three existing single compound based LFER models (Potts & Guy 
(1992), Hostynek & Magee (1997), Abraham & Martins (2004)) by taking into consideration mixture-
related contributions. This was done by incorporation of an additional parameter, defined as Mixture 
Factor (MF), that describes the physical-chemical properties of the mixture based on those of its 
components. All three LFER models were tested by linear regression in order to identify the best fitting 
MF from a series of available physical-chemical properties (e.g. molecular volume, hydrogen bonding, 
TPSA, pKa). The dataset used for the derivation of the mixture models is composed of 288 data 
points/treatment combinations (12 different compounds in 24 mixtures) obtained from flow-through 
porcine skin diffusion cells. This process yielded two well-fitting models, based on the Potts and Guy 
algorithm15.  
In the first model (model 9), the mixture factor (MF) is related to the topological polar surface area of 
the mixture, mTpSA, which is derived as described in chapter 2.7.2.4. 
The algorithm for model 9 is defined as follows: 
      
  
 
                                                
Equation 2.7.20 
Model Implementation 
Equation 2.7.20 was implemented in Excel, with mTpSA expressed in Å² as calculated from TpSA 
values of the mixture components,        corresponding to the octanol/water partition coefficient of 
the a.s., and    corresponding to the molecular weight of the a.s.. Calculation of the mixture factor 
(mTpSA) is described in section 2.7.2.4. The model was applied only to experiments conducted with 
products for which detailed information on the composition could be retrieved. For the methodology 
followed for the full product characterization please refer to section 2.6.3. Similarly to the other 
models, the calculated    was translated to %DA as described in section 2.5.1 by combination with 
the DAME model yielding two different %DA values, since two different      scenarios were considered 
(    =0;     = calculated). 
2.7.2.2 Model 10 – Riviere Brooks 2007 No. 2 
Model Description 
The model was derived by the methodology described above (2.7.2.1). In this second model (model 
10), the mixture factor (MF) is related to the hydrogen bond acceptor count of the mixture, mHA, 
which is derived as described in chapter 2.7.2.4. 
The algorithm for model 10 is defined as follows: 
      
  
 
                                               
Equation 2.7.21 
 
                                               
15 The rest of the model fittings discussed in the publication (associated with Hostynek & Magee, Abraham & Martins models) 
were not examined in the present study and are thus not introduced here. 
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Model Implementation 
Equation 2.7.21 was implemented in Excel, with mHA calculated from HA values of the mixture 
components,        corresponding to the octanol/water partition coefficient of the a.s. and    
corresponding to the molecular weight of the a.s.. Calculation of the mixture factor is described in 
section 2.7.2.4. The model was applied only to experiments conducted with products for which 
detailed information on the composition could be retrieved. For the methodology followed for the full 
product characterization please refer to section 2.6.3. Similarly to the other models, the calculated    
was translated to %DA as described in section 2.5.1 by combination with the DAME model yielding 
two different %DA values, since two different      scenarios were considered (    =0;     = 
calculated). 
2.7.2.3 Model 11 – Atobe 2015 
Model Description 
The feedforward artificial neural network (ANN) model developed by Atobe et al. (2015) predicts the 
permeability coefficient kp of permeants by additional consideration of the physical-chemical properties 
of the vehicle. Input parameters for the training of the model were the octanol water partition 
coefficients (LogPow) and the molecular weights (MW) of 359 samples for which literature data on 
logkp were available. The training dataset comprised hydrocarbons, alcohols, aldehydes, ketones, 
ethers, esters, carboxylic acids, amines and amides, which were dissolved in various pure and mixed 
solvents. The ANN consisted of one input layer (input parameters: MW of permeant, LogPow of 
permeant, LogPow of vehicle), five hidden layers, and one output layer for the response variable kp. 
The reported values of MW and LogPow for the substance and the vehicle were in the ranges of 18.02 
to 765.05, -3.70 to 7.88 and -1.39 to 8.72, respectively.  
The resulting ANN model was compared to its multiple linear regression model (MLR) by calculating 
the root mean square errors (RMSE). The RMSE of 0.68 for the ANN model was lower than the one of 
the MLR model (0.89), indicating better performance of the ANN model (Atobe et al. 2015). For the 
10-fold cross validation, an RMSE of 0.72 was calculated for the ANN model. 
Model Implementation 
The model was reconstructed on the basis of the training set published in the paper. The 
reconstruction was realized in MATLAB 2016b using Neural Network Toolbox, with 3 inputs, 20 hidden 
layers, and one output. The inputs corresponded to variables MW and LogPow of the permeant, and 
LogPow of the vehicle (also mLogPow), as provided in the paper, while the output corresponds to the 
variable Logkp (with kp in cm/h). The RMSE after 10-fold cross validation was 0.68 for the 
reconstructed model with 20 hidden layers, while the RMSE of the original model was 0.72 after cross-
validation according to Atobe et al. (2015).  
The reconstructed ANN model was further used to estimate the value of Logkp given the input values 
for MW and LogPow of the active substance, and mLogPow of the mixture for 154 sets of data from the 
EFSA dataset. The parameter mLogPow is defined as a Mixture Factor (MF) describing physical 
chemical properties of the vehicle mixture and is calculated from LogPow of the individual mixture 
components as described in section 2.7.2.4. 
Similarly to the other models, the calculated    was translated to %DA as described in section 2.5.1 
by combination with the DAME model yielding two different %DA values, since two different      
scenarios were considered (    =0;     = calculated). 
2.7.2.4 Calculation of Mixture Factors (MF) 
The mixture models examined here describe individual compound penetration by additionally 
considering the effects of the co-formulants/vehicle, expressed as Mixture Factor (MF). Therefore, the 
results obtained by these models do not reflect the absorption of each single component of the 
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product, but only of the main a.s.. The mixture factors were calculated by summing up the 
mathematical product of the weight percentage and the respective parameter value for each of the 
identified components of a mixture. This was done for each of the three needed parameters. This 
process can be described using the following equations:  
 
Total weight: 
Wtot= Wa.s.+Wc.f.1 …   c.f.n 
Relative contribution of each component to the mixture: 
RCa.s.= 
     
    
 ; RCc.f.1.= 
      
    
 ;…; R c.f.n.= 
     
    
 
R          R      R         R        
Relative contribution of the mixture and diluting agent (water) to the experimentally tested item: 
R         =R         
       
            
 
R        =  R        
Calculation of the mParameter (mP) 
mP= R            R                R               +R       *       
with        -       corresponding to co-formulants 1 to n. 
 
For water, TpSA was 1Ǻ2 and HA was taken as 1. LogPow was assumed as -0.50 for water. For TpSA, 
HA and LogPow of a.s. and co-formulants, values retrieved from pubchem were preferred when 
available, otherwise computed values with Molinspiration (TpSA and HA) or EPI Suite (LogPow) were 
used (see also 2.6.3).  
For weight, the concentration of the a.s. in the product [g/kg or g/l] and the co-formulant content 
[g/kg or g/l] were taken.              corresponds to the experimental concentration of the a.s. when 
tested as concentrate, and was taken for the whole experiment including the respective dilutions. For 
the studies where no tested concentrate was provided in the database, the concentrate concentration 
(            ) values were taken from the composition of the product for which also the co-formulant 
data were collected. 
2.8 Statistical Analysis 
2.8.1 Variability between replicates and the adjusted logit scale 
As demonstrated in Appendix B of the EFSA (2017) guidance on dermal absorption and further 
confirmed in Appendix H of the present document, an "adjusted logit scale" is statistically appropriate 
when analyzing and presenting dermal absorption data. The adjusted logit scale was used in many 
places when averaging replicates from a block: the adjusted logit was computed for each replicate, 
the sample mean was computed using the adjusted logit values and the result was restored to the 
absorption scale by undoing the adjusted logit transformation. 
Most of the plots which appear in the Results use the adjusted logit scale on one or both axes. 
Adjusted logit scales are used to enhance the communication and extraction of information. Some 
additional description and justification is provided in Appendix H. 
2.8.2 Correlation analysis 
2.8.2.1 Rank correlation analysis 
Spearman rank correlation was used for comparison of predicted versus reported data. Analyses were 
performed on individual data and on block aggregates representing averages between replicates of 
one experiment. Analysis was also performed on coarse aggregates representing averages of all data 
for one active substance in order to check the possibility that correlations might be stronger for 
aggregates representing larger numbers of data. 
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Correlations were calculated using the whole data-set and also separately for concentrates and 
dilutions and the 4 formulation groups used in EFSA (2017) when considering the setting of default 
values: solids, water-based, organic solvent based and other. Averaging was performed on 
untransformed or logit-transformed data. Kendall’s tau and P-values derived from Kendall’s tau were 
calculated to assess the quality of the correlation, supported by visual inspection of respective plots. 
2.8.2.2 Analysing the influence of covariates by restricting correlation analysis to 
subsets 
A method for selecting subsets to evaluate was required which could be applied systematically with 
reasonable computational effort and which would allow a subset to be determined by more than one 
covariate. It was also important that the resulting subsets would have natural structure and would 
represent contiguous ranges of values for covariates 
The building block is to divide the range of each covariate into 4 sub-ranges with roughly equal 
numbers of data in each sub-range. Exactly equal numbers are often not possible and the sub-ranges 
used were the best that could be found given the often discrete nature of the distributions of 
covariates. For a single covariate, the possible subsets are then made from contiguous groups of sub-
ranges. Subsets involving multiple covariates are defined as intersections of subsets defined by single 
covariates. 
It was decided to evaluate all subsets which are larger than some minimum size threshold which was 
set at 10% of the total number of cases for each covariate analysis in order to constrain the 
computational effort to be manageable. For the same reason, a limit was also set on the total number 
of covariates. Careful coding was required in order to avoid excessive computation time. 
A method was needed to measure the extent to which a subset had a correlation which was worth 
considering. The basic principle was to take into account both the magnitude of correlation and the 
associate P-value for the test of no correlation. Due to skewness, outliers and non-linearity, non-
parametric correlation methods were used; for calculating P-values, the test based on Kendall’s tau 
was used because P-value computations were found to be more stable than using Spearman’s rank 
correlation. However, for reporting correlations, Spearman’s rank correlation was used due its greater 
familiarity and ease of interpretation as the usual Pearson product-moment correlation applied to 
ranks of data. The informal rules applied to identify interesting subsets were: (i) to require a P-value 
at least as significant as for all cases in covariate analysis; and (ii) to require a rank correlation at least 
as large as for all cases. The P-value requirement was relaxed for the analysis of model 7 due to a 
lack of interesting subsets using the original criteria. This approach involves comparison of the relative 
size of P-values. The P-values need to be interpreted with care due to the fact that: (i) many sub-sets 
are being evaluated; and (ii) the random sampling assumptions of Kendall’s test are invalid for a 
dataset with hierarchical structure (active substances, formulations, etc). 
2.8.2.3 Selection of covariates for correlation analysis 
Eleven descriptors where selected for the purpose of covariate/correlation analysis: 
 It is well established that molecular weight (MW) and octanol-water partition coefficient 
(LogPow) impact dermal absorption. Both parameters are included in various prediction 
models. In database found as: "Molecular Weight [g/Mol]" and "Log PO/W". 
 The EFSA Guidance on dermal absorption (2012) and (2017) recommends selection of default 
or worst-case assumptions in the absence of measured data based on concentration of the 
active substance (EFSA, 2012) or the type of formulation and whether a concentrate or a 
dilution thereof is assessed (EFSA, 2017). Accordingly, parameters on concentration ("Conc"), 
concentrate/dilution status ("Concentrate") and formulation ("MergedForm") were included in 
the covariate analysis. The parameters are to be found in the database as: "Concentration 
Tested (g/L or g/kg)" for "Conc", and "Type of concentration tested (concentrate, dilution 1-
3)" for "Concentrate". The data on the formulation ("MergedForm") were derived using 
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information on the formulation type (in database as "Formulation type") and assignment of 
formulation groups as defined in table B.2 of the EFSA Guidance (EFSA, 2017), see also Table 
2.5 of the present report. 
 Water solubility (Saq) can limit the availability of the substance for absorption from water 
based formulations. Therefore, when measured information was available, Saq (in the dataset 
named as "Water solubility [mg/L at pH 7 and 20/25 °C] (EFSA conclusion, or (d)RR / DAR / 
RAR / RAC opinion)") was included in the analysis. Otherwise, computed Saq were considered 
(in the dataset named as "Water solubility computed (IJC) pH = 7 [mg/L]"). 
 Partitioning into and out of the SC is, among others, pH dependent and should thus relate to 
the ionization status of the permeant. For that purpose pKa was also considered for covariate 
analysis. Experimental (or computed, whenever experimental values not available) pKa (in 
dataset named as"pKa at 20 °C (EFSA conclusion, or (d)RR / DAR / RAR / RAC opinion)" or 
"pKa computed (IJC)") were used for the analysis. 
 Another parameter considered in order to assess the influence of charge, was the sum of the 
absolute values of the net atomic charges of oxygen and nitrogen atoms which were 
hydrogen-bond acceptors, QO.N (in dataset named as "QO.N [e] (IJC)". 
 Similarly, hydrogen bond formation may limit diffusivity, since permeants can bond to skin 
structures and therefore not reach the systemic circulation. To explore this, the sum of 
hydrogen bond donor and acceptor numbers (HB) was considered as covariate (= the sum of 
"HD [no] (pubchem)" and "HA [no] (pubchem)", as found in the dataset). 
 The difference between the energies of the highest and the lowest occupied molecular orbital 
are frequently used to describe reactivity of the molecule. Therefore, the difference between 
"ELUMO [eV] (MOPAC2016, AM1 method)" (as found in the dataset) and "EHOMO [eV] 
(MOPAC2016, AM1 method)" (as found in the database) was also explored as covariate.  
 Finally, melting point was considered as covariate, since it is imput parameter in two of the 
models (model 6 and 7) and is also influencing water solubility and thus absorption. Measured 
values (in the database named as "MP [°C] (EFSA conclusion, or (d)RR / DAR / RAR / RAC 
opinion)") were preferred. When unavailable, predicted values (in the database named as "MP 
[°C] (Episuite)") were used. 
The table below lists potential covariates that were not included in the analysis and provides a brief 
justification. 
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Table 2.7: Substance properties not included in covariate analysis and justification for non-inclusion. 
Parameter Parameter name in dataset Justification 
Soct: solubility in 
octanol 
"solubility in octanol [g/L at 20/25 
°C] (EFSA conclusion, or (d)RR / DAR 
/ RAR / RAC opinion)" 
Parameter is linked to octanol-water partition 
coefficient (LogPow) and water solubility (Saq) which 
were both already included (see above). 
Hd/Ha Hydrogen 
bond donor/acceptor 
activity 
"Hydrogen bond donor activity = 
hydrogen bond acidity" OR 
"Hydrogen bond acceptor activity = 
hydrogen bond basicity" 
A correlation with the hydrogen bond 
donor/acceptor counts (HD/HA) is expected. The 
latter was preferred because it is available from 
public database. HD/HA were included in the 
covariate analysis as sum of no. of hydrogen bond 
donors and acceptors (see above). 
TpSA: Topological 
polar surface area 
"TpSA [Å²] (pubchem)" OR "TpSA 
[A²] (molinspiration)" 
Parameter is linked to octanol-water partition 
coefficient (LogPow) and molecular weight (MW) 
which were both already included (see above).  
MV or Ve: Molecular 
volume or Van der 
Waals effective 
volume 
"MV [A³] (molinspiration)" OR "Ve, 
van der Waals effective volume [A³] 
(IJC)" 
Some correlation with molecular weight (MW) 
which was already included (see above).  
computed 
HD/HA: hydrogen 
bond donor/acceptor 
counts 
"HD [no.] (molinspiration)" OR "HA 
[no.] (molinspiration)" 
For HD and HA number, information from public 
sources was preferred and available (already 
included, see above). 
experimental or 
computed BP: 
boiling point 
"BP [°C] (EFSA conclusion, or (d)RR / 
DAR / RAR / RAC opinion)" OR "BP 
[°C] (Episuite)" 
Typically correlated to/predicted from further 
structural properties. Very little experimental 
(reported) data. Mostly computed values of 
unknown reliability. 
experimental or 
computed VP: 
vapour pressure 
"VP [Pa at 25°C] (EFSA conclusion, 
or (d)RR / DAR / RAR / RAC 
opinion)" OR "VP [mmHg at 25°C] 
(Episuite)" 
As for boiling point (BP), VP is typically correlated 
to/predicted from BP and, to a lesser degree, 
further structural properties. In addition, 
experimental conditions restrict/control loss of 
material through evaporation and experiments with 
low recovery were not included in the EFSA 
database 
Qh: sum of the net 
atomic charges of 
the hydrogen atoms 
bound to nitrogen or 
oxygen atoms 
"Qh [e] (IJC)" 
QO.N. (the sum of the absolute values of the net 
atomic charges of oxygen and nitrogen atoms 
which were hydrogen- bond acceptors) was 
included instead (see above). 
MR: molar 
refractivity 
"MR [10^6 m³/mol] (IJC)" Computed values of unknown reliability. 
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2.8.3 Bayesian Modelling 
The Bayesian random effects (BREM) statistical modelling approach used to analyse the predictive 
performance of models evaluated in this report is similar to that taken in EFSA (2017). The main 
differences are:  
i. that EFSA (2017) did not have the component corresponding to the model prediction and had 
instead more structure relating to dilutions versus concentrations and formulation groups than 
the model selected for use in section 3.5.2.3;  
ii. modelling of variation between replicates. EFSA (2017) assumed a homogeneous normal 
distribution for variation between replicates. Based on further data analysis, a refined "heavy-
tailed" t-distribution model was used in this report while the homogeneity assumption was 
retained. 
Both EFSA (2017) and the modelling presented here use normal distributions for the random effects 
components which are treated as additive on adjusted-logit scale. The Bayesian model is described 
further in Appendix I. 
2.8.4 Software 
All calculations were carried out using R (R Core Team, 2017) with the support of a number of 
additional packages: Auguie (2017) and Wickham (2009, 2017) to assist with preparing graphics; 
Højsgaard & Halekoh (2016), Komsta & Novometsky (2015) and Wickham (2011) for general data 
analysis; Plate (2016) and Wickham & Bryan (2017) for data management; Plummer (2016), Plummer 
et al (2006) and Su and Yajima (2015) for Bayesian modelling and computation. 
2.9 Survey on regulatory needs and questions in the context of dermal 
absorption modelling 
A "Questionnaire on the practical applicability and potential regulatory implementation of in silico tools 
for the prediction of pesticides dermal absorption" was prepared considering also feedback by EFSA 
and the European Crop Protection Association (ECPA) and is provided as Supporting Information (file 
name: “Consultation Report and Questionnaire.pdf”). The purpose of this questionnaire was to receive 
feedback from Member State Competent Authorities (MSCAs) on regulatory needs and raise technical 
questions that should be considered and addressed in the statistical review of model predictions.  
The questionnaire consisted of totally twelve (12) questions organised in three sets with increasing 
level of specificity and technical detail. The first set of questions concerned general issues on the use 
of in silico tools: 
1. Please describe your involvement in the risk assessment of pesticides. 
2. Do you currently use any in silico tools for regulatory purposes, such as prediction of toxicity? 
3. Have you had any training on the use of in silico tools for regulatory purposes? 
The second set of questions was related to the use of in silico tools for dermal absorption: 
4. Are you aware of the in silico tools currently available for the prediction of dermal absorption 
of pesticides (active substance)? 
5. Are you aware of the in silico tools currently available for the prediction of dermal absorption 
of pesticide mixtures (products)? 
6. Do you currently use in silico tools for the prediction of dermal absorption of pesticides for 
regulatory purposes? 
7. Do you consider that the use of in silico tools for the prediction of pesticide dermal absorption 
is linked to high level of uncertainty? 
8. Would you use in silico approaches only as screening tools that may not be considered in 
replacement of experimental data on dermal absorption? 
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9. Would you consider in silico approaches as valuable tools that could be used in replacement of 
experimental data on dermal absorption? 
Other more specific technical questions were addressed at the end of the questionnaire: 
10. Which of the following input parameters do you consider critical and applicable for an in silico 
tool to be used for the prediction of dermal absorption? 
 Formulation type (EC, SC, WP, WG, etc). 
 Exact formulation composition 
 Main solvent(s) (in case of liquid formulations) 
 Particle size distribution (in case of solid formulations) 
 Content of the active substance in the formulation 
 Octanol-water partition coefficient (log POW) 
 Molecular weight of active substance 
 Permeation constants 
 Other physicochemical parameters 
 Other 
11. Do you consider that a probabilistic or a deterministic in silico model would be more suitable 
for regulatory implementation? 
12. Do you consider that classification (e.g. product classification) is relevant for an in silico tool to 
be used for the prediction of dermal absorption? 
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3 Assessment/Results 
3.1 Regulatory needs and questions in the context of dermal absorption 
modelling 
Thirteen (13) responses on the "Questionnaire on the practical applicability and potential regulatory 
implementation of in silico tools for the prediction of pesticides dermal absorption" were received from 
ten MSCAs, i.e. Finland (FI), Austria (AT), the Czech Republic (CZ), Germany (DE), Denmark (DK), 
Spain (ES), France (FR), the Netherlands (NL), Poland (PL) and the United Kingdom (UK). AT, ES and 
PL provided two separate responses from two different experts. Since the answers from the individual 
experts from AT, ES and PL were not identical, they were considered as separate expert opinions 
rather than national positions. So, the results are presented from all 13 completed questionnaires. 
All experts responded that they were involved in the mammalian toxicology evaluation and risk 
assessment of active substances and their products, confirming their relevance to the topic. 
In general, the use of in silico tools is driven by the regulatory needs as described in current 
legislation and related guidelines. Since in silico tools are currently not recommended for the 
prediction of dermal absorption of pesticides (EFSA, 2017), none of the experts is using them, 
routinely. Furthermore, there is a general scepticism on the use of in silico tools for dermal absorption 
of pesticides for several reasons. Firstly, very few of the experts have the technical knowledge on how 
to use the available tools reliably, highlighting the need for training on the topic. In addition, the 
multifactorial nature of dermal absorption is recognised as a parameter limiting the in silico tools 
reliability. 
However, several experts would be willing to use in silico tools for the prediction of pesticide dermal 
absorption if validated methods are available and are recommended by regulatory bodies (e.g. EFSA). 
In this case training will be necessary. 
Based on the feedback from MSCA, the following questions could be considered as starting points in 
the selection of models from the literature for statistical review of model predictivity or in the 
statistical analysis itself: 
- Is the applicability domain of the model relevant for the prediction of dermal absorption of 
pesticides?  
- Is the model only restricted to aqueous solutions or neat test substances or is it also 
applicable to other formulation types (e.g. organic solvent-based, solid formulations)? 
- Is the model applicable for the prediction of dermal absorption of active substances in 
complex mixtures? 
- Does the tested model predict dermal absorption with a clearly defined level of 
uncertainty? Is it possible to lower the estimated uncertainty for specific formulation types? 
- Does the model take into consideration the complexity of agrochemical formulations, 
including the physicochemical properties of the formulations (e.g. surface tension, pH, 
viscosity) and their in-use dilutions, the active substance (e.g. physical state, molecular 
weight, lipid/water partition coefficient Ionization, water solubility, pKa, local skin effects), 
the vehicle(s) and other co-formulants (e.g. solubility, volatility, distribution in stratum 
corneum, excipients effect on the stratum corneum pH; 4)? 
- Does the model take into consideration the broad variety of experimental conditions (e.g. 
state of occlusion (occlusive, semi-occlusive or non-occlusive) or preparation of the skin 
sample (epidermal sheet, dermatomed skin or full-thickness skin), skin area in contact with 
vehicle and duration of exposure)? 
- Does the model take into consideration differences in skin parameters due to species (e.g. 
rat or human), anatomical site, temperature (of skin), hydration of stratum corneum, 
damage to stratum corneum, metabolism, diseased skin, desquamation blood and lymph 
flow? 
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- Does the model take into consideration product classification with regard to skin 
irritation/corrosion?  
- Is the model easily accessible to the expert? Is the model validated? 
- Is it possible to repeat the prediction with the same level of uncertainty considering 
specific instructions by the model developer or in case training is provided? 
A detailed analysis of the completed questionnaires is provided as Supporting Information (file name: 
“Consultation Report and Questionnaire.pdf”) to this report. The feedback received is used as guiding 
information for the analysis of dermal absorption models in this study. 
3.2 Literature Search and Appraisal 
The literature search performed as described in chapter 2.1 revealed a total of 2212 records published 
between 1990 and June 2017 in the public domain. Assessment of relevance of these records based 
on title and abstract, if available, identified 288 publications describing one or more mathematical 
models for in silico prediction of dermal absorption. Based on the first stage of the scientific review, 
103 of the 288 papers originally regarded as relevant were excluded from further consideration as 
they proved to not be relevant when the full publication was assessed. The remaining 185 publications 
were subdivided over four categories based on type of publication (review/original study) and on type 
of model (single substance or mixture model) as shown in Table 3.1. 
Table 3.1: Categorisation of relevant papers. Between brackets the final numbers after the scientific 
review: two papers attributed to "single substance models" were misclassified and are on mixture 
models, while one paper on single substance models had been classified as "original" while it was a 
review paper.  
Type of compounds 
Type of paper 
Total 
Original Review 
Single substances 128 (125) 41 (42) 169 (167) 
Mixtures 15 (17) 1 17 (18) 
Total 143 (142) 42 (43) 185 
 
Only the publications describing original work were entered for the second stage of the scientific 
review as the reviews were not expected to contribute additions to the pool of models extracted from 
the original studies.  
The 142 original papers described a total of 233 models, 188 predicting absorption of single 
substances (in the overwhelming majority from an aqueous vehicle) and 45 predicting absorption of 
substances from mixtures. A detailed list is provided as Supporting Information (file name: “Model 
Review.xlsx”). 
Most models described were algorithm based: 141 out of 188 single substance models and 37 out of 
45 mixture models. 122 single substance models and 31 mixture models passed the criterion of having 
a clear algorithm and being suitable for reconstruction. In addition, machine learning tools were 
identified of which 15 single substance models and 7 mixture models in principle can be reconstructed 
as the training sets with the descriptor values are available. The suitability of the models for pesticide 
risk assessment was examined taking into account the outcome on the survey described in chapter 
3.1. Models deemed not suitable for pesticides were excluded, leaving 84 single substance models and 
36 mixture models. The algorithmic models that proved to be possibly relevant for the prediction of 
dermal absorption in the framework of pesticide risk assessment are further detailed in Appendix D. 
Restriction to the most recent versions of all models leaves 75 single substance models and 36 
mixture models (Table 3.2). 
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Table 3.2: Overview of the selection of models from the 142 relevant original papers for ranking. 
Selection criterion 
Single substances Mixtures 
Total Algorithm 
based 
Machine 
Learning 
Algorithm 
based 
Machine 
Learning 
Reconstructible 122 15 31 7 175 
Suitability pesticide 
RA 
70 14 29 7 120 
Most recent version 61 14 29 7 111 
 
The overwhelming majority of the single substance models that are, in principle, suitable for 
predicting pesticide dermal absorption, predict the permeation constant kp, some predict the 
maximum flux Jmax and only one predicts percentage absorption (see Table 3.3). The same accounts 
for mixture models, where 27 models predict kp, while the remainder predict the steady state flux Jss 
as absorption parameter.  
Table 3.3: Overview of absorption parameters predicted by the selected models. Cells report number 
of models predicting a specific absorption parameter. 
Model type 
Single substances Mixtures 
Total 
% abs. J
max
 k
p
 J
SS
 k
p
 
Algorithm based 0 6 55 3 26 90 
Machine learning 1 0 13 6 1 21 
Total 1 6 68 9 27 111 
 
Models identified were based on a large number of physicochemical descriptors as input parameters 
for prediction. A comprehensive list of these descriptors and terminologies is provided in Appendix D, 
Table D.3. 
Many of the algorithm based single substance models use simple physicochemical properties as input 
parameters, of which 16 employ only MW and/or Pow (see Table 3.4). Single substance machine 
learning models tend to use more complex descriptors, as do mixture models in general.  
Table 3.4: Overview of descriptor types used by the selected models. Cells report number of models 
using a specific descriptor type. Descriptor types are sorted from simple types to more complex types. 
Models using a more complex descriptor type may also employ in addition less complex types of 
descriptors, e.g. models using complex physicochemical properties may also need Pow as an input. 
Algo. Stands for Algorithm based models and ML for Machine learning models. 
Most "complex" descriptor type used 
Single subst. 
mod. 
Mix. mod. 
Algo. ML Algo. ML 
Simple physicochemical properties: MW 1 0 0 0 
Simple physicochemical properties: POW 3 0 0 0 
Simple physicochemical properties: POW and MW 11 1 1 1 
Simple physicochemical properties: other 14 1 3 0 
Abraham 7 1 13 0 
Complex physicochemical properties 1 2 0 0 
Complex structural and/or quantum-chemical descriptors 24 9 12 6 
Total 61 14 29 7 
 
Complex descriptors may be difficult to obtain for all chemicals because of the availability of the 
software tools needed or because they have to be generated in a specific chemical test when not 
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predictable from chemical structure. This may be especially problematic for mixture models, as for 
each prediction of absorption of an active substance also the descriptors of other constituents of the 
mixture need to be available. 
The full results of the first and the second stage of this evaluation are provided in Appendix D and as 
Supporting Information (file name: “Model Review.xlsx”). 
3.3 Model Implementation 
For the 111 models representing most recent versions identified as described in chapter 3.2, the 
availability of required input data as a pre-requisite for implementation was assessed. A weighted 
procedure was chosen, resulting in a score of 0 when one or more of the essential input parameters 
was considered inaccessible and giving a maximum score of 5 when all input data is provided in the 
EFSA dataset (refer to chapter 2.4 for details). In Table 3.5 are presented the different levels of 
availability with their respective frequencies: 
Table 3.5: Frequency of parameter availability scores for models identified in the systematic literature 
search (rounded to two significant figures). 
Parameter availability Frequency 
Score Description No. (total 284) % 
5 provided for a.s. in EFSA dataset 10 3.5 
4 provided for a.s. in DAR or study report 16 5.6 
3 data or QSPR tool open access 37 13 
2 QSPR proprietary but available in consortium 37 13 
1 replacement by surrogate feasible 76 27 
0 not accessible with reasonable effort 108 38 
 
In the second step of model selection, all individual parameter availability scores were integrated into 
one single model parameter score (MPS) using the following equation: 
                 …    
  
Equation 3.3.1 
where     corresponds to the parameter scores of each parameter of a given model 
Models with many input parameters were neither preferred nor discriminated. Models with MPS < 1 
were excluded from the selection process. As a result, 43 single substance models and 7 mixture 
models received an overall model parameter availability score above zero. These were taken forward 
to the next stage. 
These 50 comprised models were 
 based on artificial neural networks (ANN) and, more conventionally, mathematical algorithms,  
 using as input either few physicochemical descriptors as MW and LogP, a more complex 
combination of many physico-chemical values or quantum-chemical descriptors,  
 predicting the permeability constant kp, maximum flux Jmax or percentage dermal absorption 
%DA. 
In accordance with the project objective, models were grouped accordingly and representative 
approaches were selected to ensure wide coverage for single substance as well as mixture models. A 
reserve list of models was created to serve as backup list in case ANN based models cannot be 
reconstructed or unforeseen problems are encountered during model implementation, e.g. with 
collection of individual input parameters. 
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In addition, since the classical Potts & Guy (1992) algorithm is the most common applied model in 
literature, it was decided to also include this one as a "historic reference" despite the existance of 
more recent version with minor revisions. 
An overview of selected models for implementation within the project is provided in Table 3.5. 
Following collection of required input data as described in chapters 2.6.2 and 2.6.3, model 
implementation was performed as outlined in chapter 2.7. All selected models could be successfully 
implemented and the reserve list was not used. Notably, interpretation of ambiguous instructions to 
the complex MS-Excel based Model 7 initially caused implausible predictions which required 
corrections to the approach the supplied tool was used. 
Results of all predictions are provided asSupporting Information (file name: “Human in vitro PPP EFSA 
dataset with add parameters and predictions.xlsx”) and were subjected to detailed statistical analysis. 
All detailed calculation steps are available upon request at EFSA. 
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Table 3.6: Overview of selected single substance models and mixture models for model implementation. 
Paper Model Parameters Model Algorithm Training Dataset 
Single substance models (SSM)    
Paper#19 
Potts  R. O. and Guy  R. H. 1992 
MW: molecular weight 
Pow: octanol-water partition coefficient 
log kp [cm/h] = 0.71 LogPow – 0.0061 
MW – 2.7 
data compiled by Tayar et al. 1991 and 
Flynn 1990 
Paper#13 
Magnusson  B. M. and Anissimov  Y. G. 
and Cross  S. E. and Roberts  M. S. 
2004 
MW: molecular weight logJmax  
   
     
  = –0.0141MW – 4.52 alcohols, steroids, phenol derivatives, 
and other chemical classes (Magnusson 
dataset) 
Paper#19 
Potts R. O. and Guy  R. H. 1995 
Ha: Hydrogen bond acceptor activity 
(also B - solute overall (summation) 
hydrogen bond basicity) 
Hd: Hydrogen bond donor activity (also 
A - solute overall (summation) 
hydrogen bond acidity ) 
MV: molecular volume  
log kp [cm/h] = 0.0256MV – 1.72HD – 
3.93HA – 1.29 
alcohols, steroids, phenol derivatives, 
and other chemical groups 
Paper#44 
Dancik  Y. and Miller  M. A. and 
Jaworska  J. and Kasting  G. B. 2013 
Pow: octanol-water partition coefficient 
MW: molecular weight  
VP: vapour pressure 
MP: melting point  
BP: boiling point 
#double bonds 
#triple bonds 
#aromatic and non-aromatic rings 
optional: 
ρ: Molecule density 
Saq: Water solubility 
measured kp: permeation coefficient 
pKa: negative logarithm (to the base 
10) of the dissociation const 
n/a: complex model predicting %DA  
 
 
n.a. 
Paper#49 
Frasch  H. F. 2002 
MW: molecular weight 
Pow: octanol-water partition coefficient 
k_p [cm/h] = k_sc · k_aq/k_sc+k_aq 
k_aq = 0.1151 cm/h 
k_sc = K_mv x D /l* 
log K_mv = 0.59 log K_ow - 0.024 
alcohols, steroids, phenol derivatives, 
and other chemical groups 
(Flynn, 1990 database) 
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Paper Model Parameters Model Algorithm Training Dataset 
log D = log _D_cor_D_lip/1+EXP- log 
K_cor_lip + 0.1974 - 0.3668 log 
D_cor/D_lip/0.2488 + -0.134 log 
D_cor/D_lip 
log D_cor/D_lip = -0.0087 MW 
l* = 0.003 x 1 - 0.9113 log K_cor/lip + 
0.9896  log _Kcor_lip^2 + 0.3111  log 
K_cor/lip^3 
log K_cor/lip = -0.8075 log K_ow + 
2.4194 
 
Paper#51 (1) 
Fu  X. C. and Ma  X. W. and Liang  W. 
Q. 2002 
MV: molecular volume  
Qh: the sum of the net atomic charges 
of the hydrogen atoms bound to 
nitrogen or oxygen atoms 
QO.N: the sum of the absolute values 
of the net atomic charges of oxygene 
and nitrogen atoms which were 
hydrogen-bond acceptors 
EHOMO: the energy of the highest 
occupied molecular orbital (eV) 
ELUMO: the energy of the lowest 
unoccupied molecular orbital (eV) 
log k_p [cm/h] = 3.69 MV - 2.86 Qh - 
2.19 QO.N - 0.033 EHOMO - 0.22 
ELUMO - 1.20 
alcohols, phenol derivates, carboxylic 
acids, steroids 
(Abraham et al. (1997) data set) 
Paper#51 (2) 
Fu  X. C. and Ma  X. W. and Liang  W. 
Q. 2002 
MV, Qh, QO.N, EHOMO, ELUMO n/a: ANN model 
 
alcohols, phenol derivates, carboxylic 
acids, steroids 
(Abraham et al.  (1997) data set) 
Paper#85 
Milewski  M. and Stinchcomb  A. L. 
2012 
MW: molecular weight 
Pow: octanol-water partition coefficient 
MP: melting point 
log J_max  
    
     
 = 4.6- 0.219 LogPow - 
0.0086 MW - 0.0102 (MP – 25) 
alcohols, steroids, phenol derivatives, 
and other chemical classes (Magnusson 
dataset) 
Single substance models (SSM) – 
Reserve list 
   
Paper#5 
Buchwald  P. and Bodor  N. 2001 
N: hydrogen bonding-related 
parameter for special functional groups 
log k_p = 0.0208 log V_e – 0.723N – 
2.69 
steroids, alcohols, phenol derivatives, 
pharmacologically active molecules, 
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Paper Model Parameters Model Algorithm Training Dataset 
(alternative to Paper#51) of molecules 
Ve: Van der Waals effective molecular 
volumes 
and other chemical groups 
Paper#112 
Thomas  J. and Majumdar  S. and 
Wasdo  S. and Majumdar  A. and Sloan  
K. B. 2007 (alternative to 
Paper#13/#85) 
log Soct: solubility in octanol 
logSaq: solubility in water 
MW: molecular weight 
log J_max = -2.574 + 0.5861 log Soct 
+ 0.4139 log Saq - 0.00440 MW 
phenols, hydrocortisone esters, 
aliphatic alcohols, aliphatic carboxylic 
acids, analgetics, steroids, 
miscellaneous (edited Flynn database) 
Paper#74 
Kilian  D. and Lemmer  H. J. R. and 
Gerber  M. and Du Preez  J. L. and Du 
Plessis  J. 2016 (alternative to #49) 
MW: molecular weight 
Pow: octanol-water partition coefficient 
log k_p = 0.739 log K_ow - 0.0089 MW 
- 2.36 
published datasets from Lian et al. 
(2008), Moss and Cronin (2002), 
Wilschut et al. (1995) 
Mixture models (MM)    
Paper#9 (1) 
Riviere  J. E. and Brooks  J. D. (2007) 
MW: molecular weight 
Pow: octanol-water partition coefficient 
mTPSA: mixture Topological Polar 
Surface Area difference 
logkp [cm/h] = -0.04 mTPSA - 0.03 
LogPow- 0.00080 MW - 2.05 
substituted phenols, 
organophosphates, triazine herbicides 
Paper#9 (2) 
Riviere  J. E. and Brooks  J. D. (2007) 
MW: molecular weight 
Pow : octanol-water partition coefficient 
mHA: mixture number of hydrogen 
bond acceptors 
 
logkp [cm/h] = -1.19 mHA - 0.03 
logPow - 0.00081 MW - 1.12 
substituted phenols, 
organophosphates, triazine herbicides 
Paper#15 (2) 
Atobe  T. and Mori  M. and Yamashita  
F. and Hashida  M. and Kouzuki  H. 
(2015) 
MW(chemical): molecular weight 
Pow (chemical): octanol-water 
partition coefficient 
Pow (vehicle): octanol-water partition 
coefficient 
n/a: ANN using MW(chemical), Pow 
(chemical), Pow (vehicle) 
hydrocarbons, alcohols, aldehydes, 
ketones, ethers, esters, carboxylic 
acids, amines, amides 
Mixture models (MM) – Reserve 
list 
   
Paper#15 (1) 
Atobe  T. and Mori  M. and Yamashita  
F. and Hashida  M. and Kouzuki  H. 
(2015) (alternative to Paper#9 (2)) 
MW(chemical): molecular weight 
Pow (chemical): octanol-water 
partition coefficient 
Pow (vehicle): octanol-water partition 
logkp [cm/h] =  −0.193 x logPow 
(chemical) x logPow (vehicle) + 0.00124 
x MW(chemical) x  logPow (vehicle) - 
0.00476 x MW(chemical) + 0.0184 x  
hydrocarbons, alcohols, aldehydes, 
ketones, ethers, esters, carboxylic 
acids, amines, amides 
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Paper Model Parameters Model Algorithm Training Dataset 
coefficient logPow (vehicle))^2 - 0.00000352 x 
MW(chemical)^2 - 2.23  
 
Paper#9 (3) 
Riviere  J. E. and Brooks  J. D. (2007) 
(alternative to Paper#9 (1)) 
MR: molar refractivity 
HBA: hydrogen bond acceptors = 
counts of hydrogen bond donors 
HBD: hydrogen bond acceptors = 
counts of hydrogen bond donors 
mTPSA: mixture Topological Polar 
Surface Area difference 
logkp [cm/h] = -0.04 mTPSA - 0.48 MR 
+ 0.09 HBA - 0.42 HBD - 0.49 
substituted phenols, 
organophosphates, triazine herbicides 
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3.4 Statistical analysis – general aspects 
3.4.1 The influence of lag-time 
As described in the model implementation sections (2.7) the predicted permeability constant kp or 
maximum flux Jmax derived by selected models were combined with DAME to yield %DA values. Two 
types of predictions were made for each model, one based on a lag time set to 0 ("worst case"), and 
one with a calculated lag time. This applies to all selected models with the exception of model 7. An 
initial analysis relating the results of the two sub-versions, showed that the differences between the 
two sub-versions of each model (tlag=0 vs calculated tlag) are not sufficient to merit producing a 
separate in-depth evaluation for each sub-version. When applicable, the calculated tlag sub-versions 
are used hereafter for all models in further assessment. The results are presented in detail in 
Appendix J. 
3.4.2 Variability between replicates and averaging 
The plots provided in the next chapters and appendices show averages of replicates within blocks of 
replicates ("block aggregates"). In principle, this is done to reduce the risk of bias due to varying 
numbers of replicates and one would also expect some reduction in statistical noise in relationships 
due to averaging. This should also be reflected in the outcome of the following correlation analyses. 
One might expect that predictions for a set of replicate measurements would all be the same and 
would therefore not need averaging. However, the models use the "Applied Concentration (µg/cm2) 
PER CELL" in calculations and this is not always constant for a group of replicates even though the 
"Concentration Tested (g/L or g/kg)" is constant within each group. When available, the computed 
values were derived by using as "applied concentration" the one that was introduced per replicate 
(Franz cell), i.e. in that particular cell. However, this was not always reported/measured at the 
individual replicate level. In these cases, the introduced concentration means from many 
replicates/cells of the same experimental block were used. For this reason, the relationship between 
predictions for pairs of replicates from within the same block of replicates was examined, as a 
measure of how closely related the single replicate values are to their averaged ones. As an example 
of the actual, the following plot shows the relationship between predictions by model 1 for pairs of 
replicates from within the same block of replicates. This should be noted as a limitation to the analysis 
of the influence on between replicate variability. In addition, it provides an additional reason to 
perform correlation analysis preferably on block aggregates in order to reduce the risk of bias due to 
varying numbers of replicates. 
  
Figure 3.1: Relationship between %DA predictions by model 1 for pairs of replicates from within the 
same block of replicates. X- and Y-axes correspond to predicted values for different replicates of the 
same block.  
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3.5 Performance of Single Substance Models 
3.5.1 Models 1, 2, 3, 4, 5, 6, 8 
3.5.1.1 Correlations 
Plots depicting the relationship between the experimental % Dermal Absorption (%DA) values and 
predicted values do not reveal any correlation. This is true both for individual replicates and for block 
aggregates (i.e. averages of measured replicates within blocks of replicates and corresponding 
average predictions). In addition to linear scales, log and logit transformations/scaling and 
combinations thereof were employed as an attempt to extract any visual relation, however with no 
success. Rank plots also do not show any correlation; this is not surprising since rank plots are known 
for reducing apparent association. 
Below, an example of the relationship between averages of measured replicates within blocks of 
replicates and corresponding average predictions with model 1 is provided. The calculated lag time 
version of the model was used (for explanations refer to 2.5.1 & Appendix J). Similar correlations are 
observed for the other models (models 2, 3, 4, 5, 6, 8) and are to be found in Appendix K. 
 
Figure 3.2: Relationship between the experimental % Dermal Absorption (%DA) values and the 
predicted ones with model 1 (M1), the combination of Frasch (2002) and Buist (2010) (DAME) model. 
Adjusted logit scales (Appendix H) are used for both axes, each data point corresponds to averaged 
values for a block of replicates. 
 
The visual observations stated above were confirmed by Spearman rho and Kendall tau rank 
correlations between measured and predicted %DA. 
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Table 3.7: Rank correlations between measured and predicted %DA for each model (or model 
version). The second and third columns refer to the correlations for individual replicates and 
corresponding %DA predictions. The fourth and fifth columns refer to the correlations for block 
aggregates, i.e. the mean of replicates within blocks and the corresponding averaged %DA prediction. 
Averages were computed using the adjusted logit scale (see section 2.8.1). For explanations on the 
models refer to Appendix G. 
Model 
Spearman 
rho -
replicates 
Kendall 
tau -
replicates 
No. of 
replicates  
Spearman 
rho - block 
aggregates 
Kendall 
tau - block 
aggregates 
No. of 
blocks  
1 0.11 0.07 6232 0.11 0.07 947 
2 0.12 0.08 6232 0.12 0.08 947 
3 (exp. Saq) 0.01 0.00 6050 0.00 0.00 919 
3 (calc. Saq) -0.01 -0.01 6232 -0.02 -0.01 947 
4 0.07 0.05 6224 0.07 0.05 946 
5 0.07 0.05 6200 0.08 0.06 943 
6 (exp. Saq) 0.04 0.03 6050 0.03 0.02 919 
6 (calc. Saq) 0.07 0.05 6232 0.07 0.05 947 
6 (exp. Saq, nT) 0.01 0.01 6050 -0.01 -0.01 919 
6 (calc. Saq, nT) -0.03 -0.02 6232 -0.04 -0.03 947 
8 -0.03 -0.02 6232 -0.03 -0.02 947 
3.5.1.2 Influence of covariates 
The relationships described above were broken down into subsets16 /plots that additionally 
distinguishbetween: 
i. dilution status (concentrate/in-use dilution) 
ii. dilution status (concentrate/in-use dilution) and formulation types (organic solvent/ 
solid/water based/other) 
Visual inspection of the relationship plots (Appendix L, Figure L.1 and Figure L.2) and rank correlation 
coefficients (Table 3.8a&b) revealed no apparent improvement for any of the subsets justifying 
statistical follow-up. 
Table 3.8a: Spearman rank correlations between measured and predicted %DA for each model (or 
model version), separately for concentrates and dilutions and the three main formulation groups. 
Block aggregates were used. For explanations on the models refer to Appendix G. 
Model Dilutions 
Concen-
trates 
Solids Water based 
Organic 
solvent 
1 0.18 (n=595) 0.17 (n=352) 0.14 (n=107) 0.03 (n=391) 0.16 (n=406) 
2 0.20 (n=595) 0.18 (n=352) 0.20 (n=107) 0.04 (n=391) 0.16 (n=406) 
3 (exp. Saq) 0.01 (n=576) 0.09 (n=343) -0.13 (n=105) -0.01 (n=374) 0.01 (n=399) 
3 (calc. Saq) -0.01 (n=595) 0.07 (n=352) -0.14 (n=107) -0.03 (n=391) 0.00 (n=406) 
4 0.14 (n=594) 0.10 (n=352) 0.19 (n=106) -0.04 (n=391) 0.18 (n=406) 
5 0.14 (n=592) 0.06 (n=351) 0.15 (n=106) -0.01 (n=388) 0.16 (n=406) 
6 (exp. Saq) 0.05 (n=576) 0.15 (n=343) -0.12 (n=105) 0.00 (n=374) 0.04 (n=399) 
6 (calc. Saq) 0.12 (n=595) 0.14 (n=352) -0.1 (n=107) 0.01 (n=391) 0.10 (n=406) 
6 (exp. Saq, nT) 0.00 (n=576) 0.02 (n=343) 0.06 (n=105) -0.03 (n=374) -0.03 (n=399) 
6 (calc. Saq, nT) -0.02 (n=595) -0.02 (n=352) -0.1 (n=107) -0.03 (n=391) 0.00 (n=406) 
8 -0.06 (n=595) -0.00 (n=352) -0.13 (n=107) -0.05 (n=391) -0.09 (n=406) 
 
                                               
16 Sub-categorisation is in line with the proposals outlined in the revised EFSA Dermal Absorption guidance (2017) 
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Table 3.8b: Kendall tau rank correlations between measured and predicted %DA for each model (or 
model version), separately for concentrates and dilutions and the three main formulation groups. 
Block aggregates were used. For explanations on the models refer to Appendix G. 
Model Dilutions 
Concentrate
s 
Solids Water based 
Organic 
solvent 
1 0.12 (n=595) 0.12 (n=352) 0.09 (n=107) 0.02 (n=391) 0.11 (n=406) 
2 0.13 (n=595) 0.12 (n=352) 0.13 (n=107) 0.03 (n=391) 0.11 (n=406) 
3 (exp. Saq) 0.01 (n=576) 0.06 (n=343) -0.09 (n=105) -0.01 (n=374) 0.01 (n=399) 
3 (calc. Saq) 0.00 (n=595) 0.05 (n=352) -0.09 (n=106) -0.02 (n=391) 0.00 (n=406) 
4 0.09 (n=594) 0.07 (n=352) 0.13 (n=106) -0.02 (n=391) 0.13 (n=406) 
5 0.09 (n=592) 0.04 (n=351) 0.10 (n=107) -0.01 (n=388) 0.11  (n=406) 
6 (exp. Saq) 0.04 (n=576) 0.11 (n=343) -0.08 (n=105) 0.00 (n=374) 0.03 (n=399) 
6 (calc. Saq) 0.09 (n=595) 0.10 (n=352) -0.06 (n=107) 0.01 (n=391) 0.07 (n=406) 
6 (exp. Saq, nT) 0.00 (n=576) 0.02 (n=343) 0.04 (n=105) -0.02 (n=374) -0.02 (n=399) 
6 (calc. Saq, nT) -0.01 (n=595) -0.01 (n=352) -0.06 (n=107) -0.02 (n=391) 0.00 (n=406) 
8 -0.04 (n=595) 0.00 (n=352) -0.09 (n=107) -0.04 (n=391) -0.06 (n=406) 
 
3.5.1.3 Predictive capacity 
In addition to the above exploration of the predictive capacity of the models by considering plots of 
measured absorption versus predicted absorption for each model and by calculating rank correlations 
between measured and predicted absorption, a more formal, empirical analysis of the predictive 
capacity of model 1 was performed. 
It needs to be noted that empirical analysis has two weaknesses. Firstly, the true absorption is not 
available and has to be approximated by measured absorption which may be either at the level of an 
individual cell or be the average of a block of replicates. Secondly, empirical analysis is specific to the 
particular substances, formulations as well as test conditions considered and does not attach any 
uncertainty to the results when extrapolating to consider a new active substance or formulation. 
For the analysis for model 1, averages of blocks of replicates were used. Even though, as stated 
above, no substantial correlation between measured and predicted absorption is evident, there is still 
a pattern of under- and over-prediction. Predictions which are low will tend to under-predict and 
predictions which are high will tend to over-predict. This is shown in Table 3.9 and Figure 3.3 (left 
panel) for model 1, where ratios of measured to predicted absorption are broken down by the range 
of the prediction. However, this pattern does not have any real predictive meaning. There would be 
no advantage of using the model predictions for a particular case than simply picking a random value 
from all the predictions made by the model (Figure 3.3, right panel). The apparently striking 
correlation in Figure 3.3 (left panel) arises from the fact that predicted absorption is included both as 
the variable on the horizontal axis and as the denominator in the ratio used for the vertical axis. It is 
well known that such correlations are often spurious (Kronmal, 1993). Similar considerations apply to 
the rest of the models (models 2-6 & 8). 
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Table 3.9: Table for model 1 of how frequently model exceeds measurement by specified factor or 
measurement exceeds model by specified factor. 
 Model absorption prediction  
(depending on range of predicted value) 
Number of blocks:  7 145 734 61 
Model prediction is: 0.1-1% 1-10% 10-100% 100% 
100 times lower than measured 0% 0% 0% 0% 
20 times lower than measured 0% 11% 0% 0% 
5 times lower than measured 0% 16% 0% 0% 
2 times lower than measured 71% 32% 1% 0% 
higher than measured 29% 53% 98% 100% 
2 times higher than measured 29% 43% 94% 97% 
5 times higher than measured 14% 21% 78% 89% 
10 times higher than measured 14% 17% 60% 70% 
100 times higher than measured 0% 1% 22% 26% 
 
 
 
 
Figure 3.3: Left panel: ratio of measured to predicted absorption versus predicted absorption for 
model 1. Vertical and horizontal lines highlight the categories used in Table 3.9. Right panel: Box and 
whisker plots of ratio of measure to predicted absorption using either (i) the specific prediction from 
model 1 for the measurement or (ii) a randomly selected prediction from model 1. Averages of blocks 
of replicates were used for both cases. 
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3.5.2 Model 7 – Dancik/NIOSH 
3.5.2.1 Correlations 
This part provides insight into the correlations between measured and model-predicted absorption 
values. Below, the relationship of the averages of replicates within blocks of measured replicates and 
their corresponding average model predictions is depicted. The use of averages aims to reduce the 
risk of bias due to varying numbers of replicates and the statistical noise in relationships due to 
averaging. Four versions of the same relationship, with different scales on the axes, are used. In each 
case, the measured absorption is on the vertical axis and the absorption predicted by model 7 is on 
the horizontal axis. The top-left panel shows the relationship using the unmodified percentage 
absorbed scale for both axes. The bottom-left panel uses the adjusted logit scale for the vertical axis. 
The bottom-right panel uses the adjusted logit scale for both axes. The top-right panel uses a rank 
scale for both axes. In other words, each measurement is replaced by its rank amongst all 
measurements and each prediction is replaced by its rank amongst all the predictions from the model. 
This panel does not depend on potentially arbitrary choices of scale and is the basis of the Spearman 
rank-correlations presented later.  
 
 
Figure 3.4: Relationship between the experimental % Dermal Absorption (%DA) values and the 
predicted ones with model 7 (M7), theNIOSH model. Top-left panel: unmodified (linear) percentage 
absorbed scale for both axes; bottom-left panel: adjusted logit scale for the vertical axis; bottom-right 
panel: adjusted logit scale for both axes; top-right panel: rank scale for both axes. 
 
From Figure 3.4, it is visually apparent that model 7 exhibits a positive correlation between measured 
and predicted %DA values, as seen on the bottom-right (adjusted logit) and top-right (rank scale) 
plots. This is confirmed by Spearman and Kendall tau rank correlations (Table 3.10). 
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Table 3.10: Rank correlations between measured and predicted %DA for model 7. The second and 
third columns refer to the correlations for individual replicates and corresponding %DA predictions. 
The fourth and fifth columns refer to the correlations for block aggregates, i.e. the mean of replicates 
within blocks and the corresponding averaged %DA prediction. For averaging, logit-transformation 
was applied (see section 2.8.1). 
Rank 
correlations 
Spearman 
rho -
replicates 
Kendall 
tau - 
replicates 
No. of 
replicates  
Spearman 
rho - block 
aggregates 
Kendall tau 
- block 
aggregates 
No. of 
blocks 
Model 7 0.61 0.43 1558 0.64 0.45 233 
 
 
The correlations in the table suggest that model 7 is worthy of further statistical investigation. For 
subsequent analyses, use of block aggregates obtained by averaging at the logit-scale appears 
preferable and is used unless indicated otherwise. 
3.5.2.2 Influence of covariates 
The better overall rank correlations for model 7 warrant detailed analyses examining the influence of 
covariates on correlation. First, the impact of restriction to subsets defined by concentration status 
and merged formulation type on the correlation between measured values and those predicted by 
model 7 was evaluated (Figure 3.5 & Table 3.11). Concentration status was linked to both, measured 
values and those predicted by model 7, confirming the recommendations in the EFSA guidance for 
selection of default assumptions based on concentration status. Sub-categorisation into concentrates 
and in-use dilutions did, however, not improve the correlation between measured and predicted data 
(Figure 3.5, left panel). The correlations within the two categories are weak. There is evidence of 
predictive relationships within some sub-groups representing the different groups of formulation types 
(Figure 3.5, right panel & Table 3.11a&b) although the correlations are not very strong, and are never 
stronger than the correlation using all the data shown in Table 3.10. 
 
 
  
Figure 3.5: Relationships between the averaged experimental % Dermal Absorption (%DA) values 
and values predicted by model 7, divided (left) according to concentration status into concentrates 
and in-use dilutions; (right) by formulations groups and into concentrates and dilutions. 
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Table 3.11a: Spearman rho rank correlations between measured and predicted %DA for model 7, 
separately for concentrates and dilutions and the three main formulation groups. Block aggregates 
were used. 
Spearman Rank 
correlation 
Dilutions Concentrates Solids 
Water 
based 
Organic 
solvent 
Model 7 0.38 (n=145) 0.15 (n=88) 0.67 (n=61) 0.58 (n=84) 0.64 (n=74) 
 
Table 3.11b: Kendall tau rank correlations between measured and predicted %DA for model 7, 
separately for concentrates and dilutions and the three main formulation groups. Block aggregates 
were used. 
Kendall tau 
Rank correlation 
Dilutions Concentrates Solids 
Water 
based 
Organic 
solvent 
Model 7 0.26 (n=145) 0.12 (n=88) 0.49 (n=61) 0.41 (n=84) 0.46 (n=74) 
 
Other covariates 
In addition to sub-setting for concentration status and merged formulation type, it was decided to 
perform additional detailed correlation analyses on more covariates as described in chapter 2.8.2.3. 
There are 233 data points (blocks of replicates) for which there is model 7 output. As described in 
2.8.2.2, the system of making four categories for each covariate was used. The results of the 
subcategorization are shown in Appendix L, Table L.1. For all subsets defined by that system which 
had at least 24 data points (10% threshold), correlation analysis was performed.  
No subset had a smaller P-value than the original data without sub-categorisation using Kendall's tau 
test for the correlation between model 7 output and measured absorption (data not shown). When 
looking at subsets which had a P-value no more than 100 times larger than for the original data, two 
subsets with improved correlation coefficients – active substances with pKa up to 9.4 or water 
solubility of at least 6.8 mg/L - could be identified for further consideration. 
 
Table 3.12: Improved correlation between measured and predicted dermal absorption using Model 7 
for selected subsets of data. 
Subset 
log_10 P-value 
from Kendall test 
Spearman rho Kendall tau n 
All data -24.2 0.64 0.45 233 
pKa ≤ 9.4 -23.9 0.72 0.52 176 
Water solubility (Saq) 
≥ 6.8 
-22.6 0.71 0.50 177 
Note: Very small P-values should not necessarily be interpreted as reflecting "extraordinarily 
significant" findings, as large datasets nearly always produce extreme statistical significance even 
when the predictive/scientific significance may not be much and the P-value assumes that the data 
points are a random sample (whereas here, there are hierarchical structures with multiple points per 
active substance). 
 
The subset of data with pKa>9.4 for active substances had a noticeably weaker correlation (Figure 
3.6). This subset would represent basic substances that predominantly carry cationic charges at 
neutral pH. Potentially, these may cause electrostatic interaction with polyanionic biopolymers of the 
skin, which might not be appropriately captured in model 7. When excluding predictions for active 
substances with pKa>9.4, the correlation of model 7 with measured data improved from 0.64 to 0.72.  
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For water solubility of active substances (Saq), an increase in correlation coefficient when restricting 
the analysis to solubilities ≥6.8 mg/L from 0.64 to 0.71 is observed (Table 3.12)., the figure below 
shows that data points relating to solubility below 6.8 mg/L (red points) within the subset containing 
substances with high pKa (bottom right in the panel) are less structured.  
 
 
Figure 3.6: Relationship between the averaged experimental % Dermal Absorption (%DA) values 
and those predicted using model 7, subdivided into pKa and Saq (water solubility in mg/l) categories, 
as defined Appendix L, Table L.1.  
Overall, Figure 3.6 illustrates that the P-values did not get smaller in the subsets because there is no 
really striking improvement in the pattern compared to the full dataset, neither when restricting pKa 
(compare individual figures of the panel) nor water solubility (compare colors). This cannot off-set the 
effect of the reduced number of data points on P-values. 
3.5.2.3 Predictive capacity 
In addition to the correlations analyses performed above (3.5.2.1 and 3.5.2.2), the predictive capacity 
of model 7 is analysed more formally by performing empirical analysis and statistical modelling. As 
noted in section 3.5.1.3, the empirical analysis performed in the present context faces some 
limitations. For that reason the predictivity was additionally explored by statistical/probabilistic 
modelling. 
Here, the empirical analysis of the predictive capacity was performed with averages of blocks of 
replicates. Model 7 has some real predictive power as seen from the corresponding table and figure 
(Table 3.13 & Figure 3.7, left panel) and box and whisker plots which show that the "error" tends to 
be smaller using the case-specific prediction than using a random prediction (Figure 3.7, right panel).  
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Table 3.13: Table for model 7 of how frequently model exceeds measurement by specified factor or 
measurement exceeds model by specified factor. 
 Model absorption prediction  
(depending on range of predicted value) 
Number of blocks: 28 31 77 79 3 
Model prediction is: 
0.01-
0.1% 
0.1-1% 1-10% 
10-
100% 
100% 
100 times lower than measured 7% 10% 0% 0% 0% 
20 times lower than measured 75% 26% 3% 0% 0% 
5 times lower than measured 86% 55% 10% 1% 0% 
2 times lower than measured 100% 74% 29% 5% 0% 
higher than measured 0% 10% 53% 91% 100% 
2 times higher than measured 0% 3% 39% 71% 100% 
5 times higher than measured 0% 3% 13% 39% 67% 
10 times higher than measured 0% 3% 6% 14% 33% 
100 times higher than measured 0% 3% 1% 0% 0% 
 
 
 
Figure 3.7: Left panel: Ratio of measured to predicted absorption versus predicted absorption for 
model 7. Vertical and horizontal lines highlight the categories used in Table 3.13. Right panel: Box and 
whisker plots of ratio of measured to predicted absorption using either (i) the specific prediction from 
model 7 for the measurement or (ii) a randomly selected prediction from model 7. 
 
However, the scatter-plot of measured versus predicted absorption (Figure 3.4, lower-left panel) 
shows that model 7 still tends to over-estimate absorption when it makes a high prediction and to 
under-estimate absorption when it makes a low prediction. This can in principle be corrected by using 
a regression model as described below.  
For the statistical modelling analysis, Bayesian modelling was employed. The aim was to develop a 
Bayesian random effects model (BREM) that can incorporate components relating to important 
features of the problem: 
(A) the fact that, despite the correlation, model 7 exhibits biases in relation to low and high 
predicted absorption can be addressed by building a regression relationship between true 
absorption and model prediction. A key assumption made in doing so is that there is a real 
predictive relationship which is not, for example, due solely to differences between 
concentrates and dilutions. 
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(B) the regression "error" term can be structured hierarchically: 
- component for variation between active substances ("random effects" of active 
substance) 
- component for variation between blocks of replicates for the same active substance 
("random effects" representing different studies, concentrations, etc for 
measurements on the same substance) 
- component for variation between replicates within a block 
The box and whisker plots shown in Figure 3.8 demonstrate the homogeneity of within-block 
variability for dilutions and concentrates, across formulation groups and for different concentration 
levels. The quantile-quantile plot demonstrates that the variability between replicates is not normal, 
since there is clear evidence of heavy-tails (Figure 3.9). 
 
  
Figure 3.8: Boxplots assessing homogeneity of within-block variability for concentrates and dilutions 
(left) and for formulation groups (right). 
 
 
Figure 3.9: Quantile-quantile plot of differences of adjusted-logit values for pairs of replicates from 
the same block. 
The regression relating true absorption to model prediction was based on a linear relationship 
between the adjusted-logit of true absorption and the logarithm (base 10) of the model prediction (as 
a percentage x%). This relationship is shown in the figure where the solid black curve shows where 
predicted and measured absorption are equal and the solid red line shows the line of best fit (least 
squares) corresponding to the regression carried out in the conventional way without hierarchical 
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structure for the regression errors. The logarithm was used because it results in a clearly linear 
relationship in Figure 3.10 whereas the bottom-right panel of Figure 3.4, which uses  the adjusted-
logit scale for the model prediction, has some non-linearity. 
 
 
Figure 3.10: Measured absorption versus model 7 prediction using adjusted logit scale for the former 
and logarithm scale for the latter. The solid black curve is shows where measured equals predicted; it 
is not a straight line because the axes have different scales. The red line is the line of best fit (least 
squares) using the adjusted logit and logarithmic scales. i.e. it is the regression line for predicting the 
adjusted logit of measured absorption from the base 10 logarithm of the predicted absorption. 
The observed rank correlation for the relationship in the figure is 0.64. The standard (Pearson 
product-moment) correlation for the strength of linear relationship in the regression is 0.59. 
Table 3.14: Results of fitting the BREM for model 7. 
BREM parameter Estimate 
95% credible interval 
Lower limit Upper limit 
Intercept of linear relationship -3.52 -3.87 -3.18 
Slope of linear relationship 1.01 0.86 1.15 
Standard deviation of variation between substances 0.98 0.71 1.33 
Standard deviation of variation between blocks for the 
same substance 
1.13 1.02 1.27 
Scale of variation between replicates within a block 0.46 0.42 0.49 
Degrees of freedom for within-block variation t-
distribution 
3.1 2.5 3.8 
 
The BREM, described technically in 2.8.3 and Appendix I, has structure which allows evaluation of 
how well a model predicts true absorption and what kind of correlations should be expected from an 
empirical analysis of the type reported earlier. However, there is an ambiguity about which sources of 
variation should be excluded when defining "true absorption". Clearly, variability between replicates 
should be excluded. However, it is possible that some or all of the variation between studies should 
also be excluded. This is however more difficult to define and implement. Consequently, the focus 
here is on predicting the true absorption for each block of replicates. 
Although the BREM includes a representation of the true absorption, the true absorption remains 
unknown. To assess the likely level of observed correlation between true absorption and measured 
absorption, two scenarios were considered: (i) where the model prediction is exactly correct; (ii) 
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where the measured absorption is exactly correct. In both scenarios, the correlation was computed 
between the assumed true absorption and synthetic data with measurement variability added 
according to the BREM component describing variability between replicates. The process for 
generating synthetic data is random and so the correlation obtained varies if the process is repeated. 
1000 synthetic data-sets were generated for each scenario. For scenario (i), 95% of the resulting rank 
correlations for individual cell data were in the range [0.969, 0.978] and and for averages were in the 
range [0.991, 0.996]. For scenario 2, the corresponding ranges were [0.923, 0.942] and [0.980, 
0.990]. Clearly the observed correlations in Table 3.10 are much lower than this and this analysis 
indicates that they are not low simply due to variability of absorption measurements within blocks. 
The BREM enables quantification of the probability that the model over- or under-estimates the true 
absorption by any specified amount at any specified level of model prediction. It also enables 
quantification of statistical uncertainty relating to the probability. 
  
Figure 3.11: Probability that model 7 under-predicts (left) or over-predicts (right) true absorption by 
specified factor. Factors: 1 (black), 2 (red), 5 (green), 10 (blue), yellow (100). 
 
Adjusted predictions of model 7 
The BREM can also be used to adjust the prediction of model 7 in order to try to adjust for the 
tendency for predictions of low absorption to under-predict and for predictions of high absorption to 
over-predict. By passing the output of the model through the linear regression, it is possible to 
achieve better predictive performance. The method is to compute the (base 10) logarithm of the 
prediction from model 7, multiply by the estimate of the slope parameter from table 13 and add the 
estimate of the intercept parameter from table 13, and complete the prediction by inverting the 
adjusted-logit calculation.  
For example, if the model predicts 0.5% absorption, the adjusted prediction can be obtained as 
follows. First apply the regression equation to find the adjusted-logit of the adjust prediction using the 
linear regression: 
                                
Then apply equations (2) and (3) from appendix H to undo the logit and then undo the shrinking used 
in the adjusted-logit: 
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The adjusted prediction is 0.0211 = 2.11% absorption. 
The estimated probability that the adjusted prediction exceeds the true absorption by a specified 
factor can then be calculated using the BREM. Figure 3.12 illustrates the resulting performance. It 
should be recognised that the adjustment and calculation of performance are both conditional on the 
BREM being a good statistical model for the data and on the data being appropriately representative.  
 
  
Figure 3.12: Estimated probability that adjusted model 7 under-predicts (left) or over-predicts (right) 
true absorption by a specified factor. Factors: 1(black), 2(red), 5 (green), 10 (blue), yellow (100). 
Solid lines represent the probability of over-/underestimating by a specified factor. The dashed lines 
indicate "uncertainty about the probability of over-/underestimating by the specified factor". To be 
more precise, for a fixed value on the horizontal axis (adjusted prediction from model 7), the dashed 
lines indicate a "95% credible interval for the frequency with which the adjusted prediction will over-
/underpredict by at least the specified factor" where "frequency" refers to repeat use of the adjusted 
model for new substances. The uncertainty shown is the uncertainty from within the BREM and does 
not cover uncertainty about the structure of the statistical model used to relate measured absorption 
to predicted absorption. 
 
It can be seen that the estimated probability of under- or over-estimating absorption by a specified 
factor is much less dependent on the level of absorption prediction when comparing the adjusted 
model to the original model. This indicates that that approach is reasonably successful. The 
probabilities of under-prediction fall away at high predicted absorption but this is  a  consequence of 
the fact that absorption cannot exceed 100%. For over-prediction, the estimated probabilities increase 
little for low predicted absorption and this is due to the adjustment made to the logit scale. 
Despite the success in achieving reasonably homogeneous under- and over-prediction probabilities, 
there is still a high chance of substantial under- or over-prediction. This is due to the relatively weak 
correlation between predicted and measured absorption. The strength of correlation is a fundamental 
limitation on the process of adjusting model predictions. 
Further considerations on uncertainties in model prediction are presented in chapter 3.8 focussing on 
regulatory relevance. 
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3.6 Performance of Mixture Models  
3.6.1 Models 9 and 10 – Riviere Brooks 2007 1&2 
3.6.1.1 Correlations 
Below, the relationship of the averages of replicates within blocks of measured replicates and their 
corresponding average model predictions is depicted. The use of averages aims to reduce the risk of 
bias due to varying numbers of replicates and the statistical noise in relationships due to averaging. 
For all these figures the calculated lag time version of the model was used (for explanations refer to 
2.5.1 & Appendix J). Four versions of the same relationship, with different scales on the axes, are 
used. In each case, the measured absorption is on the vertical axis and the absorption predicted by 
models 9 and 10 is on the horizontal axis. The top-left panel shows the relationship using the 
unmodified percentage absorbed scale for both axes. The bottom-left panel uses the adjusted logit 
scale for the vertical axis only. The bottom-right panel uses the adjusted logit scale for both axes. The 
top-right panel uses a rank scale for both axes. In this representation, each measurement is replaced 
by its rank amongst all measurements and each prediction is replaced by its rank amongst all the 
predictions from the model.  This panel does not depend on potentially arbitrary choices of scale and 
is the basis of the Spearman rank-correlations presented later. 
Figure 3.13 reveals somewhat positive correlations between measured and predicted %DA for Models 
9 and 10.These findings are in line with the Spearman rho and Kendall tau rank-correlations analysis 
presented in Table 3.15. The correlations in the table suggest that the mixture models 9 & 10 are 
worthy of further statistical investigation. For further analyses, use of block aggregates obtained by 
averaging at the logit-scale appears preferable and is used unless indicated otherwise. 
 
 
  
Figure 3.13: Relationship between the experimental % Dermal Absorption (%DA) values and the 
predicted ones with (left) model 9 (M9), the combination of Riviere & Brooks (2007) algorithm No.1 
and Buist (2010) (DAME) model using calculated lag-time; and (right) model 10 (M10), the 
combination of Riviere & Brooks (2007) algorithm No.2 and Buist (2010) (DAME) model using 
calculated lag-time. Top-left panels: unmodified (linear) percentage absorbed scale for both axes; 
bottom-left panels: adjusted logit scale for the vertical axis; bottom-right panels: adjusted logit scale 
for both axes; top-right panels: rank scale for both axes. 
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Table 3.15: Rank correlations between measured and predicted %DA for models 9 and 10. The 
second and third columns refer to the correlations for individual replicates and corresponding %DA 
predictions. The fourth and fifth columns refer to the correlations for block aggregates, i.e. the mean 
of replicates within blocks and the corresponding averaged %DA prediction. Averages were computed 
using the adjusted logit scale (see section 2.8.1). 
Model 
Spearman 
rho 
Replicates 
Kendall tau 
Replicates 
Number of 
replicates  
Block 
aggregates 
Kendall tau  
Block 
aggregates 
Number 
of blocks 
9 0.39 0.26 945 0.43 0.29 155 
10 0.37 0.25 945 0.41 0.27 155 
 
3.6.1.2 Influence of covariates 
The influence of covariates on the correlation detected in the previous section was examined by 
splitting the dataset into various subsets. First, the impact of restriction to subsets defined by 
concentration status and merged formulation type on the correlation between measured values and 
those predicted by mixture models 9 and 10 was evaluated (Figure 3.14 & Table 3.16).  
 
  
  
Figure 3.14: Relationships between the averaged experimental % Dermal Absorption (%DA) values 
and values predicted by models 9 (top) and 10 (bottom), divided according to (left) concentration 
status into concentrates and in-use dilutions; (right) by formulations groups and into concentrates and 
dilutions. 
Concentration status was linked to both, measured values and those predicted by models 9 and 10, 
confirming the recommendations of EFSA for selection of default assumptions based on concentration 
status. Overall, subsetting for concentration status and formulation type did not lead to the 
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identification of stronger relationships. Only for water based formulations there appears to exist an 
improved relationship for both models 9 and 10; a finding also supported by the respective Spearman 
and Kendall tau rank correlations that are higher than the ones for the whole dataset. 
 
Table 3.16a: Spearman rank correlations between measured and predicted %DA, separately for 
concentrates and dilutions and the three main formulation groups. Block aggregates were used. 
Model Dilutions Concentrates Solids Water based 
Organic 
solvent 
9 0.00 (n=99) 0.17 (n=56) -0.14 (n=23) 0.51 (n=72) 0.41 (n=55) 
10 0.03 (n=99) 0.20 (n=56) -0.14 (n=23) 0.52 (n=72) 0.31 (n=55) 
 
Table 3.16b: Kendall tau rank correlations between measured and predicted %DA, separately for 
concentrates and dilutions and the three main formulation groups. Block aggregates were used. 
Model Dilutions Concentrates Solids Water based 
Organic 
solvent 
9 0.00 (n=99) 0.10 (n=56) -0.09 (n=23) 0.35 (n=72) 0.28 (n=55) 
10 0.03 (n=99) 0.13 (n=56) -0.08 (n=23) 0.35 (n=72) 0.21 (n=55) 
 
Other covariates 
In addition to sub-setting for concentration status and merged formulation type, additional correlation 
analyses on more covariates, as described in chapter 2.8.2.3, were performed. There are 155 data 
points (blocks of replicates) for which there is model 9 and 10 output. The system of making four 
categories for each covariate was used, as described in 2.8.2.2. The results of the sub-categorization 
are shown in Appendix L, Table L.2. For all subsets defined by that system which had at least 16 data 
points (10% threshold), correlation analysis was performed. 
Model 9 had eleven subsets of data with lower P-value than for all the data. In all of these cases, the 
Spearman and Kendall tau correlations were higher for the subset than for all the data.  
 
Table 3.17: Improved correlation between measured and predicted dermal absorption using model 9 
for selected subsets of data. 
Subset 
log_10 P-value 
from Kendall test 
Spearman 
correlation 
Kendall tau n 
Conc>0.58 -8.2 0.53 0.37 116 
HB≤7 -7.9 0.49 0.33 132 
Charge>0.59, 4<HB≤7 -7.5 0.67 0.49 60 
Charge>0.59, Conc>0.58, 
HB>4 
-7.4 0.69 0.51 56 
Conc>0.58, HB>4 -7.3 0.61 0.43 74 
Conc>0.58, HB≤7 -7.2 0.52 0.36 106 
HB≤7, logPow>1.25 -7.1 0.53 0.37 100 
4<HB≤7 -7.1 0.57 0.41 80 
Conc>0.58, logPow>1.25 -7.0 0.56 0.38 90 
Conc>0.58, logPow≤4.11 -7.0 0.56 0.39 87 
Conc>0.58, MW>249 -6.9 0.57 0.39 85 
All data -6.9 0.43 0.29 155 
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In particular, sub-categorisation for concentration of the active substance and HB, the sum of 
hydrogen bond donors and acceptor numbers had the potential to improve correlation between 
measured and predicted values. Correlation was better when excluding the lowest category of test 
item concentration, i.e. very dilute mixtures, and when excluding active substances with low and high 
hydrogen bonding capacity. Figure 3.15 illustrates that the lowest and highest sub-ranges for HB have 
weaker association than the middle two ranges and removing the red points (lowest concentration 
range) clearly strengthens the associations, especially for the highest HB range. Restricting molecular 
weight to >249 g/mol may improve correlation (Spearman rho from 0.53 to 0.57) as this excludes 
preferentially small molecules which should typically have lower number of hydrogen bond donors / 
acceptors. 
Model 10 had three subsets with lower P-value than for all the data and in every case the Spearman 
and Kendall tau correlations were higher than for all the data. As for Model 9, exclusion of data points 
associated with low test item concentrations (Table 3.18, Conc>0.58) and high number of hydrogen 
bond donors/acceptors (Table 3.18, HB≤7) improved correlation between measured and predicted 
data (Spearman rho from 0.41 to 0.50 and to 0.46, respectively). As illustrated in Figure 3.15, the 
model predicts much the same percentage dermal absorption for most cases with higher logPow. The 
previously described observation that high concentration yields lower measured absorption may be 
causative for improved correlation when excluding the data points relating to dilute test items.  
It is considered that restriction of the model to certain ranges of logPow and/or concentration may 
optimise the predictive capacity of model 10. For example, the correlation in the subset with 
logPow≤4.11 and concentration above 0.58 g/L was 0.56 or 0.39 compared to 0.41 or 0.27 for the 
unrestricted dataset when performing Spearman or Kendall rank correlation analysis. 
 
Table 3.18: Improved correlation between measured and predicted dermal absorption using Model 
10 for selected subsets of data. 
Subset 
log_10 P-value 
from Kendall test 
Spearman 
correlation 
Kendall tau n 
Conc>0.58 -7.2 0.50 0.34 116 
HB≤7 -7.0 0.46 0.31 132 
Conc>0.58, 
logPoW≤4.11  
-6.9 0.56 0.39 87 
All data -6.4 0.41 0.27 155 
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Figure 3.15: Relationship between the averaged experimental % Dermal Absorption (%DA) values 
and those predicted using: (left) model 9, subdivided into HB and Conc. (number of Hydrogen Bonds 
and concentration in mg/l, respectively) categories; (right) model 10, subdivided into LogPow and 
Conc. (concentration in mg/l) categories. Categories created as defined in Table L.2.  
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3.6.1.3 Predictive capacity 
In addition to the correlations analyses presented above (3.6.1.1 and 3.6.1.2), a more formal, 
empirical analysis of the predictive capacity of models 9 and 10 is shown here.  
The empirical analysis of the predictive capacity for models 9 and 10 was conducted with averages of 
blocks of replicates. In comparison to model 7, the predictive capacity of models 9 and 10 is not as 
strong. This can be seen in Figure 3.16 where the difference between using the specific prediction and 
a randomly selected prediction is not as great as for model 7. This is due to the weaker correlation 
between predicted and measured absorption for these models. As previously noted (section 3.5.1.3), 
the empirical analysis performed in the present context faces some limitations. Even though it would 
be possible to complement the empirical approach with statistical modelling (as for model 7 in 
3.5.2.3), the results outlined here do not suggest that this follow-up would not facilitate the 
understanding of the predictivity. 
 
  
  
Figure 3.16: Left panels: Ratio of measured to predicted absorption versus predicted absorption for 
(top left) model 9 and (lower left) model 10. Vertical and horizontal lines highlight the categories used 
in Table 3.19 and Table 3.20. Right panels: Box and whisker plots of ratio of measured to predicted 
absorption using either (i) the specific prediction from model 9 (top right/ model 10 (lower right) for 
the measurement or (ii) a randomly selected prediction from model 9 (top right)/ model 10 (lower 
right). 
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Table 3.19: Table for model 9 of how frequently model exceeds measurement by specified factor or 
measurement exceeds model by specified factor. 
 
Model absorption prediction 
(depending on range of predicted value) 
Number of blocks: 4 150 1 
Model prediction is: 1-10% 10-100% 100% 
100 times lower than measured 0% 0% 0% 
20 times lower than measured 0% 0% 0% 
5 times lower than measured 0% 0% 0% 
2 times lower than measured 25% 0% 0% 
higher than measured 75% 95% 100% 
2 times higher than measured 25% 82% 100% 
5 times higher than measured 25% 56% 0% 
10 times higher than measured 0% 39% 0% 
100 times higher than measured 0% 6% 0% 
 
 
Table 3.20: Table for model 10 of how frequently model exceeds measurement by specified factor or 
measurement exceeds model by specified factor. 
 
Model absorption prediction 
(depending on range of predicted value) 
Number of blocks: 2 123 30 
Model prediction is: 0.1-1% 1-10% 10-100% 
100 times lower than measured 0% 0% 0% 
20 times lower than measured 50% 0% 0% 
5 times lower than measured 50% 0% 0% 
2 times lower than measured 100% 25% 0% 
higher than measured 0% 50% 92% 
2 times higher than measured 0% 0% 80% 
5 times higher than measured 0% 0% 54% 
10 times higher than measured 0% 0% 39% 
100 times higher than measured 0% 0% 5% 
 
Further considerations on uncertainties in prediction of models 9 and 10 are presented in chapter 3.8 
focussing on regulatory relevance. 
 
3.6.2 Model 11 – Atobe 2015 
3.6.2.1 Correlations 
Similar to most of the models examined here (see 3.5.1.1 for other models), no correlation between 
experimental and predicted %DA was apparent for model 11 (plots are to be found in Appendix K). 
This visual finding is also in line with the study of rank correlations (i) between measured individual 
replicates and corresponding %DA predictions and (ii) between measured logit transformed block 
aggregates, i.e. the mean of replicates within blocks and the corresponding averaged %DA prediction. 
The analysis resulted in low Spearman rho and Kendall tau rank correlation coefficients, ranging from 
0.12 to 0.13 for Spearman rho and 0.08 to 0.09 for Kendall tau.  
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3.6.2.2 Influence of covariates 
To explore potentially improved correlations, the relationships described above were broken down into 
subsets/plots17 that additionally distinguish between: 
i. dilution status (concentrate/in-use dilution) 
ii. dilution status (concentrate/in-use dilution) and formulation types (organic solvent/ 
solid/water based/other) 
The relationship plots (Appendix L, Figure L.1 & Figure L.2) and Spearman/Kendall tau rank 
correlations (Table 3.21a&b) revealed no apparent improvement in the correlation for any of the 
formulation types, justifying a more detailed statistical follow-up. 
 
Table 3.21a: Spearman rank correlations between measured and predicted %DA for model 11, 
separately for concentrates and dilutions and the three main formulation groups. Block aggregates 
were used. 
Spearman Rank 
correlation 
Dilutions Concentrates Solids Water based 
Organic 
solvent 
Model 11 -0.01 (n=99) 0.4 (n=56) 0.08 (n=23) 0.06 (n=72) 0.13 (n=55) 
 
Table 3.21b: Kendall tau rank correlations between measured and predicted %DA for model 11, 
separately for concentrates and dilutions and the three main formulation groups. Block aggregates 
were used. 
Kendall tau 
Rank 
correlation 
Dilutions Concentrates Solids Water based 
Organic 
solvent 
Model 11 -0.01 (n=99) 0.28 (n=56) 0.06 (n=23) 0.03 (n=72) 0.08 (n=55) 
 
3.7 Performance of Model Combinations  
One of the objectives of the present study was to explore the possibility to improve predictions by 
model combination. Various combinations of the three strongest models 7, 9 and 10 were examined 
using the subset of the data for which the mixture models were applicable and predictions were 
available from both model 7 and the mixture models. As shown in Table 3.22, however, none of the 
combinations did a correlation that can be considered substantially better than the best individual 
model (here: model 9). It is considered unlikely that weighted averaging or use of a different form of 
mean would have a substantial impact on this outcome. However, this doesn't rule out the possibility 
that the models have different domains of strength, defined for example by certain physico-chemical 
properties of the active substance, or that particular combinations could perform more strongly in 
some restricted domain. Although some indications for better performance of individual models within 
such restricted domains were seen in the covariates analyses, the improvement of the quality of the 
correlation was moderate and at the price of significantly reducing the size of the corresponding data 
set. The number of blocks for the analysis in table 3.21 is already low and would become lower if 
subsets of the data were considered for models being combined and therefore this possibility was not 
pursued. In summary, this does currently not provide much encouragement for averaging. 
 
                                               
17 Sub-categorisation is in line with the proposals outlined in the revised EFSA Dermal Absorption guidance (2017) 
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Table 3.22: Various combinations of the three strongest models. Correlations were calculated for 
block aggregates using the subset of the data (n=44 blocks of replicates) for which model 7 was 
applied and for which the mixture models were applicable and provided output. 
Combination of models 
Correlation with measured 
absorption (Spearman rho) 
Correlation with measured 
absorption (Kendall tau) 
7 alone 0.48 0.32 
9 alone 0.57 0.41 
10 alone 0.54 0.38 
7 and 9 averaged 0.59 0.41 
7 and 10 averaged 0.58 0.39 
9 and 10 averaged 0.57 0.41 
7 and 9 and 10 averaged 0.59 0.43 
minimum of 7 and 9 0.52 0.35 
minimum of 7 and 10 0.52 0.34 
minimum of 9 and 10 0.54 0.38 
minimum of 7, 9 and 10 0.52 0.34 
maximum of 7 and 9 0.59 0.41 
maximum of 7 and 10 0.58 0.40 
maximum of 9 and 10 0.57 0.41 
maximum of 7, 9 and 10 0.59 0.41 
 
3.8 Regulatory relevance of tested models  
Member state consultation (see chapter 2.9) revealed several points of concern currently limiting the 
integration of in silico tools in the estimation of dermal absorption for pesticide risk assessment. 
This included the relevance of the applicability domain of models for the prediction of dermal 
absorption of pesticides. Accordingly, both the literature assessment and the model selection took into 
consideration this issue. Only models with wide applicability domains - representing the majority of 
cases - were taken forward for detailed evaluation, while those limited to a certain class of chemicals 
were not considered potentially relevant to regulatory assessment of pesticides.  
Another concern related to validation and transparency of model algorithms. Therefore, only 
publications that provided details on the training sets used for model development and the model’s 
applicability domain were considered in detail in the literature review. Only well-defined and explicit 
algorithmic models and reconstructible machine learning models were evaluated further. Although 
proprietary in silico models were not excluded from the start, all of the eleven models that were 
eventually tested for predictivity are publicly available and easily accessible to the experts for use. The 
original published papers also provide statistical parameters to illustrate the goodness-of-fit, 
robustness and predictivity of the models as well as external validations. An additional asset is that for 
the tested models input data are accessible to a risk assessor or there are software tools available to 
calculate descriptors necessary to run the models. Thus, for all tested models, it should be feasible for 
an expert/risk assessor to both retrieve any of them and perform predictions.  
Interestingly, a range of parameters that were regarded by experts as potentially influencing dermal 
absorption of pesticides were not taken into consideration by the models identified and evaluated 
here. This includes the substance/product classification with regard to skin irritation/corrosion or the 
effects of active substances and co-formulants on the stratum corneum, skin metabolism or surface 
tension of the active substance. 
In this context, it is worth to note that the best performing models represented either mixture models 
(models 9 and 10), taking into account physicochemical properties of the co-formulants aggregated 
into a "mixture factor", or the complex single substance model no.7, which accounts for the type of 
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vehicle. Therefore, the outcome of the analysis may be related to this capacity. Information on the 
composition of the formulation was available only for a subset of the data, restricting the evaluation of 
the mixture models 9 and 10. Likewise, the manual effort associated with implementation of model 7 
restricted the dataset for evaluation of this approach as well, although representativeness was 
assured. 
Model 7 or "NIOSH model" is a complex spreadsheet-based model for estimating bioavailability of a 
chemical from dermal exposure. The model takes into consideration differences in skin parameters 
between species (e.g. rat or human), anatomical site, temperature (of skin) and hydration of stratum 
corneum. It also takes into consideration the experimental conditions e.g. state of occlusion 
(occlusive, semi-occlusive or non-occlusive) or preparation of the skin sample (epidermal sheet, 
dermatomed skin or full-thickness skin) and duration of exposure. Further, it also considers some 
physicochemical properties of the formulations (e.g. pH) and their in-use dilutions, the active 
substance (e.g. physical state, molecular weight, lipid/water partition coefficient, ionization, water 
solubility, pKa), the vehicle(s) and other co-formulants (e.g. solubility, volatility). Also, the partition 
partition coefficient of the compound of interest between vehicle and water needs to be known or 
estimated. For the purpose of the project, the vehicle was either treated as water or octanol 
depending on formulation type and dilution status allowing the use of Ko/w. Since a common template 
is available for this model, competent authorities and applicants could, in principle, perform the 
predictions in a harmonised manner. The wide variety of exposure and computation settings that are 
offered by the model, requires users to make assumptions before performing any calculation, as also 
seen in the present study and extensively described in 2.7.1.7. As these may influence model 
prediction, agreement on these choices would be necessary and a practical guide should be available 
to avoid other pitfalls. 
Models 9 and 10 are both algorithm-based, mixture models that predict kp
 by considering the 
octanol/water partition coefficient and the molecular weight of the active substance as well as the 
physical-chemical properties of the mixture based on its components (mixture factor). In model 9 the 
mixture factor is related to the topological polar surface area of the mixture, whereas in model 10 it is 
related to the number of hydrogen bond acceptor of the mixture. For development of models 9 & 10, 
test compounds were diluted in different vehicles by creating in total 24 different vehicle mixtures 
from ethanol, methylnicotinic acid, propylenglycol, sodium laureth sulfate and water. Therefore, the 
training dataset can be considered to include aqueous and organic based formulations. There is no 
information in the publication regarding the use of solids. No other physicochemical properties of the 
formulation are considered. There is also no consideration of the complexity of skin or the 
experimental conditions in either of models 9 or 10. Accordingly, there may be various options for 
refinement of these models.  
The overall outcome of the performance of models 7, 9 and 10, as presented in detail in chapters 3.5 
and 3.6, has been the basis for further discussion on their potential integration within the regulatory 
framework. With respect to the outcome of the survey with the MSCA experts (see chapter 3.1), the 
following points have been further elaborated: 
The possibility to improve predictivity by restriction to subsets of data, i.e. by narrowing the 
applicability domain, was investigated. This included proposals to consider subsets for (a) 
concentrates and dilutions or (b) different formulation types (three main formulations groups have 
been considered, i.e. solids, water-based and organic solvent). In some cases, predictivity was slightly 
but not strikingly improved. Similarly, the consideration of testing the skin type (full thickness, dermis, 
epidermis, scissors) as a covariate was not successfull. For model 7, no new subsets could be 
produced with regard to SkinType. The correlation outcome for models 9 and 10, when subsetting the 
data with respect to SkinType, was not stronger compared to the non-subsetted dataset (data not 
included). 
Since model 7 performed slightly better than models 9 and 10, more extensive analyses were 
performed. When pKa was used for subgrouping of substances in the statistical analysis of this model, 
it was revealed that there might be a difference in predictivity for substances with pKa ≤ 9.4 and 
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those with pKa > 9.4. It is noted that during implementation of model 7, pKa data (either measured 
or calculated) were not included in the prediction, since pKa is one of the optional input parameters in 
the model (Dancik et al., 2013). It would thus be interesting to further investigate the influence of 
pKa and other optional physical-chemical properties, such as water solubility, density, vehicle 
solubility, non-ionised unbound fractions, on the predictivity of model 7.  
Finally, a Bayesian random effects model (BREM) was used to adjust the prediction of model 7 in 
order to achieve better predictive performance as described in chapter 3.5.2.3. Using this approach, 
adjustment for the tendency for predictions of low absorption to under-predict and for predictions of 
high absorption to over-predict was made. 
Within the established tiered approach for assessment of dermal absorption of pesticides, modelling 
would allow a refinement over default values only when reliable values below the applicable defaults 
are predicted. Accordingly, predictions from models 7, 9 and 10, taking into account the degree of 
over- und under-predictions, were compared to default values as presented in the new EFSA Guidance 
(EFSA, 2017). First, an analysis was conducted to calculate the percentage of experimental blocks for 
which each of models 7, adjusted model 7 as well as models 9 and 10 gives predictions below the 
respective default value as set in the Table 2 in the EFSA GD (2017). Results are summarised in 
Tables 3.23 and 3.24 below. The possibility to also use assessment factors (AF) of 5 and 10 to the 
adjusted predictions from model 7 was further investigated. The assessment factor was applied by 
first calculating the adjusted prediction from model 7 and then multiplying the result by the 
assessment factor. If the result exceeds 100%, it is is capped at 100%. Continuing the earlier 
example, if model 7 predicts 0.5% absorption, the adjusted prediction is 2.1% which becomes 
               when an assessment factor of 5 is applied or 21% if the assessment factor is 10. 
It was shown that in case of the adjusted model 7 (Table 3.23) 100% of the predicted values are less 
than the respective EFSA (2017) default values for both the concentrate and the dilution for all 
formulation types. Thus, if acceptable, this model would allow refinement of default values in 
essentially all cases. For the other models, the percentage of cases were refinement may be possible 
was dependent on the formulation group, the dilution status and the application of an assessment 
factor. 
Table 3.23: For model 7 and adjusted model 7 with and without assessment factor (AF): percentage 
of blocks for which prediction is less than the EFSA (2017) default value based on formulation group 
and concentrate/dilution status. 
Formulation 
group 
Concentrate 
or Dilution 
Default 
value 
Model 
No of 
blocks  
7 7 adj. 
7 adj., 
AF=5 
7 adj., 
AF=10 
Organic solvent Dilution 70% 58% 100% 54% 27% 52 
Organic solvent Concentrate 25% 95% 100% 91% 82% 22 
Other Dilution 70% 50% 100% 50% 25% 8 
Other Concentrate 25% 100% 100% 100% 25% 4 
Solid Dilution 50% 71% 100% 46% 20% 35 
Solid Concentrate 10% 100% 100% 58% 38% 26 
Water based Dilution 50% 85% 100% 71% 38% 48 
Water based Concentrate 10% 97% 100% 67% 58% 36 
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Table 3.24: For models 9 and 10: percentage of blocks for which prediction is less than the EFSA 
(2017) default value based on formulation group and concentrate/dilution status. 
 
Formulation 
group 
Concentrate 
or Dilution 
Default 
value 
Model 
No of blocks 
9 10 
Organic solvent Dilution 70% 80% 80% 30 
Organic solvent Concentrate 25% 40% 44% 25 
Other Dilution 70% 100% 100% 2 
Other Concentrate 25% 100% 100% 1 
Solid Dilution 50% 30% 43% 23 
Solid Concentrate 10% N/A N/A 0 
Water based Dilution 50% 56% 65% 43 
Water based Concentrate 10% 7% 7% 29 
 
 
 
Furthermore, from a regulatory perspective, quantification the uncertainty in the predicted dermal 
absorption values for any recommended model is considered to be crucial, especially taking into 
account that the predictivity found in most cases was regarded not better than moderate. 
The following tables present how frequently model 7, 9 and 10 as well as adjusted model 7 exceed 
measurement by specified factor depending on the range of predicted values. These tables 
complement those shown in chapters 3.5 and 3.6 by specifying frequencies for the ranges below the 
70% default value of the EFSA (2017) Guidance. Only those cases are included, where use of the 
predicted value would result in a refinement of the default value to a lower estimate. 
 
Table 3.25: Table for model 7 of how frequently model exceeds measurement by specified factor or 
measurement exceeds model by specified factor. Data points (blocks) are restricted to those for which 
predictions are lower than the applicable EFSA (2017) default values. 
 
Model absorption prediction (depending on range of 
predicted value) 
Model prediction is: 
0.01- 
<0.1% 
0.1- <1% 1- <10% 10- <70% 
Number of blocks below 
applicable default: 
28 30 76 37 
100 times lower than measured 7% 10% 0% 0% 
20 times lower than measured 75% 23% 1% 0% 
5 times lower than measured 86% 53% 9% 3% 
2 times lower than measured 100% 73% 28% 11% 
higher than measured 0% 10% 54% 81% 
2 times higher than measured 0% 3% 39% 49% 
5 times higher than measured 0% 3% 13% 24% 
10 times higher than measured 0% 3% 7% 14% 
100 times higher than measured 0% 3% 1% 0% 
 
 
  
In silico tools for prediction of dermal absorption  
 
 
 
www.efsa.europa.eu/publications 78 EFSA Supporting publication 2018:EN-1493 
The present document has been produced and adopted by the bodies identified above as authors. This task has been carried out exclusively by the authors in 
the context of a contract between the European Food Safety Authority and the authors, awarded following a tender procedure. The present document is 
published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The 
European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, 
without prejudice to the rights of the authors. 
 
Table 3.26: Table for model 9 of how frequently model exceeds measurement by specified factor or 
measurement exceeds model by specified factor. Data points (blocks) are restricted to those for which 
predictions are lower than the applicable EFSA (2017) default values. 
 Model absorption prediction (depending on range of 
predicted value) 
Model prediction is: 1- <10% 10- <70% 
Number of blocks below 
applicable default: 
4 66 
100 times lower than measured 0% 0% 
20 times lower than measured 0% 0% 
5 times lower than measured 0% 0% 
2 times lower than measured 25% 0% 
higher than measured 75% 91% 
2 times higher than measured 25% 67% 
5 times higher than measured 25% 35% 
10 times higher than measured 0% 18% 
100 times higher than measured 0% 0% 
 
 
Table 3.27: Table for model 10 of how frequently model exceeds measurement by specified factor or 
measurement exceeds model by specified factor. Data points (blocks) are restricted to those for which 
predictions are lower than the applicable EFSA (2017) default values. 
 Model absorption prediction (depending on range of 
predicted value) 
Model prediction is: 0.1- <1% 1- <10% 10- <70% 
Number of blocks below 
applicable default: 
2 4 72 
100 times lower than measured 0% 0% 0% 
20 times lower than measured 50% 0% 0% 
5 times lower than measured 50% 0% 0% 
2 times lower than measured 100% 25% 0% 
higher than measured 0% 50% 85% 
2 times higher than measured 0% 0% 64% 
5 times higher than measured 0% 0% 33% 
10 times higher than measured 0% 0% 22% 
100 times higher than measured 0% 0% 0% 
 
 
When considering the respective results of the adjusted model 7 presented in Table 3.28 below, the 
model prediction is at least 2 times lower than the measured one for all cases examined when the 
range of the predicted values is low, i.e. 0.01-0.1%. When the predicted values are in the range of 10 
to 70% then for 52% of the cases the predicted value is higher than the measured one.  
In consequence, for regulatory purposes, the use of the predicted values from models 7, 9, 10 and 
adjusted model 7 in general may not be acceptable due to a notable risk of under-prediction. 
However, if circumstances (conditions) can be identified, under which the predicted value is higher 
than the measured one but lower than the respective recommended default value (EFSA, 2017), then 
the possibility to use the predicted value for a refinement could be further considered.  
  
In silico tools for prediction of dermal absorption  
 
 
 
www.efsa.europa.eu/publications 79 EFSA Supporting publication 2018:EN-1493 
The present document has been produced and adopted by the bodies identified above as authors. This task has been carried out exclusively by the authors in 
the context of a contract between the European Food Safety Authority and the authors, awarded following a tender procedure. The present document is 
published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The 
European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, 
without prejudice to the rights of the authors. 
 
Table 3.28: How frequently adjusted prediction from model 7 exceeds measurement by specified 
factor or measurement exceeds model by specified factor. Data points (blocks) are restricted to those 
for which predictions are lower than the applicable EFSA (2017) default values. 
 Adjusted Model absorption prediction (depending on 
range of predicted value) 
Model prediction is: 0.01- 
<0.1% 
0.1- <1% 1- <10% 10- <70% 
Number of blocks below 
applicable default: 
7 34 122 67 
100 times lower than measured 0% 0% 0% 0% 
20 times lower than measured 43% 9% 2% 0% 
5 times lower than measured 86% 12% 7% 0% 
2 times lower than measured 100% 29% 22% 16% 
higher than measured 0% 56% 56% 52% 
2 times higher than measured 0% 35% 39% 22% 
5 times higher than measured 0% 3% 18% 6% 
10 times higher than measured 0% 0% 7% 1% 
100 times higher than measured 0% 0% 2% 0% 
 
Thus, an attempt was made to conduct further analysis of model 7 outcomes in order to address this 
issue and provide risk assessors and risk managers as many information as possible in order to further 
consider whether the uncertainty quantified could be tolerated for regulatory purposes. Respective 
analyses could also be performed for models 9 and 10. For model 7, it was observed that when the 
predicted values are multiplied with an assessment factor of 5 or 10, the percentage of cases where 
the resulting predicted value is higher that the measured one increases to 94% and 96%, respectively 
for the range of 10 to 70% modelled dermal absorption (Table 3.29 & Table 3.30). Comparing these 
results with the presented uncertainty in prediction in the tables above, it is notable that by applying 
an assessment factor of at least 5 the chance of under-prediction is significantly reduced while still 
allowing refinement over the default values of EFSA (2017).  
 
Table 3.29: How frequently adjusted prediction from model 7, with assessment factor (AF) of 5 
applied, exceeds measurement by specified factor or measurement exceeds model by specified factor. 
Data points (blocks) are restricted to those for which predictions are lower than the applicable EFSA 
(2017) default values. 
 Model absorption prediction (depending on range of 
predicted value) 
Model prediction is: 0.01- 
<0.1% 
0.1- <1% 1- <10% 10- <70% 
Number of blocks below 
applicable default: 
 9 55 80 
100 times lower than measured  0% 0% 0% 
20 times lower than measured  22% 0% 0% 
5 times lower than measured  33% 11% 0% 
2 times lower than measured  33% 11% 0% 
higher than measured  33% 87% 92% 
2 times higher than measured  11% 73% 78% 
5 times higher than measured  0% 56% 45% 
10 times higher than measured  0% 33% 30% 
100 times higher than measured  0% 2% 1% 
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Table 3.30: How frequently adjusted prediction from model 7, with assessment factor of 10 applied, 
exceeds measurement by specified factor or measurement exceeds model by specified factor. Data 
points (blocks) are restricted to those for which predictions are lower than the applicable EFSA (2017) 
default values. 
 Model absorption prediction (depending on range of 
predicted value) 
Model prediction is: 0.01- 
<0.1% 
0.1- <1% 1- <10% 10- <70% 
Number of blocks below 
applicable default: 
 7 34 49 
100 times lower than measured  0% 0% 0% 
20 times lower than measured  0% 0% 0% 
5 times lower than measured  29% 0% 0% 
2 times lower than measured  43% 9% 6% 
higher than measured  57% 91% 94% 
2 times higher than measured  14% 88% 90% 
5 times higher than measured  0% 71% 65% 
10 times higher than measured  0% 56% 41% 
100 times higher than measured  0% 0% 0% 
 
The results summarised in Tables 3.28 to 3.30 are illustrated in the following figures: 
 
 
Figure 3.17: Plot of measured absorption versus adjusted prediction from model 7. Black line shows 
where they are equal. 
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Figure 3.18: Plot of measured absorption versus adjusted prediction from model 7 having multiplied 
the adjusted prediction by an assessment factor of 5. Values above 100% are capped at 100%. Black 
line shows where they are equal. 
 
 
Figure 3.19: Plot of measured absorption versus adjusted prediction from model 7 having multiplied 
the adjusted prediction by an assessment factor of 10. Values above 100% capped at 100%. Black 
line shows where they are equal. 
 
Overall, considering the result from model implementation and statistical analysis from a regulatory 
perspective, it is recommended to further investigate the possibility of using the adjusted model 7 
(NIOSH model) as a Tier 2 tool to estimate the dermal absorption value with a defined level of 
uncertainty in the absence of adequate experimental data when the predicted values are in the range 
of 10 to 70%,. The outcome of the above presented analyses shows that, if using the adjusted model 
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7 as been used during the implementation stage of this project, the application of an assessment 
factor of at least 5 is required to increase acceptability for regulatory purposes. In addition, it should 
be noted that the use of the adjusted model 7 may be acceptable in the range of 10 – 70% dermal 
absorption only, i. e. within the range of the default values of the EFSA Guidance on dermal 
absorption (EFSA, 2017). The uncertainty of prediction, or better, the risk of under-prediction might 
be too high for lower predicted dermal absorption values (0.01 – 10%).  
The same considerations that were exemplarily presented for model 7 could be applied to models 9 
and 10. However, as noted above, implementation of models 9 and 10 requires access to confidential 
data on the composition of the formulation, which in many cases is limited with regard to the exact 
molecular composition. This is not required for model 7. In addition, the strength of correlation 
between predicted and measured data as a prerequisite for practical implementation was regarded 
less convincing for models 9 & 10 compared to model 7. 
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4 Conclusions 
Consultation with Member State Competent Authorities (MSCAs) on the practical applicability of in 
silico tools was used as the starting point to define regulatory needs and identify technical questions 
that should be addressed in this project. The result of the survey showed that most MSCA experts 
may lack the technical knowledge for using available dermal absorption prediction tools reliably. 
Provision of clear recommendations by regulatory bodies (e.g. EFSA) would facilitate wider acceptance 
and use of in silico tools for that purpose. Two major components were identified as essential for such 
recommendations: (i) clear definition of the applicability of the model to be used, considering the 
complexity of agrochemical formulations and realistic exposure scenarios, and (ii) the possibility to 
transparently address uncertainties associated with the %DA estimations.  
A systematic literature review was performed with the aim to identify relevant in silico tools 
whichrevealed an unexpectedly high number of 142 original research papers plus 43 review papers 
describing a total of 288 models for prediction of dermal absorption with potential relevance for 
pesticide risk assessment. Following scientific review of these publications, the significant number of 
61 algorithm-based and 14 machine-learning models for prediction of dermal absorption of single 
substances and their dilutions in water were identified, while there were 29 algorithm-based and 7 
machine-learning models aimed at prediction of dermal absorption of single substances from vehicles 
representing mixtures including solvents other than water.  
When selecting models for implementation and detailed statistical evaluation in a stepwise procedure, 
the availability of input data or software tools to calculate descriptors necessary to run the model was 
identified as a major bottleneck. The availability of measured or predicted input data can severely limit 
the range of models that can practically be used. Also, it was noted during model implementation that 
strategic choices have to be made, e.g. to the inclusion of lag-time or the use of calculated versus 
experimental water solubility, showing that the same model may be used (or interpreted) differently 
between groups. Effectively, this can be generating subversions of one model or model combination in 
practice. Also, when comparing measured vs. predicted physicochemical parameters, it was noted that 
these can deviate substantially. This may potentially have a significant impact on the outcome of 
model predictions for dermal absorption. Mining of data for mixture composition, including pesticidal 
products and in-use dilutions thereof, was very labor intensive and, based on the experience made in 
this project, will usually not result in full description of the mixture with information on content, 
structure, physicochemical or quantum-chemical descriptors for some of the components often 
remaining unknown. Thus, mixture descriptors usually represent best estimates only. While 
algorithmic models are typically easily implemented in spreadsheet software, models on artificial 
neural networks require more sophisticated solutions that may not be available at evaluating 
authorities. Even if reconstructed, artificial neural networks may differ with respect to prediction 
outcome from the original ANN.  
Most models predicted either permeation coefficients or maximum flux values and thus need to be 
combined with models extrapolating to percentage dermal absorption – the output parameter 
currently used in pesticide risk assessment. Within the project, this was done by feeding the predicted 
kp values into the DAME model (Buist 2010) except for model 7. Although the authors considered 
DAME as the best available tool for the purpose, there are other legitimate approaches which could 
not be explored here, however. In this context, it was noted that predicted %DA was the sum of % 
predicted in the receptor fluid and the stratum corneum with no consideration of the barrier function 
of remaining skin layers, except for model 7, where the model allowed to predict %DA as the sum of 
% absorbed systemically, in the stratum corneum, viable epidermis, and dermis.  
Plots depicting the relationship between predicted and measured %DA, did not reveal any correlations 
between the two variables for most models. Weak to moderate associations between predicted and 
measured absorption, as demonstrated by the respective graphical representations and confirmed by 
Spearman and Kendall tau rank correlations analysis, respectively, were detected for model 7 (single 
substance model) and for models 9 & 10 (mixture models). This finding suggests that models 7, 9 and 
10 were worthy of further investigation and that the other models are less likely to be useful 
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predictively. The fact that moderate predictivity was achieved with models 9 and 10 suggests that lack 
of correlation for the poorly predicting models cannot be primarily attributed to the use of DAME. 
However, the best performing model (model 7), published by NIOSH and most recently described by 
Dancik et al. (2013), is one of the few models predicting percentage absorption directly, without the 
use of another model. With regard to models 9 and 10, it is worth to note that these were conceived 
by Riviere & Brooks (2007) based on the well-known model by Potts&Guy (1992) and do - in this 
analysis - indeed provide an improvement over the "gold standard".  
In addition, it may be concluded that the improved performance of models 7, 9 and 10 may be related 
by the capability of model 7 to take into account (semi-quantitatively) some characteristic of the 
vehicle mixtures, while models 9 & 10 were designed to address vehicles representing mixtures. 
Selection bias resulting from the restriction of the dataset to those formulations, for which the 
composition could be identified, was ruled out. However, it remains obscure why the other mixture 
model published by Atobe et al. (2015) did not perform well. Reconstruction of this ANN was shown to 
be successful, when using the original dataset.  
In a search for approaches to further improve predictivity of models 7, 9 & 10, subsets of the data 
were generated defined by different ranges of selected covariate values for which there might be 
stronger correlations. Although there was slightly better correlation for some subsets defined by 
certain pKa ranges (model 7) or the formulation type (e.g. water based), this exercise did not reveal 
any subsets with very strong correlations. This does not mean that they necessarily do not exist but 
does mean that they are likely to be difficult to detect due to the need to avoid spurious false 
positives when checking a large number of possible subsets.  
A Bayesian Random Effects Model (BREM) allowed to analyse how over- and under-prediction 
depends on the predicted level of absorption for model 7. It was also successful in showing how the 
output of model 7 might be adjusted to reduce the magnitude of over- and under-prediction in those 
ranges. However, it was concluded that no statistical methodology, including the BREM, would be 
capable of overcoming completely the problems caused by relative weak correlation between 
predictions and measurements.  
Overall, considering the result from model implementation and statistical analysis, it is recommended 
to further investigate the possibility of using the adjusted model 7 (NIOSH model) as a Tier 2 tool to 
estimate the dermal absorption value in the absence of adequate experimental data when the 
predicted values are in the range of 10 to 70%, with a defined level of uncertainty. However, the 
outcome of the above presented analyses shows that, if using the adjusted model 7, the application of 
an assessment factor of at least 5 is required to increase acceptability for regulatory purposes. In 
addition, it should be noted that the use of the adjusted model 7 is only acceptable in the range of 10 
– 70% dermal absorption, i.e. the default values of the EFSA Guidance on dermal absorption (2017). 
The uncertainty of prediction, or better the risk of under-prediction might be too high in lower 
predicted dermal absorption values (0.01 – 10%). 
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5 Recommendations 
 Clearly, further improvement of models for in silico prediction of dermal absorption is required 
to achieve wide-spread acceptance. It is recommended to further investigate the influence of 
physical properties defined as optional by Dancik et al (2013) such as pKa, water solubility, 
density, vehicle solubility, non-ionised unbound fractions, on the predictivity of model 7. Since 
the NIOSH model may use kp as an input parameter, it could be investigated whether 
combining the NIOSH model with the selected models predicting kp or Jmax would yield a 
better performing predictive tool. Notably, none of the eleven models tested takes into 
consideration the substance/product classification with regard to skin irritation/corrosion, co-
formulant’s effects on the stratum corneum, metabolism or surface tension of the pesticide; 
elements that the MSCA experts would expect to have an impact on dermal absorption 
according to the survey. 
 
 To facilitate model development, existing dermal absorption datasets, both public and private, 
should be combined, curated and filtered to build a large homogeneous and consistent 
dataset. The on-line available EDETOX-database18 provides a good structure to gather these 
data and already a fair number of curated kp data. In order to increase the probability that the 
newly developed model will include good predictions of pesticides, also measured kp values of 
pesticides should be collected. However, confidentiality issues may impact negatively on the 
representation of data for commercially relevant pesticide formulations in such a database. 
 
 Reporting identity of co-formulants in pesticidal products should be re-considered. When 
collecting information on mixture composition for the purpose of this project, it was noted 
that from the information provided in the confidential parts of the Registration Reports, the 
factual chemical composition could only be approximated. Frequently, the chemical structure 
of a co-formulant can either not be unambiguously identified or a co-formulant represents a 
mixture of substances itself with often unclear structure or content in the mixture. 
 
 Considering the result from statistical analysis, it is recommended to further investigate the 
possibility of using the adjusted model 7 (NIOSH model) as a Tier 2 tool for estimation of 
dermal absorption in the absence of adequate experimental data. However, the outcome of 
the above presented analyses shows that, if using the adjusted model 7, the application of an 
assessment factor of at least 5 is required to increase acceptability for regulatory purposes. In 
addition, it should be noted that the use of the adjusted model 7 is only acceptable in the 
range of 10 – 70% dermal absorption, i. e. the default values of the EFSA Guidance on dermal 
absorption (2017). The uncertainty of prediction, or better the risk of under-prediction might 
be too high in lower predicted dermal absorption values (0.01 – 10%).  
 
 Adjustment of data requirements may need to be considered when (Q)SAR models are to be 
used at larger scale. Depending on the individual (Q)SAR model, certain structural, 
physicochemical, or quantum-chemical descriptors are needed as input parameters to run the 
model or refine the prediction. However, in some cases, these parameters may not be 
covered by the legal data requirements and may not be available. This applies in particular to 
co-formulants. In this context, it should be considered to validate and make available tool for 
prediction of substance properties ((Q)SPR tools), needed to calculate input parameters for 
prediction models. 
                                               
18 http://edetox.ncl.ac.uk 
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 If recommending (Q)SAR for pesticide risk assessment including but not limited to prediction 
of dermal absorption, it should be considered to provide detailed technical guidance. Various 
potential pitfalls were noted during this project, starting already at the stage of collection, 
calculation or prediction of input parameters. Depending on the approach to obtain an input 
parameter, very different values can be obtained, potentially impacting the output. In 
addition, handling or interpretation errors may easily occur to the unfamiliar risk assessor 
while using (Q)SAR / (Q)SPR tools. As described above, choices to be made during 
implementation may effectively lead to establishing different subversions of one model. 
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Abbreviations/Glossary 
 
Term Explanation 
%DA percent dermal absorption 
(Q)SAR (quantitative) structure activity relationship 
3D three-dimensional 
a.s. active substance 
Al experimental solution of active substance in solvent 
ANN artificial neural network 
       : hydrogen bond acceptor activity (summation) or basicity  
BfR Bundesinstitut für Risikobewertung 
block aggregates averages between replicates of one experiment 
BP boiling point 
BPI BENAKI Phytopathological Institute 
BREM Bayesian random effects model 
c concentrate experimental concentration of the active substance 
DAME Dermal Absorption Model for Extrapolation 
DAR Draft Assessment Report  
DU Durham University 
e.g. for example 
EFSA European Food Safety Authority 
EHOMO energy of the highest occupied molecular orbital 
ELUMO energy of the lowest unoccupied molecular orbital 
EPI Suite Estimation Programs Interface Suite 
Eq. equation 
HA, HBA number of Hydrogen bond acceptor sites 
HB Sum of Hydrogen bond acceptors and donors 
HD, HBD number of Hydrogen bond donor sites 
HOMO highest occupied molecular orbital 
IJC Instant JChem 
Jmax,  maximum flux 
Kow octanol/water partition coefficient 
Kow, K(OW) octanol-water partition coefficient 
kp permeability coefficient or permeation coefficient 
log Soct logarithm (base 10) of the solubility in octanol 
LogP, LogPow, LogKow logarithm (base 10) of the octanol/water partition coefficient 
logSaq logarithm (base 10) of the water solubility 
LUMO lowest unoccupied molecular orbital 
M1 model 1 - Frasch 2002 
M10 model 10 – Riviere Brooks 2007 No. 2 
M11 model 11 – Atobe 2015 
M2 model 2 – Potts & Guy 1992 
M3 model 3 – Magnusson 2004 
M4 model 4 – Fu 2002 Algorithmic solution 
M5 model 5 – Fu 2002 Artificial Neural Network 
M6 model 6 – Milewski 2012 
M7 model 7 – Dancik / NIOSH 
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Term Explanation 
M8 model 8 – Potts & Guy 1995 
M9 model 9 – Riviere Brooks 2007 No. 1 
Mdon,0  initial mass of substance present in donor fluid 
MF mixture factor 
mixture models models that estimate individual compound (in this case pesticide 
a.s.) penetration by additional consideration of effects of the co-
formulants/vehicle, expressed as Mixture Factor (MF). The results 
obtained by these models do not reflect the absorption of each 
single component in the "mixture" 
mLogKow mixture logarithm (base 10)  of the octanol/water partition 
coefficient; sum of the weight percentage for each of the 
component´s logarithm (base 10) of the octanol/water partition 
coefficient of a mixture 
MM mixture model (for explanation of the term "mixture model" see 
above) 
MP melting point 
MPS Model parameter score: the n(th)-root of the product of the 
parameter scores of all parameters associated with a model 
MR molar refractivity 
MRL Multiple linear regression model 
mTpSA mixture topological polar surface area; sum of the weight 
percentage for each of the component´s topological polar 
surface area of a mixture 
MV molecular volume 
MW molecular weight 
NA not available 
NIOSH National Institute for Occupational Safety and Health 
No. number 
NS not specified 
pKa negative logarithm (base 10) of the acid dissociation constant 
Qh,  sum of the net atomic charges of the hydrogen atoms bound to 
nitrogen or oxygen atoms 
QO.N,  the sum of the absolute values of the net atomic charges of 
oxygen and nitrogen atoms which are hydrogen-bond acceptors 
RAR Renewal Assessment Report 
replicate Corresponds to information regarding one Franz cell in the in 
vitro experiment. The absorption of a substance at a given 
concentration and at givebn experimental conditions is derived by 
averaging the replicates that belong to the same treatment 
group. 
RMSE root-mean-square error 
RR Registration Report 
S Abraham descriptor: dipolarity/polarity of the solute 
Saq water solubility 
SC stratum corneum 
SSM single substance model 
t exposure time 
tlag,      lag time 
TNO TNO innovation for life 
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Term Explanation 
TpSA topological polar surface area 
V Abraham descriptor: solute´s McGowan characteristic volume 
Vdon  volume of donor fluid  
Ve Van der Waals volume 
VE viable epidermis 
VP vapour pressure 
Vsc  volume of stratum corneum  
WP work package 
 
 
 
 
In silico tools for prediction of dermal absorption  
 
 
 
www.efsa.europa.eu/publications 94 EFSA Supporting publication 2018:EN-1493 
The present document has been produced and adopted by the bodies identified above as authors. This task has been carried out exclusively by the authors in 
the context of a contract between the European Food Safety Authority and the authors, awarded following a tender procedure. The present document is 
published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The 
European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, 
without prejudice to the rights of the authors. 
 
Appendix A – Literature Search 
A search protocol was drafted and, following internal review, presented to EFSA for refinement at a 
meeting in Parma on June 16, 2017. The draft search protocol was adapted in conformity with the 
suggestions received during that meeting. Amongst others, it was tested whether relevant papers 
would be lost when not including "Environmental Science" as a discipline in the Scopus search. As this 
turned out to be the case, the discipline "Environmental Science" was not excluded. For further 
validation, it was examined whether relevant papers published after 1989 as listed in table 1-1 of Buist 
(2016) would be obtained using the revised search strategy in Scopus (see Table A.1). Of the 27 
papers 15 were found, 12 were missed and 4 were not listed in Scopus. Based on this outcome, the 
Scopus search protocol was refined and the results checked again against the same list of papers. 
This was done in an iterative fashion, until satisfactory results were obtained. Finally, 11 of the 12 
papers missed in the original search were retrieved in the final search. 
Table A.1: Verification of search results in Scopus. 
Reference Hit in Scopus Reference Hit in Scopus 
Originally Finally Originally Finally 
Abraham and Martins (2004)  Yes Yes McKone and Howd (1992)  No No 
Barratt (1995) No Yes Mitragotri (2002)  Yes Yes 
Buchwald and Bodor (2001) No Yes Moody and MacPherson 
(2003) 
Yes Yes 
Cleek and Bunge (1993) Yes Yes Moss and Cronin (2002) Yes Yes 
Dearden et al. (2000) No Yes Patel et al. (2002) Yes Yes 
Fiserova-Bergerova et al. 
(1990) 
No Yes Potts and Guy (1992) No Yes 
Flynn (1990)  No (not in 
Scopus) 
n/a Potts and Guy (1995) Yes Yes 
Fujiwara et al. (2003) No Yes Pugh et al. (2000) Yes Yes 
Geinoz et al. (2004) Yes Yes Tayar et al. (1991) Yes Yes 
Guy and Potts (1992) No Yes ten Berge (2009) Yes Yes 
Hostynek and Magee (1997)  Yes Yes USEPA (2004) No (not in 
Scopus) 
n/a 
Lien and Gao (1995) Yes Yes Vecchia and Bunge (2002) No (not in 
Scopus) 
n/a 
Magee (1998)  No (not in 
Scopus) 
n/a Wilschut et al. (1995) Yes Yes 
Magnusson et al. (2004) Yes Yes    
 
The Scopus search protocol was then translated into PubMed and ToxLine search protocols, taking 
into account the recommendations made at the meeting with EFSA in Parma on June 16, 2017. 
Scopus search 
Below the Scopus search string is listed. It was executed on June 20, 2017, and resulted in 1,430 hits. 
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(((TITLE-ABS-KEY (skin W/10 absorption) AND pubyear > 1989) OR (title-abs-key(skin W/10 
penetrat*) AND pubyear > 1989) OR (title-abs-key(skin W/10 permeat*) AND pubyear > 1989) OR 
(title-abs-key( "dermal absorption") AND PUBYEAR > 1989) OR (TITLE-ABS-KEY("dermal 
penetration") AND pubyear > 1989) OR (title-abs-key("dermal permeation") AND pubyear > 1989)) 
AND (qsar)) OR (((title-abs-key(skin W/10 absorption) AND pubyear > 1989) OR (title-abs-key (skin 
W/10 penetrat*) AND pubyear > 1989) OR (title-abs-key(skin W/10 permeat*) AND pubyear > 1989) 
OR (title-abs-key("dermal absorption") AND PUBYEAR > 1989) OR (TITLE-ABS-KEY("dermal 
penetration") AND pubyear > 1989) OR (title-abs-key("dermal permeation") AND pubyear > 1989)) 
AND ("in silico")) OR (((title-abs-key(skin W/10 absorption) AND pubyear > 1989) OR (title-abs-key 
(skin W/10 penetrat*) AND pubyear > 1989) OR (title-abs-key(skin W/10 permeat*) AND pubyear > 
1989) OR (title-abs-key("dermal absorption") AND PUBYEAR > 1989) OR (TITLE-ABS-KEY("dermal 
penetration") AND pubyear > 1989) OR (title-abs-key("dermal permeation") AND pubyear > 1989)) 
AND (qspr)) OR (((title-abs-key(skin W/10 absorption) AND pubyear > 1989) OR (title-abs-key (skin 
W/10 penetrat*) AND pubyear > 1989) OR (title-abs-key(skin W/10 permeat*) AND pubyear > 1989) 
OR (title-abs-key("dermal absorption") AND PUBYEAR > 1989) OR (TITLE-ABS-KEY("dermal 
penetration") AND pubyear > 1989) OR (title-abs-key("dermal permeation") AND pubyear > 1989)) 
AND ("mathematical model")) OR (((title-abs-key(skin W/10 absorption) AND pubyear > 1989) OR 
(title-abs-key(skin W/10 penetrat*) AND pubyear > 1989) OR (title-abs-key(skin W/10 permeat*) AND 
pubyear > 1989) OR (title-abs-key("dermal absorption") AND PUBYEAR > 1989) OR (TITLE-ABS-
KEY("dermal penetration") AND pubyear > 1989) OR (title-abs-key("dermal permeation") AND 
pubyear > 1989)) AND ("artificial neural network")) OR (((title-abs-key(skin W/10 absorption) AND 
pubyear > 1989) OR (title-abs-key(skin W/10 penetrat*) AND pubyear > 1989) OR (title-abs-key (skin 
W/10 permeat*) AND pubyear > 1989) OR (title-abs-key("dermal absorption") AND pubyear > 1989) 
OR (title-abs-key("dermal penetration") AND PUBYEAR > 1989) OR (TITLE-ABS-KEY("dermal 
permeation") AND pubyear > 1989)) AND (algorithm)) OR (((title-abs-key(skin W/10 absorption) AND 
pubyear > 1989) OR (title-abs-key(skin W/10 penetrat*) AND pubyear > 1989) OR (title-abs-key (skin 
W/10 permeat*) AND pubyear > 1989) OR (title-abs-key("dermal absorption") AND pubyear > 1989) 
OR (title-abs-key("dermal penetration") AND PUBYEAR > 1989) OR (TITLE-ABS-KEY("dermal 
permeation") AND pubyear > 1989)) AND ("machine learning")) OR (((title-abs-key(skin W/10 
absorption) AND pubyear > 1989) OR (title-abs-key(skin W/10 penetrat*) AND pubyear > 1989) OR 
(title-abs-key (skin W/10 permeat*) AND pubyear > 1989) OR (title-abs-key("dermal absorption") 
AND pubyear > 1989) OR (title-abs-key("dermal penetration") AND PUBYEAR > 1989) OR (TITLE-
ABS-KEY("dermal permeation") AND pubyear > 1989)) AND ( "statistical model" ) ) AND ( limit-to ( 
language , "English") OR limit- to ( language , " German")) AND ( limit-to ( subjarea , "PHAR") OR 
limit- TO ( SUBJAREA , "MEDI") OR LIMIT-TO ( SUBJAREA , "BIOC") OR LIMIT-TO ( SUBJAREA , 
"CHEM") OR LIMIT-TO (SUBJAREA, "ENVI" ) OR LIMIT-TO ( SUBJAREA , "AGRI" ) OR LIMIT-TO 
(SUBJAREA, "COMP") OR LIMIT-TO ( SUBJAREA , "VETE" ) OR LIMIT-TO ( SUBJAREA , "MATH") OR 
LIMIT-TO (SUBJAREA, "MULT') OR LIMIT-TO ( SUBJAREA , "Undefined")) AND ( exclude( doctype , 
"cp") OR exclude( doctype , "sh") OR EXCLUDE ( DOCTYPE , "le" ) OR EXCLUDE ( DOCTYPE , "ed" ) 
OR EXCLUDE ( DOCTYPE , "no")) AND ( EXCLUDE ( SUBJAREA , "BUSI" ) OR EXCLUDE ( SUBJAREA , 
"CENG") OR EXCLUDE (SUBJAREA, "DENT')| OR EXCLUDE ( SUBJAREA , "EART" ) OR EXCLUDE 
(SUBJAREA, "ENER") OR EXCLUDE ( SUBJAREA , "ENGI" ) OR EXCLUDE (SUBJAREA, "PHYS" ) OR 
EXCLUDE ( SUBJAREA , "MATE") OR EXCLUDE (SUBJAREA, "HEAL") OR EXCLUDE ( SUBJAREA , 
"IMMU") OR EXCLUDE (SUBJAREA, "SOCI" ) OR EXCLUDE ( SUBJAREA , "NURS") OR EXCLUDE ( 
SUBJAREA , "PSYC" ))  
PubMed 
Below the PubMed search string is listed. It was executed on June 20, 2017, and resulted in 1,416 
hits. 
((((((qsar OR "in silico" OR qspr OR "mathematical model" OR "artificial neural network" OR 
"algorithm" OR "machine learning" OR "statistical model" OR predict*[MeSH Terms])) OR 
(qsar[Title/Abstract] OR "in silico"[Title/Abstract] OR qspr[Title/Abstract] OR "mathematical 
model"[Title/Abstract] OR "artificial neural network"[Title/Abstract] OR "algorithm"[Title/Abstract] OR 
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"machine learning"[Title/Abstract] OR "statistical model"[Title/Abstract] OR predict*[Title/Abstract]))) 
AND ((((skin AND absorption) OR (skin AND penetrat*) OR (skin AND permeat*) OR "dermal 
absorption" OR "dermal penetration" OR "dermal permeation"[MeSH Terms])) OR ((skin AND 
absorption) OR (skin AND penetrat*) OR (skin AND permeat*) OR "dermal absorption" OR "dermal 
penetration" OR "dermal permeation"[MeSH Terms]))) AND ("german"[Language] OR 
"english"[Language])) AND ("1990/01/01"[Date - Publication] : "3000"[Date - Publication]) 
ToxLine 
Below the ToxLine search string is listed. It was executed on June 20, 2017, and resulted in 246 hits. 
( ( qsar OR "in silico" OR qspr OR "mathematical model" OR "artificial neural network" OR "algorithm" 
OR "machine learning" OR "statistical model" OR predict* ) AND ( ( skin AND absorption ) OR ( skin 
AND penetrat* ) OR ( skin AND permeat* ) OR "dermal absorption" OR "dermal penetration" OR 
"dermal permeation" ) ) AND 1990:2017 [yr] AND ( eng [la] OR ger [la] ) AND NOT PubMed [org] 
AND NOT pubdart [org] 
Effectivity check 
For verification of the effectivity of the literature searches, BfR and TNO analysed whether all relevant 
papers relating to mathematical models for dermal absorption as cited Buist (2016) (Table A.1) or in 
the recently updated EFSA Guidance on Dermal Absorption (EFSA, 2017) were found. The four papers 
that were not listed in Scopus were also absent from PubMed and ToxLine and could therefore not be 
retrieved by any of the searches. The McKone and Howd paper referred to in Buist (2016), which was 
not retrieved by the Scopus search as described above, was also not present among the hits of the 
searches in PubMed and ToxLine. The result of the effectivity check against the papers cited in the 
EFSA Guidance is presented in Table A.2. 
Table A.2: Results of effectivity check with papers cited in the EFSA dermal absorption guidance 
(EFSA, 2017). 
Paper Hit? 
Anissimov et al. (2013) Yes 
Buist (2016) No (not present in databases) 
Buist et al. (2010) Yes 
Gute et al. (1999) Yes 
Mitragotri et al. (2011) No 
Russell and Guy (2009) Yes 
 
Analysis of the key words associated with the missed papers showed that the likely cause of missing 
them was the absence of the term "permeability" from the search terms. Therefore additional 
searches were performed in the three literature databases to amend this omission. The results are 
reported below, and the amended literature search now includes the two originally missed papers 
(McKone and Howd, 1992; Mitragotri et al., 2011). 
Additional Scopus search 
Below the Scopus search string for the additional literature search is provided. The search was 
executed on July 6, 2017, and resulted in 209 hits. After unduplication in the LRT, 104 new unique 
records remained. 
((TITLE-ABS-KEY ("skin permeability") AND pubyear > 1989) OR (title-abs-key ("dermal permeability") 
AND pubyear > 1989)) AND ((TITLE-ABS-KEY ("mathematical model") AND pubyear > 1989) OR 
(TITLE-ABS-KEY ("artificial neural network") AND pubyear > 1989) OR (TITLE-ABS-KEY ("machine 
learning") AND pubyear > 1989) OR (TITLE-ABS-KEY ( "statistical model") AND pubyear > 1989) OR 
(TITLE-ABS-KEY (algorithm) AND pubyear > 1989)) AND ( limit-to ( language , "English") OR limit- to 
( language , " German")) AND ( limit-to ( subjarea , "PHAR") OR limit- TO ( SUBJAREA , "MEDI") OR 
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LIMIT-TO ( SUBJAREA , "BIOC") OR LIMIT-TO ( SUBJAREA , "CHEM") OR LIMIT-TO (SUBJAREA, 
"ENVI" ) OR LIMIT-TO ( SUBJAREA , "AGRI" ) OR LIMIT-TO (SUBJAREA, "COMP") OR LIMIT-TO ( 
SUBJAREA , "VETE" ) OR LIMIT-TO ( SUBJAREA , "MATH") OR LIMIT-TO (SUBJAREA, "MULT') OR 
LIMIT-TO ( SUBJAREA , "Undefined")) AND ( exclude( doctype , "cp") OR exclude( doctype , "sh") OR 
EXCLUDE ( DOCTYPE , "le" ) OR EXCLUDE ( DOCTYPE , "ed" ) OR EXCLUDE ( DOCTYPE , "no")) AND ( 
EXCLUDE ( SUBJAREA , "BUSI" ) OR EXCLUDE ( SUBJAREA , "CENG") OR EXCLUDE (SUBJAREA, 
"DENT')| OR EXCLUDE ( SUBJAREA , "EART" ) OR EXCLUDE (SUBJAREA, "ENER") OR EXCLUDE ( 
SUBJAREA , "ENGI" ) OR EXCLUDE (SUBJAREA, "PHYS" ) OR EXCLUDE ( SUBJAREA , "MATE") OR 
EXCLUDE (SUBJAREA, "HEAL") OR EXCLUDE ( SUBJAREA , "IMMU") OR EXCLUDE (SUBJAREA, "SOCI" 
) OR EXCLUDE ( SUBJAREA , "NURS") OR EXCLUDE ( SUBJAREA , "PSYC" )) 
 
Additional PubMed search 
Below the PubMed search string for the additional literature search is provided. The search was 
executed on July 6, 2017, and resulted in 181 hits. After unduplication in the LRT, to which the result 
from Scopus already had been added, 29 new unique records remained. 
(((("quantitative structure-activity relationship"[MeSH Terms] OR ("quantitative"[All Fields] AND 
"structure-activity"[All Fields] AND "relationship"[All Fields]) OR "quantitative structure-activity 
relationship"[All Fields] OR "qsar"[All Fields]) OR "in silico"[All Fields] OR qspr[All Fields] OR 
"mathematical model"[All Fields] OR "artificial neural network"[All Fields] OR "algorithm"[All Fields] OR 
"machine learning"[All Fields] OR "statistical model"[All Fields]) AND ((("skin"[MeSH Terms] OR 
"skin"[All Fields]) AND ("permeability"[MeSH Terms] OR "permeability"[All Fields])) OR (dermal[All 
Fields] AND ("permeability"[MeSH Terms] OR "permeability"[All Fields])))) AND ("german"[Language] 
OR "english"[Language])) AND ("1990"[PDAT] : "3000"[PDAT]) 
 
Additional ToxLine search 
Below the ToxLine search string for the additional literature search is provided. The search was 
executed on July 6, 2017, and resulted in 27 hits. After unduplication in the LRT, to which the result 
from Scopus and PubMed already had been added, 7 new unique records remained. 
( ( ( ( qsar OR "in silico" OR qspr OR "mathematical model" OR "artificial neural network" OR 
"algorithm" OR "machine learning" OR "statistical model" ) AND ( ( skin AND permeability ) OR ( 
dermal permeability ) ) ) ) AND ( eng [la] OR ger [la] ) ) AND 1990:2017 [yr] AND NOT PubMed [org] 
AND NOT pubdart [org] 
 
Google search 
In addition to searches in the literature databases, an internet search using Google was performed. 
Below the Google search string is provided.  
( qsar OR "in silico" OR qspr OR "mathematical model" OR "artificial neural network" OR "algorithm" 
OR "machine learning" OR "statistical model" OR predict* ) AND ( ( skin AND absorption ) OR ( skin 
AND penetrat* ) OR ( skin AND permeat* ) OR "dermal absorption" OR "dermal penetration" OR 
"dermal permeation" OR ( "skin permeability" ) OR ( "dermal permeability" ) )  
It was implemented on July 6, 2017 and resulted in seven webpages of hits, of which three were not 
peer-reviewed papers and not considered relevant based on title and linked webpage. The detailed 
results and their relevance assessment are reported in Table A.3. Three new references were included 
in the LRT. 
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Table A.3: Google search results. 1 Jan 2016 – 6 Jul 2017, Sorted by relevance, all results, clear, 
about 11.200 results (0,58 seconds), seven pages displayed, first three pages copied. 
 
Predicting the Rate of Skin Penetration Using an Aggregated ... - NCBI 
https://www.ncbi.nlm.nih.gov/pubmed/28335598 
by M Lindh -  2017 
Apr 17, 2017 - Predicting the Rate of Skin Penetration Using an Aggregated Conformal ... 
models use calculated descriptors and can quickly predict the skin permeation rate of ... 
Publication 
Skin models for the testing of transdermal drugs - NCBI - NIH 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5076797/ 
by E Abd -  2016 -  Cited by 1 -  Related articles 
Oct 19, 2016 - More commonly used models to conduct skin-permeation studies are ex 
vivo .... maximum flux and a trend toward decreased dermal penetration rates.35 .... in 
the interpretation of dermal absorption for human risk assessment, to predict ... 
Publication 
Simple Predictive Models of Passive Membrane Permeability ... 
pubs.acs.org/doi/pdf/10.1021/acs.jcim.6b00005 
by SSF Leung -  2016 -  Cited by 7 -  Related articles 
May 2, 2016 - biological processes, such as intestinal absorption, skin penetration, or 
blood-brain barrier permeation, involve permeation of molecules across ... for drug-
likeness described by Lipinski's rule-of-five and QSPR models for permeability.5. 
Publication 
Data-based modeling of drug penetration relates human skin barrier ... 
www.pnas.org/content/114/14/3631.full.pdf 
by R Schul  -  2017 
Mar 20, 2017 - Thereby we can predict short-time drug penetration, where experimental 
... eral models for the permeation of drugs through skin exist, which incorporate 
the skin ... 
Publication 
Surging footprints of mathematical modeling for prediction of ... 
www.sciencedirect.com/science/article/pii/S1818087617301344 
by    oyal -  2017 
Feb 23, 2017 - Mathematical models of skin permeability are highly relevant with respect 
to ... Themathematical model is based on the hypotheses that consider ..... model 
(concentration in model membrane is related to the penetration depth) and ... 
Publication 
Skin Permeation Rate as a Function of Chemical Structure (PDF ... 
https://www.researchgate.net/.../7059484_Skin_Permeation_Rate_as_a_Function_of_... 
 
Jun 4, 2017 - Multilinear and nonlinear QSAR models were built for the skin permeation 
rate (Log K(p)) of ... penetration of other substances by perturbing the barrier function. 
Publication 
Carbon nanotube membranes to predict skin permeability of compounds 
www.tandfonline.com/doi/full/10.1080/10837450.2016.1221430 
by S Ilbasmis-Tamer -  2017 -  Cited by 2 -  Related articles 
Aug 30, 2016 - Abstract. In the present study, carbon nanotube (CNT) membranes were 
prepared topredict skin penetration properties of compounds. A series of penetration ... 
Publication 
[PDF]Alkylglycerol Derivatives, a New Class of Skin Penetration Modulators 
www.mdpi.com/1420-3049/22/1/185/pdf 
 
by SA Bernal- h ve  -  2017 
Jan 22, 2017 - as well as in vitro skin permeation studies, were performed in order to ... 
[9] showed, in an in silico study, that 1-O-alkylglycerols, particularly 1-O-octadecyl. 
Publication 
[PDF]COMPUTER SIMULATION OF SKIN ABSORPTION AND ... - Xemet 
https://www.xemet.com/media/filer.../45/.../skin_simulation_brochure_10-15.pdf 
 
Apr 17, 2016 - Benefits of computer simulation of skin absorption/permeation ... 
Simulation also enables evaluation of vehicle effects, where the vehicle 
(penetration enhancer) is ... The underlyingmathematical model describes 
simultaneous absorption of ... 
Commercial in silico 
model (presentation 
saved) 
Insights into skin permeation: from theory to practice - CECAM 
https://www.cecam.org/workshop-1418.html 
Workshop: Insights 
into skin permeation: 
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by C Das 
Jan 3, 2017 - The topmost layer of the skin, the stratum corneum[1], comprises rigid 
non-viable ... include iontophoresis (use of an electrical potential to 
enhance penetration), ... Although in-silicomodels are widely used but none of the 
available models are ... 
from theory to 
practice. Not 
relevant 
Page 2 of about 11.200 results (0,64 seconds)  
Search Results 
Impact of semi-solid formulations on skin penetration of iron oxide ... 
https://jnanobiotechnology.biomedcentral.com/articles/10.1186/s12951-017-0249-6 
 
by UM Musa  i -  2017 
Feb 17, 2017 - For these reasons, the skin penetration of IONs has been gaining 
increasing ... of the nanoparticles are not the only critical determinants for their skin 
permeation. ...... Use of in vitro humanskin membranes to model and predict the 
effect of ... 
. 
Publication 
 
Using Neural Networks and Ensemble Techniques based on Decision ... 
link.springer.com/chapter/10.1007/978-981-10-4166-2_8 
by E Bu atli  -  2017 
Mar 14, 2017 - This paper presents results of development of Artificial Neural 
Network (ANN) for prediction of skin permeability. The performance of developed 
ANN was ... 
Book 
Skin penetration,Skin permeation IVPT,Solubility studies,Emulsion 
www.terguspharma.com/skin-penetration-studies/ 
 
Mar 3, 2017 - Tergus is the recognized leader in the skin permeation and 
penetration studies. ... formulation to competing products and help predict in 
vivo penetration. 
Company, in vitro 
predictions 
[PDF]Prediction of Dermal Permeability Coefficient of Nevirapine—Effect of ... 
https://file.scirp.org/pdf/PP_2016072816082094.pdf 
 
by    Mbah -  2016 -  Related articles 
Jul 25, 2016 - As the rate of penetration into the skin is quantitatively ... cate 
that permeability coefficient can be a more reliable parameter to predict transdermal 
ab- sorption of ... 
Publication 
 
[PDF]SkinCourse in Saarbrücken March2017 - Universität des Saarlandes 
www.uni-saarland.de/fileadmin/user_upload/.../fr82.../Flyer_SkinCourse_online.pdf 
 
Mar 13, 2017 - Permeation model: Franz diffusion cells. Penetration model: 
Saarbrücken model &skin segmentation. Confocal RAMAN microscopy 
for dermal analysis. In silico ... 
University course 
 
Generic Drug User Fee Amendments of 2012 > FY2016 Regulatory ... 
https://www.fda.gov/ForIndustry/UserFees/GenericDrugUserFees/ucm549169.htm 
 
Mar 29, 2017 - Figure 2: Dermal pharmacokinetics of acyclovir in vivo in human subjects 
... the skinfrom a topical product, and then permeate through the layers of 
the skin and ..... Sinner F. Can wepredict skin penetration by using TEWL 
or skin impedance? 
Regulatory 
information 
 
Effect of Size and Surface Charge of Gold Nanoparticles on their Skin ... 
https://www.nature.com › Scientific Reports › Articles 
Mar 28, 2017 - However, the mechanisms by which these AuNPs penetrate are not well 
understood. ... In contrast, Liu et al. showed that viable human skin resists permeation 
of small ...... Help Reduce Drug Candidate Attrition and Move Us Beyond QSPR? 
Publication 
 
Drug permeation and barrier damage in ... - Oxford Academic 
https://academic.oup.com/jac/article-pdf/71/6/1578/11282328/dkw012.pdf 
by K  an Bocxlaer -  2016 -  Cited by 3 -  Related articles 
Feb 21, 2016 - Drug permeation and barrier damage in Leishmania-infected 
mouse skin ... paromomycin, for Leishmania-infected skin compared with 
uninfected skin. ..... Altered penetration of polyethyl- .... Studies: In Skin, In Vitro, 
Publication 
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and In Silico Models. 
The EDETOX Database; EDETOX; Newcastle University 
https://research.ncl.ac.uk › EDETOX 
 
Jul 15, 2016 - Development of dermal absorption database for cosmetic chemicals 
from existing ... on in vitro human skin permeation- Data from updated EDETOX 
database. ... JJ ( 2008) Improving the applicability of (Q)SARs for 
percutaneous penetration in ... decision tree to predict dermally delivered systemic 
dose for comparison with ... 
In vitro and in vivo 
study results 
 
PREDICTING THE ABSORPTION RATE OF CHEMICALS THROUGH ... 
https://uhra.herts.ac.uk/.../12239113%20Ashrafi%20Parivash%20final%20PhD%20sub... 
by P Ashrafi -  2016 -  Cited by 1 -  Related articles 
May 15, 2016 - I attempt to find optimal values of skin permeability using GP 
optimisation algorithms within small datasets. ... 2 Skin Permeability and the 
Traditional QSAR/QSPR Approaches. 7 ...... ence on Perspectives in 
Percutaneous Penetration. France ... 
Thesis check 
whether also 
published in paper 
 
Dominik Selzer - Google Scholar Citations 
scholar.google.com/citations?user=-k7lUIkAAAAJ&hl=en 
 
Saarland University; Scientific  onsilience  mbH -  scientific-consilience.com 
Apr 1, 2017 - Towards drug quantification in human skin with confocal Raman 
microscopy ... A strategy for in-silico prediction of skin absorption in man ... Human 
Native and Reconstructed SkinPreparations for In Vitro Penetration and Permeation 
Studies. 
Literature list 
 
Evaluation of skin absorption of drugs from topical and transdermal ... 
www.scielo.br/pdf/bjps/v52n3/2175-9790-bjps-52-03-00527.pdf 
by ALM Ruela -  2016 -  Related articles 
Sep 15, 2016 - of skin penetration and permeation of drugs from topical and transdermal 
..... transdermal flux of the drugs to predict their in vivo behavior from different drug ... 
Publication 
 
Colloidal Dispersions (Liposomes and Ethosomes) for Skin Drug ... 
www.asiapharmaceutics.info/index.php/ajp/article/download/728/467 
by M  immathota -  2016 -  Related articles 
Sep 7, 2016 - permeate or penetrate through the skin. ... Routes of 
drug penetration through theskin[10-12] .... predict the permeation profiles of liposomal 
vesicles through. 
Publication 
 
[PDF]Molecular dynamics simulation study of translocation of fullerene C 60 ... 
pubs.rsc.org/-/content/articlepdf/2017/nr/c6nr09186e 
 
by R  upta -  2017 
Feb 22, 2017 - fullerene-based peptide penetrated intact skin, and mechan- ical 
stressors, such as those ... permeation of pristine fullerene C60 with a model skin mem- 
brane using ...... candidate attrition and move us beyond QSPR, Chem. Biol. Drug Des. 
Publication 
 
European Commission : CORDIS : Projects & Results Service : Final ... 
cordis.europa.eu/result/rcn/182206_en.html 
 
May 17, 2016 - Final Report Summary - COSMOS (Integrated In Silico Models for the ..... 
In addition,skin permeability data were donated from the EDETOX Database and ..... 
These emphasise that estimation of skin penetration may be challenging for ... 
Check for in silico 
model 
(COSMOS project) 
 
[PDF]In Silico Estimation of Skin Concentration of Dermally ... - Peertechz 
https://www.peertechz.com/.../in-silico-estimation-of-skin-concentration-of-dermally-... 
 
Jan 23, 2017 - were determined from the in vitro permeation data through full-
thickness skin and stripped skin after application of ... chemical; In silico estimation; Skin 
permeation; Skin ...... In vivo methods for the analysis of the penetration of topically 
applied. 
Publication 
 
In Vitro Testing & Other Services | AltTox.org 
alttox.org › Resource  enter 
 
Jun 14, 2017 - Absorption Systems, LP (Exton, Pennsylvania, U.S.): preclinical contract ... 
In vitro 
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UK):dermal research and development including in vitro human skin permeation .... in 
silico, the in vitro epidermis screening test (INVEST) and other ex vivo skin models. ..... 
including GLP services, for skinirritation and corrosion, dermal penetration, ... 
transdermal penetration of acyclovir in the presence and absence.of ... 
https://dspace.nwu.ac.za/bitstream/handle/10394/301/myburgh_m.pdf?sequence=1 
by M Myburgh -  2003 
Jan 4, 2016 - acyclovir is the permeation in sufficient amounts to deeper layers of 
the skin and ... acyclovir, transdermal delivery, permeation, penetration enhancers, 
terpenes ..... To predict skintransport of a drug molecule, it is important to understand 
the ... 
In vitro 
 
Prediction of human pharmacokinetic profile after transdermal drug ... 
jpharmsci.org/article/S0022-3549(17)30159-4/pdf 
by S Yamamoto 
Mar 2, 2017 - compartment model using in vitro human skin permeation parameters as 
zero-orderabsorption ... represent the stratum corneum and viable skin may predict in 
vivo human ... skin penetration of drug substances have been proposed.14-16. 
Publication 
 
[PDF]Investigation of Caffeine Permeation in the Skin PAMPA Model 
abstracts.aaps.org/Verify/AAPS2016/PosterSubmissions/26W0400.pdf 
 
Nov 7, 2016 - Caffeine was selected as a model permeant as the skin permeation 
properties of ...penetration enhancers for caffeine were selected, namely dimethyl ... 
In vitro 
 
 
Checked additional 4 pages (of seven in total): no relevant hits. 
 
Unduplicating in EndNote 
The records resulting from the searches in Scopus, PubMed and ToxLine were exported to EndNote.  
Since the automatic unduplication function of EndNote is limited to records directly imported via a web 
search executed in EndNote, this was performed manually. Furthermore, all references to the 
Reporter Database of NIH were removed as this database represents a repository of (future) projects 
rather than of scientific reports or papers. This removal and unduplication resulted in a final list of a 
total of 2533 records (2111 from the main search) to be exported to the TNO Literature Review Tool 
(LRT). This was more than twice the limit intended in Technical Offer. However, since attempts to 
further cut down this number to 1000 would increase the risk of missing relevant papers, all were 
taken forward to the next phase in the selection procedure. The EndNote file is available upon request 
at EFSA. 
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Appendix B – Literature Relevance Assessment 
Relevance check on title and abstract in the TNO Literature Review Tool (LRT) 
Main search 
When the 2111 records from the main search as described in 1.2 to 1.4 were imported from EndNote 
into the LRT, 2069 unique records remained, which all received an unique five-digit identifier, the 
LRT-ID. These publications were first checked for relevance based on their title. In the context of this 
check, "relevant papers" were defined as "papers addressing mathematical models of dermal 
absorption". Records considered irrelevant based on their title were not taken forward to the 
evaluation according to scientific criteria (see chapter 2). The remaining publications were further 
examined for relevance based on their abstract. However, in some cases abstracts were not 
(publically) available at the time of the execution of the relevance check. These papers were not 
excluded due to missing abstract at this initial step of relevance check. The relevance of these papers 
according to the abstract was evaluated, when the abstract was made available after ordering full-
texts via the library service. Records considered irrelevant based on their abstract were also excluded 
form the next selection phase. The reasons for exclusion were documented. The following questions 
were answered in the tool in order to come to this selection to should be answered with YES or NO 
(with a number of sub-options for the latter):  
  
  
Only papers for which both questions were answered with YES will be considered in the scientific 
review. Following internal peer review of this initial relevance assessment (see section below), 266 
papers were selected for the scientific review. Results of the relevance assessment for all individual 
references are available in an MS Excel file upon request at EFSA.  
Quality control relevance check 
Internal quality control was performed regarding the relevance check. Approximately 5% of all 
publications retrieved during the main literature search, i.e. approx. 100 papers, were evaluated for 
concordance by the internal reviewer (Nadine Engel, BfR). Each twentieth paper in the list of 
publications (starting with number 1, then 21, then 41, then 61, etc.) were blindly selected for this 
procedure. When the reviewer did not concord, the reason of deviation was be registered. It was 
defined prior to starting the assessment that if the percentage of unjustly EXCLUDED papers is higher 
than 5% of the papers checked (i.e. more than 5 papers), an additional 10% of the scored papers will 
be checked by selecting and checking every tenth paper, starting with number 5, then numbers 15, 
25, 35, etc.). If the percentage of unjustly EXCLUDED papers remains higher than 5% (i.e. more than 
approx. 10 papers), all remaining scored papers would be checked. 
Out of the 104 publications checked blindly, the internal reviewer did not agree with the conclusions 
of the assessor in 4 cases. In one of these cases the assessor did not agree with the conclusions of 
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the internal reviewer. After discussion, the internal reviewer accepted the evaluation of the assessor. 
Therefore, in 3 out 104 cases the first assessment did not pass internal QC, which amounts to 2.9% 
and was regarded as acceptable according to the established protocol.  
Additional searches 
Of the 143 records resulting from the additional searches (see Appendix A for background), 33 
publications were considered to be relevant based on title and/or abstract (when present). Of these 
11 were identified as duplicates of papers already found in the main search. Accordingly, 22 relevant 
papers resulting from the additional search were added to the 266 publications from the main search 
yielding a total 288 relevant papers. These were subjected to the scientific appraisal as described in 
chapter 2.2. 
  
In silico tools for prediction of dermal absorption  
 
 
 
www.efsa.europa.eu/publications 104 EFSA Supporting publication 2018:EN-1493 
The present document has been produced and adopted by the bodies identified above as authors. This task has been carried out exclusively by the authors in 
the context of a contract between the European Food Safety Authority and the authors, awarded following a tender procedure. The present document is 
published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The 
European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, 
without prejudice to the rights of the authors. 
 
Appendix C – Methodology for Stage 2 of the Systematic Literature 
Appraisal 
The second stage of the scientific review was executed in Excel. The issues addressed in the second 
stage of the scientific review are listed in Table C.1 including the questions and the selectable 
answers, respectively. Models for which questions 1, 2, or 5 were answered with "No", or question 3 
was answered with "Yes", were not further considered and the questions that follow thereafter were 
not answered for those models.   
Table C.1: Questions answered during the second stage of the scientific review. 
Question 1: Algorithm based model? 
Answers Yes/No  
Options if "Yes"  Well-defined and specific algorithm 
 Not a well-defined and specific algorithm 
Options if "No"  Reliable reconstruction possible 
 No reliable reconstruction possible 
Motivation  <free text> 
Question 2: Addresses a clearly defined need in pesticide RA? 
Answer Yes/No  
Options if "Yes"  Global model predicting kp 
 Global model predicting Jmax 
 Global model predicting % absorption 
 Local model predicting kp for pesticide group(s) 
 Local model predicting Jmax for pesticide group(s) 
 Local model predicting % absorption for pesticide 
group(s) 
 Other 
Specify pesticide group(s) if local model <free text> 
Specify "Other" if selected <free text> 
Options if "No"  does not predict a dermal absorption parameter 
 Local model predicting kp for non-pesticide group(s) 
 Local model predicting Jmax for non-pesticide group(s) 
 Local model predicting % absorption for non-pesticide 
group(s) 
 categorical model of dermal absorption 
 Other 
Specify non-pesticide group(s) if local 
model 
<free text> 
Specify "Other" if selected <free text> 
Question 3: Are there more recent similar models by the same research group? 
Answer Yes/No <if yes, specify paper> 
Question 4: Details of the training set provided? 
Answer Yes/No  
Options if "Yes"  Chemical IDs of all members of the training set 
 Measured absorption parameters 
 Parameter values used in model 
 Other 
specify "Other" if selected <free text> 
Question 5: Can the model be reproduced based the materials and methods of the paper? 
Answer Yes/No  
Options if "Yes"  Completely 
 Partly 
Motivation <free text> 
Question 6: Internal validation performed? 
Answer Yes/No  
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Options if "Yes"  Parameter Value 
 R2 <number> 
 Adjusted R2 <number> 
 RMSE <number> 
 number of predictors <number> 
 number in training set <number> 
 Other <number> 
specify "Other" if selected <free text> 
Question 7: External validation performed? 
Answer Yes/No  
Options if "Yes"  Parameter Value 
 R2 <number> 
 Adjusted R2 <number> 
 RMSE <number> 
 number of predictors <number> 
 number in validation set <number> 
 Other <number> 
specify "Other" if selected  <free text> 
Question 8: Can the model be interpreted mechanistically? 
Options A Clear how input parameters might cause changes in 
absorption rate and model does specify quantitative 
influence of parameter values on predicted absorption 
parameter 
B Clear how input parameters might cause changes in 
absorption rate, but model does NOT specify 
quantitative influence of parameter values on predicted 
absorption parameter 
C NOT clear how input parameters might cause changes 
in absorption rate, but model does specify quantitative 
influence of parameter values on predicted absorption 
parameter 
D NOT clear how input parameters might cause changes 
in absorption rate and model does NOT specify 
quantitative influence of parameter values on predicted 
absorption parameter 
Motivation <free text> 
Question 9: Proprietary model? 
Answer Yes/No  
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Appendix D – Detailed Results of the Systematic Literature Appraisal 
Table D.1: Algorithm models possibly relevant for pesticide risk assessment - Single substance models. 
Citation 
Model 
No. 
Model algorithm(s) LRT-ID 
Abraham  M. H. and Martins  
F. (2004) 
1 log kp = 0.106R2 − 0.473πH2 − 0.473ΣαH2 − 3.00ΣβH2 + 2.296 x − 1.866 26295 
Abraham  M. H. and Martins  
F. and Mitchell  R. C. (1997) 
1 log kp = 0.44R2 − 0.49πH2 − 1.48ΣαH2 − 3.44ΣβH2 + 1.94 x − 1.57 26296 
Barratt  M. D. (1995) 1 log kp = 0.820 logPow – 0.0093MV – 2.36 – 0.0039Mpt 29150 
Baba  H. and Ueno  Y. and 
Hashida  M. and Yamashita  F. 
(2017) 
3 log kp  = 4.41 x 10-1 LogD - 3.58 x 10-3 MW - 5.91 26371 
Buchwald  P. and Bodor  N. 
(2001) 
1 log kp = 0.0208log Ve – 0.723N – 2.69 29160 
Cleek  R. L. and Bunge  A. L. 
(1993) 
1 
kp  =  klip /(1+ (klip  ×  √(MW))/2.6) 
log klip = − 2.32 +0.574 logPow – 0.005MW 
26543 
Cronin  M. T. and Dearden  J. 
C. and Moss  G. P. and 
Murray-Dickson  G. (1999) 
1 log kp = 0.772l logPow – 0.0103MW − 2.33 26553 
Cronin  M. T. and Dearden  J. 
C. and Moss  G. P. and 
Murray-Dickson  G. (1999) 
2 log kp = −0.0705HALP + 0.494 logPow – 0.230 4χv − 2.77 26553 
Dearden  J. C. and Cronin  M. 
T. D. and Patel  H. and 
Raevsky  O. A. (2000) 
1 log kp = −0.626∑ a – 23.8∑(Q+)/α – 0.289 SsssCH – 0.0357SsssOH – 0.482IB +0.405BR + 0.834 29167 
Fujiwara  S. I. and Yamashita  
F. and Hashida  M. (2003) 
1 log kp = 0.5356 logPow – 0.005227MW – 2.56 26735 
Guy  R. H. and Potts  R. O. 
(1992) 
1 log kp = 0.74 logPow – 0.006MW – 2.8 28277 
Magnusson  B. M. and 
Anissimov  Y. G. and Cross  S. 
E. and Roberts  M. S. (2004) 
1 log Jmax = –0.0141MW – 4.52 28496 
McKone  T. E. and Howd  R. A. 
(1992) 
1 kp  = MW
-0.6 × [0.33 + δskin /(−2.4·10
-6 + 3·10-5 POW
0.8)] 29201 
Mitragotri  S. (2002) 1 log kp = –0.20 r
2 + 0.7 logPow – 1.70 27272 
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Citation 
Model 
No. 
Model algorithm(s) LRT-ID 
Moody  R. P. and MacPherson  
H. (2003) 
1 log kp = 0.81 logPow – 0.009 LMV – 2.33 27290 
Moody  R. P. and MacPherson  
H. (2003) 
2 log kp = 0.77 logPow – 0.018 MV – 2.25 27290 
Moody  R. P. and MacPherson  
H. (2003) 
3 log kp = 0.77 logPow – 0.010 MW – 2.28 27290 
Moody  R. P. and MacPherson  
H. (2003) 
4 log kp = 0.81 logPow – 0.004 LMV  – 0.23 STW + 2.06 27290 
Moss  G. P. and Cronin  M. T. 
D. (2002) 
1 log kp = 0.74l logPow – 0.0091MW – 2.39 27297 
Patel  H. and Berge  W. T. and 
Cronin  M. T. D. (2002) 
1 log kp = –2.3 + 0.652 logPow – 0.00603MW –  0.623ABSQon – 0.313SsssCH 27415 
Potts  R. O. and Guy  R. H. 
(1992) 
1 log kp = 0.71 logPow – 0.0061MW – 2.7 28668 
Potts  R. O. and Guy  R. H. 
(1995) 
1 log kp = 0.0256MV – 1.72HD – 3.93HA – 1.29 27448 
Pugh  W. J. and Degim  I. T. 
and Hadgraft  J. (2000) 
1 log kp = –2.724 – 0.00264 MW × charge + 0.59 logPow 27458 
ten Berge  W. (2009) 1 
log kpSC-intercellular = 0.7318 logPow – 0.006832MW – 2.59 
log kpSC-transcellular = –1.361log MW – 1.367 
kp = kpSC-intercellular + kpSC-transcellular 
27716 
Ashrafi, P (2016) 1 n/a : Gaussian Process model with Matérn covariance function v=3/2 29272 
Ashrafi, P (2016) 2 n/a: Support Vector Machine 29272 
Atobe  T. and Mori  M. and 
Yamashita  F. and Hashida  M. 
and Kouzuki  H. (2015) 
1 see mixture models 26359 
Atobe  T. and Mori  M. and 
Yamashita  F. and Hashida  M. 
and Kouzuki  H. (2015) 
2 see mixture models 26359 
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Citation 
Model 
No. 
Model algorithm(s) LRT-ID 
Baert  B. and Deconinck  E. 
and Van Gele  M. and Slodicka  
M. and Stoppie  P. and Bode  
S. and Slegers  G. and Vander 
Heyden  Y. and Lambert  J. 
and Beetens  J. and De 
Spiegeleer  B. (2007) 
1 
log kp = 0.41 ALO P + 0.61 Mor13v + 0.51  hetv − 1.40 Mor26v + 0.97 x P2v − 0.70 Mor11m − 0.48 MATS2e 
+ 0.081 Mor09u − 0.11  ATS4e − 4.5 
26375 
Baert  B. and Deconinck  E. 
and Van Gele  M. and Slodicka  
M. and Stoppie  P. and Bode  
S. and Slegers  G. and Vander 
Heyden  Y. and Lambert  J. 
and Beetens  J. and De 
Spiegeleer  B. (2007) 
2 
log kp = -3.1 H.050 -1.0 Hpypertens.50 + 0.10 ALOGP - 0.00048 SRW09 + 0.15 RDF075m - 0.14 H.052 - 0.48 
T.(S..F) +0.48 C.025 - 10.6 R1m+ - 6.2 RTm+ - 2.7 
26375 
Beydon  D. and Payan  J. P. 
and Ferrari  E. and 
Grandclaude  M. C. (2014) 
1 
log Jmax, rat = –0.31 logPow + 3.7 
Tlag, rat = 0.22 x exp(0.34 logPow) 
26426 
Beydon  D. and Payan  J. P. 
and Ferrari  E. and 
Grandclaude  M. C. (2014) 
2 
log Jmax, human = –0.50 logPow + 3.75 
Tlag, human = 0.25 x exp(0.44 logPow) 
26426 
Bunge  A. L. and Cleek  R. L. 
(1995) 
1 
kp  =  klip /(1+ (klip  ×  √(MW))/2.6) 
log klip = − 2.8+0.74 logPow – 0.006 MW 
28068 
Bunge  A. L. and Flynn  G. L. 
and Guy  R. H. (1994) 
1 
log K(SC/W) = 0.74 logPow 
log (D(SC)/L(SC) = - 0.006 MW - 2.80 
L(SC) = assumed to be 10-20 µm (to expressed in cm in the formula above!) 
For t(expo) ≤ t* : 
DA = 2 A  0(v) K(S /v) √(D(S )t(expo)/π) 
For t(expo) > t* : 
DA =   A C0(v) K(SC/v) L(SC)/(1 + B) [D(SC) t(expo)/(L(SC))2 + (1 + 3 B (1 + B))/ (3 (1 + B)] 
t* (= time required to reach steady state) = 0.4 (L(S ))2 / D(S ) for B ≤ 0.60 
t* = [b - √(b2 - c2)] (L(SC))2 / D(SC) for B > 0.60 
b = 2 (1 + B)2 / π - c 
c = (1 + 3 B + 3 B2)/ 3 (1 + B) 
B = Kwp,SC x (MW)1/2 / 2.59 cm/h 
log Kwp,SC = 0,74 logPow - 0,0060 MW - 2.80 
26482 
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Citation 
Model 
No. 
Model algorithm(s) LRT-ID 
Chen  L. J. and Lian  G. P. and 
Han  L. J. (2007) 
1 log kp = 0.34 R2 − 0.77 πH2 − 0.69 ΣαH2 − 2.32 ΣβH2 + 1.77  x − 2.77 26518 
Chen  L. J. and Lian  G. P. and 
Han  L. J. (2007) 
2 n/a: ANN 26518 
Dancik  Y. and Miller  M. A. 
and Jaworska  J. and Kasting  
G. B. (2013) 
1 n/a: in silico PBPK-model 26565 
Degim  T. and Hadgraft  J. and 
Ilbasmis  S. and Ozkan  Y. 
(2003) 
1 n/a: ANN 26580 
Frasch  H. F. (2002) 1 
kp = k_sc*kaq/(k_sc+kaq) 
kaq = 0.1151 cm/h 
k_sc = K_mv x D*/l* 
log K_mv = 0.59* logPow - 0.024 
log D* = log_Dcor_Dlip/(1+EXP(-(log K_cor_lip + 0.1974 - 0.3668 log (Dcor/Dlip)/(0.2488 + -0.134 log 
(Dcor/Dlip)))) 
log (Dcor/Dlip) = -0.0087 MW 
l* = 0.003 x (1 - 0.9113 log_Kcor_lip + 0.9896 (log_Kcor_lip)^2 + 0.3111 (log_Kcor_lip)^3) 
log_Kcor_lip = -0.8075 logPow + 2.4194 
26719 
Fu  X. C. and Ma  X. W. and 
Liang  W. Q. (2002) 
1 log kp = 3.69 MV - 2.86 Q(h) - 2.19 Q(O.N) - 0.033 E(HOMO) - 0.22 E(LUMO) - 1.20 26732 
Fu  X. C. and Ma  X. W. and 
Liang  W. Q. (2002) 
2 n/a: ANN model 26732 
Fu  X. C. and Wang  G. P. and 
Wang  Y. F. and Liang  W. Q. 
and Yu  Q. S. and Chow  M. S. 
(2004) 
1 log kp =  0.82 logPow - 6.83 MV - 2.38 26733 
Fu  X. C. and Wang  G. P. and 
Wang  Y. F. and Liang  W. Q. 
and Yu  Q. S. and Chow  M. S. 
(2004) 
2 log kp = 0.67 logPow - 1.11 M  − 1.52 ΣαH2 − 1.21 ΣβH2  − 1.61 26733 
Fu  X. C. and Wang  G. P. and 
Wang  Y. F. and Liang  W. Q. 
and Yu  Q. S. and Chow  M. S. 
(2004) 
3 log kp = 0.52 logPow -1.51 ΣαH2 − 1.45 ΣβH2  − 1.60 26733 
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Citation 
Model 
No. 
Model algorithm(s) LRT-ID 
Fu  X. C. and Wang  G. P. and 
Wang  Y. F. and Liang  W. Q. 
and Yu  Q. S. and Chow  M. S. 
(2004) 
4 log kp = 11.6 MV -1.49 ΣαH2 − 3.87 ΣβH2  − 1.47 26733 
Guth  K. and Riviere  J. E. and 
Brooks  J. D. and Dammann  
M. and Fabian  E. and van 
Ravenzwaay  B. and Schafer-
Korting  M. and Landsiedel  R. 
(2014) 
1 see mixture models 26811 
Katritzky  A. R. and Dobchev  
D. A. and Fara  D. C. and Hur  
E. and Tamm  K. and Kurunczi  
L. and Karelson  M. and 
Varnek  A. and Solov ev  V. P. 
(2006) 
1 
log kp = -7.20 + 0.67* logPow - 0.24*Kier & Hall index (order 3) + 0.74*rotational entropy (300 K)/no. of atoms 
- 23.43*HASA-2/TMSA (Zefirov Partial Charge) + 0.20*number of O atoms + 3.5563 
27004 
Keshwani  D. M. and Jones  D. 
D. and Brand  R. M. (2005) 
1 n/a: fuzzy in silico model 27010 
Khajeh  A. and Modarress  H. 
(2014) 
1 log kp = -0.877 EEig15r + 0.642 ALOGP -  1.554  Neoplastic-80 -  3.179 27015 
Khajeh  A. and Modarress  H. 
(2014) 
2 log kp = -1.012 EEig15r + 0.556 logPow exp -  1.601  Neoplastic-80 -  3.084 27015 
Kilian  D. and Lemmer  H. J. R. 
and Gerber  M. and Du Preez  
J. L. and Du Plessis  J. (2016) 
1 log kp = 0.739* logPow - 0.0089*MW - 2.36 27024 
Krüse  J. and Golden  D. and 
Wilkinson  S. and Williams  F. 
and Kezic  S. and Corish  J. 
(2007) 
1 log kp = 0.74* logPow - 2.8 - 0.006*MW 27077 
Lim  C. W. and Fujiwara  S. 
and Yamashita  F. and Hashida  
M. (2002) 
1 log kp = -5.016 - 0.197*µ + 0.002059*pol + 0.395*sum(N,O) - 1.668*sum(H) 27150 
Lindh  M. and Karlén  A. and 
Norinder  U. (2017) 
1 n/a: Machine learning model 27158 
Lindh  M. and Karlén  A. and 
Norinder  U. (2017) 
2 n/a: Machine learning model 27158 
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Citation 
Model 
No. 
Model algorithm(s) LRT-ID 
Lindh  M. and Karlén  A. and 
Norinder  U. (2017) 
3 n/a: Machine learning model 27158 
Lindh  M. and Karlén  A. and 
Norinder  U. (2017) 
4 n/a: Machine learning model 27158 
Luo  W. and Medrek  S. and 
Misra  J. and Nohynek  G. J. 
(2007) 
1 log kp = 0.5347* logPow - 0.09686*X0 - 0.141*SsssCH - 2.54333 27184 
Luo  W. and Medrek  S. and 
Misra  J. and Nohynek  G. J. 
(2007) 
2 log kp = 0.4828* logPow - 0.003544*MW - 2.62741 27184 
Luo  W. and Nguyen  H. and 
Telesford  Q. and Fung  W. 
(2004) 
1 log kp = -0.005530*MW + 0.6205* logPow + 0.000000303*Sw + 0.08239*logD(pH7.4) - 0.001483*MP - 2.759 28485 
Milewski  M. and Stinchcomb  
A. L. (2012) 
1 log Jmax = 4.600 - 0.219* logPow - 0.0086*MW - 0.0102*(MP - 25) 27255 
Mitragotri  S. (2003) 1 kp = 0.0000056* Pow ^0.7*exp(-0.46*r^2) 27273 
Neely  B. J. and Madihally  S. 
V. and Robinson Jr  R. L. and 
Gasem  K. A. M. (2009) 
1 n/a: Neural Network model 27337 
Neely  B. J. and Madihally  S. 
V. and Robinson Jr  R. L. and 
Gasem  K. A. M. (2009) 
2 n/a: Neural Network model 27337 
Neumann  D. and Kohlbacher  
O. and Merkwirth  C. and 
Lengauer  T. (2006) 
1 n/a: machine learning model 28600 
Poulin  P. and Krishnan  K. 
(2001) 
1 kp = (Pl:w*Dl*Fl)/Ll + (Pp:w*Dp*(Fp+Fw)/Lt 27449 
Pugh  W. J. and Hadgraft  J. 
(1994) 
1 log kp = -0.262 + 0.335*Halide + 0.187*[C] - 0.297*[O] - 0.639*[N] + 0.275*c 29212 
Pugh  W. J. and Hadgraft  J. 
(1994) 
2 to be specified if model is selected as useful 29212 
Pugh  W. J. and Hadgraft  J. 
(1994) 
3 to be specified if model is selected as useful 29212 
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Citation 
Model 
No. 
Model algorithm(s) LRT-ID 
Rocco  P. and Cilurzo  F. and 
Minghetti  P. and Vistoli  G. 
and Pedretti  A. (2017) 
1 log kp = -1.43 + 0.72*log(Pow *D/MV) 27524 
Rocco  P. and Cilurzo  F. and 
Minghetti  P. and Vistoli  G. 
and Pedretti  A. (2017) 
2 log kp = 0.21 + 0.75*log(Pow *D300/MV^2) + 0.066*MV*(T-300) 27524 
Rocco  P. and Cilurzo  F. and 
Minghetti  P. and Vistoli  G. 
and Pedretti  A. (2017) 
3 log kp = -21.21 + 0.75*log(Pow *D300/MV^2) + 0.072*T 27524 
Santos-Filho  O. A. and 
Hopfinger  A. J. and Zheng  T. 
(2004) 
1 log kp =  497 − 599  urs-FPSA-1 + 0.52 Area − 1.84  urs-PNSA-1 27569 
Santos-Filho  O. A. and 
Hopfinger  A. J. and Zheng  T. 
(2004) 
2 log kp = 31.34 − 1909  urs-FPSA-3 +4.80 Jurs-PPSA-3 + 479 Jurs-FNSA-1 − 1.57  urs-PNSA-1 27569 
Santos-Filho  O. A. and 
Hopfinger  A. J. and Zheng  T. 
(2004) 
3 
log kp = 35.27 − 1.56  urs-PNSA-1 − 1.72  HI-V-3_P − 2037  urs-FPSA-3 + 5.19 Jurs-PPSA-3 + 475 Jurs-FNSA-
1 
27569 
Santos-Filho  O. A. and 
Hopfinger  A. J. and Zheng  T. 
(2004) 
4 
log kp =  121 − 217  urs-R    − 37.50  X − 7.17  HI-V-3_P + 4.37 Jurs-RPCS + 110 Jurs-FNSA-1 + 4.02 
Kappa6 
27569 
Santos-Filho  O. A. and 
Hopfinger  A. J. and Zheng  T. 
(2004) 
5 log kp =  −4.85 − 0.10 ( urs-RNCS - 5.35)2 − 688 ( urs-RNCG - 0.21)2 + 1.34 (Jurs-RPCS - 2.91)2 27569 
Santos-Filho  O. A. and 
Hopfinger  A. J. and Zheng  T. 
(2004) 
6 
log kp =  −3.20 − 0.002 ( urs-DPSA-1 - 277)2 − 0.002 ( urs-PNSA-1 - 40.1)2 + 0.001 (Jurs-PPSA-1 - 352)2 + 
999 (Jurs-FNSA-1 - 0.11)2 
27569 
Santos-Filho  O. A. and 
Hopfinger  A. J. and Zheng  T. 
(2004) 
7 
log kp =  −0.49 − 0.69 ( urs-RPCS - 3.00)2 + 0.62 (Jurs-RPCS - 2.47)2 + 702 (Jurs-RNCG - 0.21)2 − 24.9  urs-
RPCG + 0.12 (Jurs-RNCS - 5.10)2 
27569 
Santos-Filho  O. A. and 
Hopfinger  A. J. and Zheng  T. 
(2004) 
8 
log kp =  −3.26 − 0.77 ( urs-RPCS - 3.47)2 + 0.10 (Jurs-RNCS - 3.20)2 − 747 ( urs-RNCG - 0.23)2 − 0.62 ( urs-
RPCS - 2.32)2 + 0.94 Shadow-Zlength − 38.9  urs-RPCG 
27569 
Santos-Filho  O. A. and 
Hopfinger  A. J. and Zheng  T. 
(2004) 
18 log kp = 0.28* logPow - 0.007*MW - 2.00 27569 
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Citation 
Model 
No. 
Model algorithm(s) LRT-ID 
Santos-Filho  O. A. and 
Hopfinger  A. J. and Zheng  T. 
(2004) 
19 log kp = 0.22* logPow - 0.14*Ess(tor) - 0.05*Einter(vdW) - 2.97 27569 
Steinmetz  F. P. and Madden  
J. C. and Cronin  M. T. (2015) 
1 log kp = -2.51 + 0.50* logPow - 0.0051*MW 27667 
Thomas  J. and Majumdar  S. 
and Wasdo  S. and Majumdar  
A. and Sloan  K. B. (2007) 
1 log Jmax = -2.500 + 0.5571*logSoct + 0.4429*logSaq - 0.00502*MW 27725 
Thomas  J. and Majumdar  S. 
and Wasdo  S. and Majumdar  
A. and Sloan  K. B. (2007) 
2 log Jmax = -2.574 + 0.5861*logSoct + 0.4139*logSaq - 0.00440*MW 27725 
Walker  J. D. and Rodford  R. 
and Patlewicz  G. (2003) 
1 log kp = 0.595* logPow - 3.212 27803 
Williams  F. M. and Rothe  H. 
and Barrett  G. and Chiodini  
A. and Whyte  J. and Cronin  
M. T. and Monteiro-Riviere  N. 
A. and Plautz  J. and Roper  C. 
and Westerhout  J. and Yang  
C. and Guy  R. H. (2016) 
1 Jmax = Kp,mod * Caq,sat 27847 
Williams  F. M. and Rothe  H. 
and Barrett  G. and Chiodini  
A. and Whyte  J. and Cronin  
M. T. and Monteiro-Riviere  N. 
A. and Plautz  J. and Roper  C. 
and Westerhout  J. and Yang  
C. and Guy  R. H. (2016) 
2 Qmax = A*Jmax*Texp 27847 
Xu  G. and Hughes-Oliver  J. 
M. and Brooks  J. D. and 
Yeatts  J. L. and Baynes  R. E. 
(2013) 
1 log kp = -2.50 + 0.04*Ei + 0.83*Si - 0.13*Ai - 1.00*Bi + 0.27*Vi 27872 
Yu  Y. J. and Su  R. X. and 
Wang  L. B. and Qi  W. and He  
Z. M. (2010) 
1 log kp = -1.56 - 0.153*Dipole - 0.259*alogPow + 0.0385*Har - 0.543*Xu + 0.976* logPow - 0.00626*Mp 27901 
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Citation 
Model 
No. 
Model algorithm(s) LRT-ID 
Yu  Y. J. and Su  R. X. and 
Wang  L. B. and Qi  W. and He  
Z. M. (2010) 
2 
log kp = -0.255 - 0.127*Dipole + 24.6*CP + 0.053*MolP + 0.014*Har - 1.94*AE - 1.29*Xu + 0.080*LSI - 
0.00186*TE - 0.00413*Mv + 0.774* logPow - 0.00691*Mp 
27901 
Zhang  K. and Abraham  M. H. 
and Liu  X. (2017) 
1 log kp = -5.328 + 0.137*E - 0.604*S - 0.338*A - 2.428*B + 1.797*V - 1.485*J+ + 2.471*J- 29242 
Zhang  K. and Chen  M. and 
Scriba  G. K. E. and Abraham  
M. H. and Fahr  A. and Liu  X. 
(2012) 
1 log kp = -5.420 - 0.102*E - 0.457*S - 0.324*A - 2.680*B + 2.066*V - 1.938*J+ + 2.548*J- 27918 
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Table D.2: Algorithm models possibly relevant for pesticide risk assessment - Mixture models. 
Citation Model 
No. 
Model algorithm(s) 
LRT-ID 
Chittenden  J. T. and Riviere  
J. E. (2016) 
1 log kp = -7.245 - 0.6775 (logPow - 2.910) + 0.00832 (MW-225) - 0.0304 (mCMA - 75.3) - 0.0229 (mTPSAd - 
27.3) + 0.778 
26534 
(Ghafourian et al., 2010b) 1 log kp = −0.956 − 0.00322 Δmp − 0.000320W(P) − 0.0121 BP( ) − 0.114 Lipole(P)  26771 
Ghafourian  T. and Samaras  
E. G. and Brooks  J. D. and 
Riviere  J. E. (2010) 
2 log kp = −310 − 0.000315W(P) − 0.00771 δ( ) x E(HOMO)(P) − 0.0102 BP( ) − 0.0750 Lipole(P) 26771 
Ghafourian  T. and Samaras  
E. G. and Brooks  J. D. and 
Riviere  J. E. (2010) 
3 log kp = −2.48 − 0.0474  (atoms)(P) − 0.00798 δ( ) x E(HOMO)(P) − 0.0102 BP( ) − 0.0723 Lipole(P) 26771 
Ghafourian  T. and Samaras  
E. G. and Brooks  J. D. and 
Riviere  J. E. (2010) 
4 log kp = −4.29 − 0.0474  (atoms)(P) − 0.00904 (BP − MP)( ) − 0.345 E(HOMO)(P) − 0.0790 Lipole(P) 26771 
Riviere  J. E. and Brooks  J. D. 
(2005) 
1 log kp = - 10.394 mRI − 1.527 ΣαH2 + 0.045 ΣβH2  + 0.327 πH2 - 0.561 R2 - 1.904 Vx + 13.921 27505 
Riviere  J. E. and Brooks  J. D. 
(2005) 
2 log kp = - 9.242 mRI − 0.525 ΣαH2 + 0.329 ΣβH2  + 0.407 πH2 - 0.411 R2 - 1.385 Vx + 10.751 27505 
Riviere  J. E. and Brooks  J. D. 
(2005) 
3 log kp = - 0.318 mPo − 1.529 ΣαH2 + 0.043 ΣβH2  + 0.327 πH2 - 0.563 R2 - 1.902 Vx + 0.81 27505 
Riviere  J. E. and Brooks  J. D. 
(2005) 
4 log kp = - 0.149 mPo − 0.155 ΣαH2 + 0.546 ΣβH2  + 0.421 πH2 - 0.433 R2 - 1.255 Vx - 1.255 27505 
Riviere  J. E. and Brooks  J. D. 
(2005) 
5 log kp = - 0.479 mlog(1/H ) − 1.282 ΣαH2 + 0.195 ΣβH2  + 0.280 πH2 - 0.453 R2 - 1.863 Vx + 2.372 27505 
Riviere  J. E. and Brooks  J. D. 
(2005) 
6 log kp = - 0.419 mlog(1/H ) − 0.050 ΣαH2 + 0.693 ΣβH2  + 0.388 πH2 - 0.323 R2 - 1.328 Vx + 0.105 27505 
Riviere  J. E. and Brooks  J. D. 
(2007) 
1 log kp = -0.04 mTPSA - 0.03 logPow - 0.00080 MW - 2.05 27506 
Riviere  J. E. and Brooks  J. D. 
(2007) 
2 log kp = -1.19 mHA - 0.03 logPow - 0.00081 MW - 1.12 27506 
Riviere  J. E. and Brooks  J. D. 
(2007) 
3 log kp = -0.04 mTPSA - 0.48 MR + 0.09 HBA - 0.42 HBD - 0.49 27506 
Riviere  J. E. and Brooks  J. D. 
(2007) 
4 log kp = -10.42 mRI - 0.49 MR + 0.10 HBA - 0.45 HBD + 13.01 27506 
Riviere  J. E. and Brooks  J. D. 
(2007) 
5 log kp = - 0.04 mTPSA − 1.45 ΣαH2 + 0.31 ΣβH2  + 0.0.004 πH2 - 0.45 R2 - 1.92 Vx + 0.54 27506 
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Citation Model 
No. 
Model algorithm(s) 
LRT-ID 
Riviere  J. E. and Brooks  J. D. 
(2007) 
6 log kp = - 10.38 mRI − 1.54 ΣαH2 + 0.25 ΣβH2  + 0.092 πH2 - 0.53 R2 - 1.92 Vx + 13.98 27506 
Riviere  J. E. and Brooks  J. D. 
(2011) 
1 log kp =  − 1.45 ΣαH2 + 0.01 ΣβH2  + 0.27 πH2 - 0.55 R2 - 1.39 Vx + 2.55 27508 
Riviere  J. E. and Brooks  J. D. 
(2011) 
2 log kp =  77.66/mMP − 1.47 ΣαH2 + 0.01 ΣβH2  + 0.27 πH2 - 0.56 R2 - 1.39 Vx + 3.14 27508 
Riviere  J. E. and Brooks  J. D. 
(2011) 
3 log kp =  -1.21 mHbacc  − 1.40 ΣαH2 + 0.03 ΣβH2  + 0.27 πH2 - 0.55 R2 - 1.38 Vx + 4.25 27508 
Riviere  J. E. and Brooks  J. D. 
(2011) 
4 log kp =  -1.21 mHbacc  − 1.44 ΣαH2 + 0.28 πH2 - 0.55 R2 - 1.38 Vx + 4.27 27508 
Riviere  J. E. and Brooks  J. D. 
(2011) 
5 log kp = –0.10 logPow – 0.00058 MW + 1.13 27508 
Riviere  J. E. and Brooks  J. D. 
(2011) 
6 log kp = –1.23 mHBacc – 0.10 logPow – 0.00058 MW + 2.89 27508 
Riviere  J. E. and Brooks  J. D. 
and Collard  W. T. and Deng  
J. and de Rose  G. and 
Mahabir  S. P. and Merritt  D. 
A. and Marchiondo  A. A. 
(2014) 
1 log kp = - 1.43 mlogPow − 14.86 ΣαH2 + 2.02 ΣβH2  + 2.97 πH2 - 11.86 R2 + 8.87 27509 
Riviere  J. E. and Brooks  J. D. 
and Collard  W. T. and Deng  
J. and de Rose  G. and 
Mahabir  S. P. and Merritt  D. 
A. and Marchiondo  A. A. 
(2014) 
2 log kp = - 1.39 mlog WS(M) − 14.17 ΣαH2 + 1.64 ΣβH2  + 2.93 πH2 - 11.80 R2 + 9.30 27509 
Samaras  E. G. and Riviere  J. 
E. and Ghafourian  T. (2012) 
1 log JSS = 0.00235 m(BP - MP) + 0.000001 [donor] - 0.00570 MW + 3.96 vsurf_G + 0.0137 S log P_VSA4 - 1.93 
fiAB - 0.343 VAdjMa - 1.92 
27563 
Samaras  E. G. and Riviere  J. 
E. and Ghafourian  T. (2012) 
2 log JSS = 0.00192 m(BP - MP) + 0.000001 [donor] - 0.00561 MW + 3.82 vsurf_G + 0.0140 S log P_VSA4 - 1.95 
fiAB - 0.312 VAdjMa - 1.67 - 0.201 Thickness 
27563 
Samaras  E. G. and Riviere  J. 
E. and Ghafourian  T. (2012) 
3 log JSS = 0.00230 m(BP - MP) + 0.000001 [donor] - 0.00592 MW + 3.55 vsurf_G + 0.00992 S log P_VSA4 - 1.85 
fiAB - 0.293 VAdjMa - 1.08 - 0.391 Infinite/Finite 
27563 
Samaras  E. G. and Riviere  J. 
E. and Ghafourian  T. (2012) 
4 n/a: Regression Tree model based on parameters listed in previous column 27563 
Samaras  E. G. and Riviere  J. 5 n/a: Regression Tree model based on parameters listed in previous column 27563 
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Citation Model 
No. 
Model algorithm(s) 
LRT-ID 
E. and Ghafourian  T. (2012) 
Samaras  E. G. and Riviere  J. 
E. and Ghafourian  T. (2012) 
6 n/a: Regression Tree model based on parameters listed in previous column 27563 
Samaras  E. G. and Riviere  J. 
E. and Ghafourian  T. (2012) 
7 n/a: Regression Tree model based on parameters listed in previous column 27563 
Samaras  E. G. and Riviere  J. 
E. and Ghafourian  T. (2012) 
8 n/a: Regression Tree model based on parameters listed in previous column 27563 
Samaras  E. G. and Riviere  J. 
E. and Ghafourian  T. (2012) 
9 n/a: Regression Tree model based on parameters listed in previous column 27563 
Atobe  T. and Mori  M. and 
Yamashita  F. and Hashida  M. 
and Kouzuki  H. (2015) 
1 log kp =  −0.193 x logPow (chemical) x logPow (vehicle) + 0.00124 x MW(chemical) x logPow (vehicle) - 0.00476 x 
MW(chemical) + 0.0184 x  (logPow (vehicle))
2 - 0.00000352 x MW(chemical)2 - 2.23  
26359 
Atobe  T. and Mori  M. and 
Yamashita  F. and Hashida  M. 
and Kouzuki  H. (2015) 
2 n/a: ANN using MW(chemical), Pow (chemical), Pow (vehicle) 26359 
Guth  K. and Riviere  J. E. and 
Brooks  J. D. and Dammann  
M. and Fabian  E. and van 
Ravenzwaay  B. and Schafer-
Korting  M. and Landsiedel  R. 
(2014) 
1 log (max kp) = 0.6 Rf2 + 0.5 SpI - 0.1 mTPSA- 2.3 26811 
(Ghafourian et al., 2010a) 1 log kp = −0.909 – 0.610 logPow+ 2.62 (^9)χ(p)  −0.00917 (SolBP − SolMP) 26770 
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Table D.3: Parameter codes. 
Code Description 
A Effective/overall hydrogen bond acidity, Abraham descriptor 
α hydrogen bond donor acidity 
ABSQon  the sum of absolute charges on oxygen and nitrogen atoms 
accptHB QikProp descriptor 
AE average of estate values 
ΣαH2 Effective/overall hydrogen bond acidity, Abraham descriptor 
ALOGP Ghose-Crippen octanol-water partition coeff. (logP) (from Dragon) 
aLogP hydrophobicity, probably the same as ALOGP 
Area molecular surface area: a 3D spatial descriptor that describes the van der Waals area of a molecule 
B Effective/overall hydrogen bond basicity, Abraham descriptor 
B03[O-O] Presence/absence of O - O at topological distance 3 (from Dragon) 
B04[C-O] Presence/absence of C - O at topological distance 4 (from Dragon) 
B05[O-O] Presence/absence of O - O at topological distance 5 (from Dragon) 
B06[C-N] Presence/absence of C - N at topological distance 6 (from Dragon) 
ΣβH2 Effective/overall hydrogen bond basicity, Abraham descriptor 
BLTF96 Verhaar Fish base-line toxicity from MLOGP (mmol/l)  (from Dragon) 
Bp =BP = boiling point 
BP - MP BP − MP is the difference between the boiling and melting points of a compound 
BR  Number of rotable bonds 
c aromatic carbon atom 
[C] single-bonded carbon atom 
C.025 the atom-centred fragment R-CR-R 
C0(v) concentration of penetrant in vehicle (mg/cm3) 
CATS2D_06_LL CATS2D Lipophilic-Lipophilic at lag 06 (from Dragon) 
cb  the number of carbons not involved in a C= O bond 
charge  the sum of the absolute values of the partial charges (calculation method described in Pugh et al. (2000)) 
chi0 Zero order molecular connectivity index (Hall and Kier (1991)) 
chi0V Zero order valence molecular connectivity index (Hall and Kier (1991)) 
chi1v_C First order carbon valence connectivity index (Hall and Kier (1991)) 
(^9)χ(p) 9th order path molecular connectivity index of the penetran 
ChiA_H2 average Randic-like index from reciprocal squared distance matrix (from Dragon) 
4χv fourth-order valence-corrected molecular connectivity 
CHI-V-3_P Kier and Hall valence-modified connectivity index CHI-3_P means third-order CHI index with three paths (bonds) 
connected; V means that electron configuration of the atom (single or multiple bonds) is considered  
In silico tools for prediction of dermal absorption  
 
 
 
www.efsa.europa.eu/publications 119 EFSA Supporting publication 2018:EN-1493 
The present document has been produced and adopted by the bodies identified above as authors. This task has been carried out exclusively by the authors in the context of a contract between the European Food Safety Authority and the authors, 
awarded following a tender procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The European Food Safety 
Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the authors. 
 
Code Description 
Count of H-acceptor sites [Zefirov] (CODESSA) calculated by CODESSA 
Count of H-donor sites [Zefirov] calculated by CODESSA 
CP charge polarization 
Csat  Concentration in water at saturation (expressed in mg/cm3) 
δ solubility parameter, calculated based on Fedor's approach (see: K.C. James, in: J. Swarbrick (Ed.), Solubility and Related 
Properties, Vol. 5, Marcel Dekker, New York, 1986, pp. 184–188) 
δ the Hildebrand solubility parameter 
ddHsolv solvation enthalpy 
den_2 not specified, probably density in µg/mL 
Dipole dipole moment 
Dl lipid diffusion coefficient 
DLS_05 modified drug-like score from Zheng et al. (2 rules) (from Dragon) 
Δmp the difference between the melting point of the penetrant and that of the solvent 
[donor] donor concentration a.i. (µg/mL) 
donorHB QikProp descriptor 
Dp protein diffusion coefficient 
δskin skin thickness in cm (0.0025 cm in McKone and Howd (1992)) 
E Excess molar refraction, Abraham descriptor 
E(HOMO) the energy of the highest occupied molecular orbital (eV) 
E(LUMO) the energy of the lowest unoccupied molecular orbital (eV) 
E1v  WHIM descriptor, calculated by DRAGON 
E2s 2nd component accessibility directional WHIM index / weighted by I-state  (from Dragon) 
EA(eV) QikProp descriptor 
EEig15r an edge adjacency index as a topological descriptor derived from the eigenvalue of the adjacency matrix of edges weighted 
by resonance integrals [33] 
Eig04_AEA(ed) eigenvalue n. 4 from augmented edge adjacency mat. weighted by edge degree (from Dragon) 
Eig10 EA(ed) eigenvalue n. 10 from edge adjacency mat. weighted by edge degree (from Dragon) 
Eta beta A eta average VEM count (from Dragon) 
fiAB Fraction of molecules ionised as anion and cation at pH 7.4 
Fl lipid fractional content 
Fp protein fractional content 
Fw water fractional content 
G2i 2nd component symmetry directional WHIM index / weighted by ionization potential (from Dragon) 
GATS4e three-dimensional (Geary autocorrelation lag 4)spatial autocorrelation coefficient 
GATS5e Geary autocorrelation of lag 5 weighted by Sanderson electronegativity (from Dragon) 
GCUT_PEOE_1 The GCUT descriptors are calculated from the eigenvalues of a modified graph distance adjacency matrix. Each ij entry of 
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Code Description 
the adjacency matrix takes the value 1/sqr(dij) where dij is the (modified) graph distance between atoms i and j. The 
diagonal takes the value of the PEOE partial charges. The  resulting eigenvalues are sorted and the smallest, 1/3-ile, 2/3-ile 
and the largest eigenvalues are reported (MOE (2011)) 
GCUT_SLOGP_1 The GCUT descriptors using atomic contribution to logPow instead of partial charge (MOE (2011)) 
GCUT_SMR_0 The GCUT descriptors using atomic contribution to molar refractivity using the instead of partial charge (MOE (2011)) 
GCUT_SMR_3 The GCUT descriptors using atomic contribution to molar refractivity instead of partial charge (MOE (2011)) 
glob QikProp descriptor 
H.050 the number of hydrogen atoms attached to a heteroatom (atom-centred fragment) 
H.052 the number of hydrogen’s attached to  (sp3) with 1 halogen attached to the next   
H3p H autocorrelation of lag 3 / weighted by polarizability (from Dragon) 
HA  Hydrogen bond acceptor activity  
HALP total number of lone pairs that can accept hydrogen bonds 
Har Harary index 
HASA-2/TMSA Zefirov Partial Charge 
Hb  number of hydrogens 
HBA  hydrogen bond acceptors = counts of hydrogen bond donors 
HBD  hydrogen bond donors = counts of hydrogen bond donors 
HD  Hydrogen bond donor activity  
HeavyAtomCount number of non-hydrogen atoms  
Hypertens.50 the Ghose–Viswanadhan–Wendoloski 50%-antihypertensive drug-like index (molecular property class) 
IB  Balaban index 
Infinite/Finite Indicator variable indicating infinite or finite exposures taking a value of 2 for finite and 1 for infinite dosing 
Jhetv Balaban type index obtained from the van der Waals volume weighed distance matrix 
Jurs-DPSA-1 difference in charged partial surface areas: partial positive solvent-accessible surface area minus  
partial negative solvent-accessible surface area 
Jurs-FNSA-1 fractional charged partial surface areas: total charge weighted negative surface area divided by the total molecular solvent-
accessible surface area 
Jurs-FPSA-1 fractional charged partial surface areas: partial positive surface area divided by the total molecular solvent-accessible 
surface area  
Jurs-FPSA-3 fractional charged partial surface areas: total charge weighted positive surface area divided by the total molecular solvent-
accessible surface area 
Jurs-PNSA-1 partial negative surface area: sum of the solvent-accessible surface areas of all negatively charged atoms 
Jurs-PPSA-1 partial positive surface area: sum of the solvent-accessible surface areas of all positively charged atoms 
Jurs-PPSA-3 atomic charge weighted positive surface area: Sum Of the product Of solvent-accessible surface area X partial charge for all 
posltlvely charged atoms   
Jurs-RNCG relative negative charge: charge of most negative atom divided by the total negative charge 
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Code Description 
Jurs-RNCS relative negative charge surface area: solvent-accessible surface area of most negative atom divided by relative negative 
charge 
Jurs-RPCG relative positive charge: charge of most positive atom divided by the total positive charge  
Jurs-RPCS relative positive charge surface area: solvent accessible surface area of most positive atom divided by descriptor 
JX Balaban index: characterizes the shape of a molecule, which can take account of the covalent radii 
Kappa6 Kiers shape indices; Kappa6 is the sixth-order index, compares the molecule graph with "minimal" and "maximal" graphs  
Kier shape index – order 1  calculated by CODESSA 
KierA1 First alpha modified shape index, also correlated with molecular size (Hall and Kier (1991)) 
KierA3 Third alpha modified shape index, informing centrality of branching with large values representing location of branching at 
the extremities of the molecule (Hall and Kier (1991)) 
Pow octanol-water partition coefficient 
L(SC) thickness of stratum corneum in cm 
L3s WHIM descriptor, calculated by DRAGON 
Linearity not further specified 
Lipole the total lipole moment of the penetrants 
Ll intercellular lipid pathway 
LMV  Liquid Molar Volume 
logPowexp experimentally determined LogPow 
logD pH dependent LogPow 
logS Log of the aqueous solubility (mol/l) calculated by MOE from an atom contribution linear atom type model (MOE (2011)) 
LSI log of superpendentic index 
Lt transcellular proteinaceous pathway 
LUMO energy lowest unoccupied molecular orbital energy calculated by CODESSA 
µ dipole moment 
m log WS(M) mixture log Water Solibility (expressed in Mol/L), WS obtained via http://www.vcclab.org/lab/alogps/ 
m(BP-MP) mixture: weighted difference between the boiling and melting points of its compounds (excluidng a.i.'s) 
MATS 1m Moran autocorrelation of lag 1 weighted by mass (from Dragon) 
MATS 1p Moran autocorrelation of lag 1 weighted by polarizability (from Dragon) 
MATS2e two-dimensional (Moran autocorrelation lag 2) spatial autocorrelation coefficient 
maxkp maximum Kp  
mCMA = mixture Conolly molecular area = concentration weighted average (based on contribution to total formula weight) of 
Conolly moleculare areas of mixture constituent molecules 
mHA mixture number of hydrogen bond acceptors (HA calulated by log P.com) 
mHBacc mixture number of hydrogen bond acceptors (HA calulated by www.molinspiration.com) 
mLogPow mixture LogPow 
mlog WS(M) mixture log water solubility (expressed as moles/L) 
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Code Description 
mlog(1/HC) mixture log(1/Henry's Law Constant) 
mMP mixture melting point 
MOE CLOGP MOE property LogPow, calculated with Molecular Operating Environment program 
MolP molecular polarizability 
Mor09u descriptor of 3D-Molecule Representation of Structures based on Electron diffraction, unweighed 
Mor11m descriptor of 3D-Molecule Representation of Structures based on Electron diffraction, weighed by atomic masses 
Mor13v descriptor of 3D-Molecule Representation of Structures based on Electron diffraction, weighed by van der Waals volumes 
Mor26v descriptor of 3D-Molecule Representation of Structures based on Electron diffraction, weighed by van der Waals volumes 
Mor28i signal 28 / weighted by ionization potential (from Dragon) 
Mor32s signal 32 / weighted by I-state (from Dragon) 
MP melting point 
MP (°C) melting point in degree Celsius 
mPo mixture Polarizability 
Mpt  melting point 
MR Molar Refractivity 
MR  molecular refractivity 
mRI mixture Refractive Index (RI calculated by SPARC) 
mTPSA  
mixture Topological Polar Surface Area = concentration weighted average (based on contribution to total formula weight) 
of polar surface areas of mixture constituent molecules: 
 
m = weight fraction of ingredient in formulation 
p = property of ingredient in formulation (in this case TPSA, calculated by ADME) 
 
  
mTPSAd  
mixture Topological Polar Surface Area difference = TPSA a.i. minus concentration weighted average (based on contribution 
to total formula weight) of polar surface areas of mixture constituent molecules: 
 
MFd = mixture factor difference 
p(j) = a.i. 
 
Mv molecular volume 
MV molecular volume (nm^3) 
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Code Description 
MV  molar volume  
MW molecular weight 
MW  molecular weight 
[N] any nitrogen atom 
N  Number of affected hydrogen bonds, calculated by summing the number of N and O atoms (aliphatic twice, aromatic once) 
(Bodor and Buchwald 1997) 
N(atoms) the total number of atoms in the molecules 
nArCOOR  number of esters (aromatic), calculated by DRAGON 
nCq  number of total quaternary C(sp3), calculated by DRAGON 
Neoplastic-80 antineoplastic-like property filter at 80% similarity, a descriptor proposed by Ghose et al. [34]. It is a set of general and 
objective rules based on the limits of structural features and physicochemical properties. 
nHAcc number of acceptor atoms for H-bonds (N,O,F) (from Dragon) 
nHDon  number of hydrogen donors, calculated by DRAGON 
nRCOOR number of esters (aliphatic) (from Dragon) 
Number of single bonds calculated by CODESSA 
NumRotatableBonds number of rotatable bonds  
[O] any oxygen atom 
Occlusion Indicator variable for occlusion of the skin during in vitro test 
P2v one of the directional WHIM (Weighted Holistic Invariant Molecular) descriptors, capturing molecular 3D information related 
to the shape of the molecule. P2v represents the 2nd component shape directional WHIM index, weighed by the atomic van 
der Waals volumes 
PEOE_RPC+ Relative positive partial charge: the largest positive atomic partial charge divided by the sum of the positive partial charges 
(MOE 2011)) 
PEOE_VSA_POL Could be a printing error as the term is not in the list of seection 5 of Samaras et al. (2012) but PEOE_VSA_POS is. 
PEOE_VSA_POS Total positive van der Waals surface area. This is the sum of the van der Waals surface area of atoms with non-negative 
partial charges (MOE 2011)) 
      Solute dipolarity/polarizability, Abraham descriptor 
PISA QikProp descriptor 
Pl:w lipid:water partition coefficient 
pol polarizability 
Polarity parameter (Qmax-Qmin) calculated by CODESSA 
Pp:w protein:water partition coefficient 
pre-Hydration Indicator variable for pre-hydration of the skin prior to the in vitro test 
PSA polar surface area  
Q(h) the sum of the net atomic charges of the hydrogen atoms bound to nitrogn or oxygen atoms 
Q(O.N) the sum of the absolute values of the net atomic charges of oxygene and nitrogen atoms which were hydrogen-bond 
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Code Description 
acceptors 
r van der Waal's  molecular radius in Å(ngstrom) (10-10 m) 
R1m R autocorrelation of lag 1 / weighted by mass  (from Dragon) 
R1m+ R maximal autocorrelation of lag 1, weighted by atomic masses 
R2 Excess molar refraction, Abraham descriptor 
R2  Excess molar refraction, Abraham descriptor 
R4p R autocorrelation of lag 4 / weighted by polarizability (from Dragon) 
R7s R autocorrelation of lag 7 / weighted by I-state (from Dragon) 
RDF070s Radial Distribution Function - 070 / weighted by I-state (from Dragon) 
RDF075m the radial distribution function 7.5 weighted by atomic masses 
RDF090i Radial Distribution Function - 090 / weighted by ionization potential (from Dragon) 
RDF1 10i Radial Distribution Function -110/ weighted by ionization potential (from Dragon) 
RDF120s Radial Distribution Function - 120 / weighted by I-state (from Dragon) 
Rf2 excess molar refraction 
RingCount number of rings  
#rotor Number of rotable bonds 
RTm+ R maximal index, weighted by atomic masses 
S Solute dipolarity/polarizability, Abraham descriptor 
S lo P_vSA4 sum of van der Waals surface area of atoms with logPow 
contributions in the range of (0.1–0.15) (MOE (2011)) 
S log P_VSA4 sum of van der Waals surface area of atoms with log P (=Pow) contributions in the range of (0.1–0.15) (MOE (2011)) 
Shadow-Zlength length of molecule in the Z dimension 
SM 1_Dz(v) spectral moment of order 1 from Barysz matrix weighted by van der Waals volume (from Dragon) 
SOLV [kJ/mol] solvation free energy 
SP solubility parameter expressed in (cal/cm3)1/2 
SpI Species Indicator varibale (rat = 2, human = 1) 
SpMaxA B(s) normalized leading eigenvalue from Burden matrix weighted by I-State (from Dragon) 
SpMaxA_EA(ri) normalized leading eigenvalue from edge adjacency mat. weighted by resonance integral  (from Dragon) 
SRW09 the self-returning walk count of order 09 
SsssCH the sum of E-state indices for all methyl groups/Electrotopological atom-type index for singly bonded CH 
SsssOH  Electrotopological atom-type index for singly bonded OH 
STW  Surface Tension in Water  
sum(H) sum of charges of hydrogen atoms bonding to nitrogen or oxygen atoms 
sum(N,O) sum of charges of nitrogen and oxygen atoms 
∑ a  HYBOT-PLUS H-bond acceptor free energy factor 
∑(Q+)/α  HYBOT-PLUS positive charge per unit volume 
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Code Description 
SolBP − SolMP difference between the boiling point and the melting point of the solvent system. 
Sw water solubility 
t(expo) exposure time in hours 
T.(S..F) the sum of topological distances between S and F atoms 
TDB05v 3D Topological distance based descriptors - lag 5 weighted by van der Waals volume (from Dragon) 
TDB09e 3D Topological distance based descriptors - lag 9 weighted by Sanderson electronegativity (from Dragon) 
TE total energy 
Thickness Thickness of the membrane expressed in mm (millimeters) 
Total dipole of the molecule  calculated by CODESSA 
TPSA Topological polar surface area 
V McGowan characteristic volume, Abraham descriptor 
VAdjMa Vertex adjacency information which depends on the number of heavy-heavy bonds  (Cruciani et al. (2000)) 
Ve  Van der Waals effective molecular volumes, calculated according to Buchwald and Bodor (1998) 
VE1_H2 coefficient sum of the last eigenvector from reciprocal squared distance matrix (from Dragon) 
VEH  vehicle type (for acetone VEH=1 and for ethanol VEH=2) 
vsa_acc Approximation to the sum of VDW surface areas of pure hydrogen bond acceptors (not counting acidic atoms and atoms 
that are both hydrogen bond donors and acceptors such as OH) (MOE (2011)) 
vsa_hyd Approximation to the sum of VDW surface areas of hydrophobic atoms  (MOE (2011)) 
vsurf_CW3 Capacity factor representing the ratio of the hydrophilic surface over the total molecular surface. These are calculated at 
eight different energy levels. (Cruciani et al. (2000)) 
vsurf_D6 Volume that can generate hydrophobic interactions. 
VolSurf computes hydrophobic descriptors at eight 
different energy levels (Cruciani et al. (2000)) 
vsurf_EWmin1 The lowest hydrophilic interaction energy 
vsurf_G The molecular globularity–how spherical a molecule is, where values above 1 is non-perfect spheres (Cruciani et al. (2000)) 
vsurf_HB5 H-bond donor capacity, representing the molecular 
envelope which can generate attractive H-donor 
interactions with carbonyl oxygen probe. The 
descriptors are computed at six different energy levels (Cruciani et al. (2000)) 
vsurf_W1 Hydrophilic volume describing the molecular envelope 
which attractively interacts with water molecules at 
eight different energy levels (Cruciani et al. (2000)) 
vsurf_Wp2 Polar volume (Cruciani et al. (2000)) 
Vx McGowan characteristic volume, Abraham descriptor 
Vx  McGowan characteristic volume, Abraham descriptor 
W the Wiener topological index (the sum of distances between all pairs of vertices in the molecular graph of an alkane) 
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Code Description 
weinerPath Wiener path number: half sum of all the distance 
matrix entries (MOE (2011)) 
WS water solubility (mg/L) 
X0 zero order molecular connectivity chi index 
Xu Xu index 
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Results of the second stage of the scientific review 
The detailed results of the critical appraisal of dermal absorption models are provided as Supporting 
Information (file name: “Model Review.xlsx”). This Excel file contains three tabs: one with the review 
of the single substance models, one with the review of the mixture models and one explaining the 
variable symbols used in the specified algorithms. 
It should be noted that there is some redundancy in the variable symbols as different authors 
sometimes use different symbols. For easy reference to the original papers mostly the notation of 
their authors has been used. In some instances of often used symbols, it was decided to use a unique 
symbol, e.g. (log) Kow for the octanol-water partitioning coefficient was always preferred over (log) P 
and kp for the permeability constant was always preferred over P or other designations. 
Below a short explanation is provided for the headings and subheadings of the columns in the review 
tabs, if not self-evident. If papers were excluded based on any question of the hierarchical second 
stage of the scientific review, the questions that follow thereafter were not answered. In these cases 
"n/a" (meaning not applicable) was entered in the respective fields in the Excel file. 
Table D.4: Explanation of headings for the file “Model Review.xlsx” with supplementary 
information from the the scientific review 
Heading Subheading Explanation 
Paper #  Sequential number 
LRT-ID  Unique ID of the paper used in the TNO Literature 
Review Tool (LRT) 
LRT_link  Link that can be pasted in the address bar of the 
web-based LRT in order to navigate to the reviewed 
paper 
Citation  Paper reference 
Remark   
Model Label No.  Models appearing in the same paper are numbered in 
order of appearance. Default number is 1 
1. Algorithm based 
model? 
Yes/No  
 Reproducible Preliminary evaluation based on presence of a well 
described algorithm for algorithm based models and 
on the availability of a detailed description of model 
structure and the complete training set with all input 
parameters for each substance for machine learning 
models 
 Motivation Justification, if deemed necessary 
2. Addresses a clearly 
defined need in pesticide 
RA? 
Yes/No  
 Specification Reason for answering yes or no to question 2 
 Chemical group(s) Specifies chemical groups addressed in local models 
3. More recent similar 
models? 
Yes/No  
 Remark Lists reference to most recent model if question 3 is 
answered with "Yes". 
4. Details of the training 
set provided? 
Yes/No  
 Chemical IDs of all 
members of the training 
set 
Answered with "Yes", when these data are provided. 
 Measured absorption 
parameters 
Answered with "Yes", when these data are provided. 
 Parameter values used in 
model 
Answered with "Yes", when these data are provided. 
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Heading Subheading Explanation 
 Other Specifies any other relevant information provided on 
the dataset 
5. Can the model be 
reproduced based the 
materials and methods of 
the paper? 
Yes/No  
 Specification Indicates whether the model can be completely or 
partly reproduced 
 Motivation When only partly reproducible, it is indicated here 
which part can and which part cannot be reproduced 
6. Internal validation Yes/No  
 R2 Lists value if provided 
 Adjusted R2 Lists value if provided 
 RMSE Lists value if provided 
 number of pre-dictors Lists value if provided 
 number in training set Lists value if provided 
 Other Lists additional relevant value if provided 
 Specified the type of additionally provided value 
7. External validation Yes/No Lists value if provided 
 R2 Lists value if provided 
 Adjusted R2 Lists value if provided 
 RMSE Lists value if provided 
 number of pre-dictors Lists value if provided 
 number in valida-tion set Lists additional relevant value if provided 
 Other Specified the type of additionally provided value 
 Lists value if provided 
8. Mechanistic 
interpretation 
Option Four different options are provided, indicated with A, 
B, C or D (description provided in Table C.1) 
 Motivation Justification, if deemed necessary 
9. Proprietary model? Yes/No  
Model parameters   
Model algorithm(s)   
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Appendix E – Data plausibility check and curation 
For the purpose of this project, a column containing record identifiers 1-6842 relating to individual 
replicated of experiments was introduced to the EFSA dataset.  
First, active substance SMILES codes were collected from the BfR internal IJC database or Pubchem. 
For cases where the no information could be found in neither sources, a google search was 
performed. This applied to the following active substance names in the provided EFSA dataset: 
 SYN545192 was identified as Benzovindiflupyr 
 for Aminopyralid-TIPA SMILES were found in ChemIDplus database 
 XDE 777- XDE 779 / XDE-777 was identified as Fenpicoxamid and molecular weight of 
614.648 g/mol was identical to molecular weight in EFSA dataset. The name of the a.s. 
remained XDE 777- XDE 779 / XDE-777 
 Imidazole/BAS 590 02 F was found to be present in pesticide product Octave 46 WP which 
could be associated with Prochloraz manganese chloride complex also having the same 
molecular weight (1632.525 g/mol). 
For several active substances, some additional information is reported below:  
 According to the EFSA conclusion on the active substance Spinetoram, Spinetoram (XDE-175) 
is a mixture of two main components, XDE-175-J-major factor and XDE-175-L-minor factor. 
SMILES and consequently physico-chemical values and other parameters were calculated for 
XDE-175-J, which represents the major factor with an amount of 50-90% in the Spinetoram 
mixture.  
 Beta Cyfluthrin and Cyfluthrin differ in isomeric composition. Thus, distinct active substance 
names were retained although no difference was made at the structural level (SMILES codes). 
Thus, physico-chemical properties are essentially identical because they were computed based 
on SMILES codes. 
 Dimethenamid and Dimethenamid-P also differ in isomeric composition. Nevertheless, as no 
difference was made at the structural level (SMILES code), calculated descriptors are 
identical. For records 1677-1694 with the a.s. name Dimethenamid, the identity could be 
confirmed from the study report. For records 1695-1704, the tested active substance was 
identified as Dimethenamid, rather than the reported Dimethenamid-P and a correction was 
performed. For all other records, study reports were not available and the identity was kept as 
Dimethenamid P. 
 Mancozeb was excluded from the dataset due to ambiguous structure. Referring to the DAR 
Part B.1, mancozeb is defined as a bulk chemical composition and there is no unique chemical 
molecule which may be identified as mancozeb.  
 In case of AE 1801486, no information on active substance chemical name could be found in 
internal regulatory documents or internet search.  
 Entries for Mancozeb and AE 1801486 were kept in the dataset but were completely excluded 
from the evaluation.They are to be filtered out by selecting "Y" at the new column "Include?" 
in the datafile provided as Supporting Information (file name: ”Human in vitro PPP EFSA 
dataset with add parameters and predictions.xlsx”). 
Based on structure (SMILES code), the molecular weight (MW) was computed with IJC. This served as 
plausibility check for identity of active substance and correctness of the SMILES codes. Computed and 
reported MWs were compared. Two out of 191 listed active substances showed deviating ratios: 
 Flupyrsulfuron methyl showed a difference of computed (465.36) versus reported MW 
(487.40) of 22.04 g/mol, which might account for sodium. When referring to the original 
study report, the tested active substance was Flupyrsulfuron methyl monosodium salt. Thus, 
reported MW is correct as reported in the dermal absorption study.   
 The deviation recognised for the active substance Prochloraz-copper can be explained with 
giving the MW for the monomeric Prochloraz (376.70) in the EFSA dataset. The computed MW 
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(1641.09) related to the Prochloraz-copper complex, because it is based on SMILES codes 
which were in turn generated based on given active substance name. It can be assumed that 
monomeric Prochloraz will be absorbed and be the molecule of interest. Additionally, some of 
the physico-chemical descriptors could only be predicted for monomers (here: Prochloraz). 
Accordingly, the structure of Prochloraz was adopted. 
In addition, a Pivot Table was created to check for different values for one a.s. name. Pivot and 
conditional formatting were used for highlighting duplicate values on MW to check for similar/same 
a.s.. Pivot and conditional formatting were further used for highlighting duplicate values on both rows 
to check whether similar a.s. are indeed the same despite differences in names. A line-by-line visual 
inspection was performed to identify missing or contradictory entries. If needed, study reports were 
consulted when available. The following substances were renamed without changes to the data to 
resolve duplicate entries for identical structures as well as for consistency, transparency and 
correctness: 
 2,4-D to 2,4-D (2,4-dichlorophenoxyacetic acid ) 
 2,4-D EHE to 2,4-D EHE (2-ethylhexyl 2-(2,4-dichlorophenoxy)acetate) 
 Cymoxynil to Cymoxanil 
 Cyflometofen to Cyflumetofen 
 Diruon to Diuron 
 E2Y to Chlorantraniliprole  
 Imidazole/BAS59002F, identified as Prochloraz manganese, to Imidazole/BAS 590 02 F 
(Prochloraz-manganese)  
 Oxyfluropfen to Oxyfluorfen 
 SYN520453 (Isopyrazam) was renamed to Isopyrazam.  
 XDE-729 methyl, identified as Halauxifen-methyl, to XDE-729 methyl (Halauxifen-methyl) 
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Appendix F – Additional information on the collection of physical-
chemical data 
 
Calculation of hydrogen bond acceptor activity and hydrogen bond donor activity: 
additional considerations 
Although superseded by Model003, Model001 was used for prediction of Hydrogen bond 
donor/acceptor activities, as it was thought to most closely reflect the tool used by the authors of the 
skin absorption model where A (there: Hd) and B (there: Ha). In addition, the webservice based on 
Model003 did not work reliably. Moreover, there are a few limitations reported for Model003 at an 
additional webpage referring to the applicability domain mentioned by the developers. First, for 
compounds outside the applicability domain errors can be the result of prediction. This might be the 
cases for substances with XLogP < -0.03, MLogP < 1.63 AND TpSA > 31.8, the compound contains a 
phenol or hetero atom and if a 5-ring is connected to a general functional group by a single bond. In 
addition, it is highlighted by the developers that A, the hydrogen bond acidity, is the most difficult 
Abraham descriptor to model. For that reason the value for A might be predicted negative, but usually 
A should be zero when the number of hydrogen bond donors is zero. Regarding these limitations, the 
application of Model001 was regarded as acceptable within the scope of the project. 
When entering the required input data for the computation with Model001 the output comprises five 
Abraham descriptors E, S, A, B, V. Defining A as the solute overall hydrogen bond acidity which 
relates to hydrogen bond donor activity and B as the solute overall hydrogen bond basicity which 
relates to hydrogen bond acceptor activity. For Model001 and the underlying training set, adjusted R² 
values of 0.6262 and 0.8327 were stated for A and B, respectively. 
 
Calculation of EHOMO and ELUMO energy values for Fu 2002: Reproducibility of 
MOPAC2016  
For the training set used by the authors of models 4 and 5 (Fu, Ma and Liang , 2002), the AM1 
method was employed for calculation of these values. Accordingly, the AM1 method was also chosen 
to predict EHOMO and ELUMO values for the pesticidal active substances. It was checked whether 
MOPAC2016 can reproduce the EHOMO and ELUMO values calculated by Fu, Ma and Liang (2002) to a 
satisfactory degree. SMILES codes for were obtained for 12 substances selected from the training set 
used by Fu et al. (2002) from PubChem public database. The results are summarized in  
 
 
Table F.1.For testosterone geometry optimization by MOPAC2016 failed and EHOMO/ELUMO values 
were not calculated. For dexamethasone, OpenBabel failed to produce a viable 3D structure as atom 
20 and atom 25 were superimposed, producing an error message in MOPAC2016. HOMO/LUMO 
energies as reported by Fu et al. (2002) and those calculated by the method described above were 
not fully identical. Despite application of the same method (AM1), values differed by between 0.0006 
and 1.9366 eV with a median of 0.2548 eV (n = 20 pairs). The largest difference between predictions 
by Fu et al. (2002) and those performed in this project were observed for ethylbenzene and 2-
naphthol. It can only be speculated that observed differences may be related to the implementation of 
the AM1 method in MOPAC2016, as the tool used by Fu et al. (2002) is not known. Nevertheless, for 
the purpose of this project, the level of reproduction was considered sufficient. This step in the 
procedure should be taken into account as a potential source of error when assessing predictivity of 
the model against the EFSA dataset and when applying the model for other purposes. 
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Table F.1: Comparison of reported EHOMO / ELUMO values for the training data set used by Fu, Ma 
and Liang (2002) to values predicted with the methodology described here. 
Substance SMILES EHOMO [eV] ELUMO [eV] 
MOPAC Fu et al. MOPAC Fu et al. 
diethylether CCOCC  -10.392 -10.3931 2.981 2.9816 
butanoic acid CCCC(=O)O -11.247 -11.5020 1.058 1.0285 
methanol CO -11.134 -11.1349 3.780 3.7783 
1-hexanol CCCCCCO -10.934 -10.8475 3.463 3.3692 
1-decanol CCCCCCCCCCO -10.909 -10.8493 3.392 3.3320 
ethylbenzene CCC1=CC=CC=C1 -8.015 -9.2984 -1.399 0.5376 
3,4-di-methylphenol CC1=C(C=C(C=C1)O)C -8.586 -8.8561 -0.506 0.4559 
4-chloro-phenol C1=CC(=CC=C1O)Cl -8.870 -9.1246 -0.329 0.0947 
4-bromo-phenol C1=CC(=CC=C1O)Br -8.931 -9.1892 -0.395 0.0204 
2-naphthol C1=CC=C2C=C(C=CC2=C1)
O 
-7.712 -8.5697 -1.858 -0.3443 
teststerone CC12CCC3C(C1CCC2O)CCC4
=CC(=O)CCC34C 
n.d. -10.0129 n.d. 0.0143 
dexamethasone CC1CC2C3CCC4=CC(=O)C=
CC4(C3(C(CC2(C1(C(=O)CO)
O)C)O)F)C 
n.d. -10.1421 n.d. -0.4457 
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Appendix G – Models’ applicability and codes 
 
Model Model sub-version code Model sub-version 
Total excluded 
(percentage of whole 
dataset) 
Exclusion criteria - presented in the order applied 
(no of replicates excluded) 
1 (all sub-
versions) 
Model 1, t_lag=0 
OR 
Model 1, calculated t_lag 
Both sub-versions with different tlag assumptions 
for kp %DA transformation (tlag= 0 OR 
tlag=calculated) 
580 (8.5 %) 
i. non-plausible negative experimental % Dermal Absorption (%DA) values as 
provided by EFSA (6) 
ii. implementation not possible: absence of data on the experimentally applied 
concentration as provided by EFSA (57) 
iii. implementation not possible: non-applicability of the DAME model for non-liquid 
experimental items (517) 
2 (all sub-
versions) 
Model 2, t_lag=0 
OR 
Model 2, calculated t_lag 
Both sub-versions with different tlag assumptions 
for kp %DA transformation (tlag= 0 OR 
tlag=calculated) 
580 (8.5 %) 
i. non-plausible negative experimental % Dermal Absorption (%DA) values as 
provided by EFSA (6) 
ii. implementation not possible: absence of data on the experimentally applied 
concentration as provided by EFSA (57) 
iii. implementation not possible: non-applicability of the DAME model for non-liquid 
experimental items (517) 
3 (sub-versions 
calculated with 
computed Saq 
values and both 
lag time options) 
Model 3 (calc. S_aq), 
t_lag=0 
OR 
Model 3 (calc. S_aq), 
calculated t_lag 
2 sub-versions (out of 4) calculated with: 
i. calculated Saq values for Jmaxkp conversion 
ii. different tlag assumptions for kp %DA 
transformation (tlag= 0 OR tlag=calculated) 
580 (8.5 %) 
i. non-plausible negative experimental % Dermal Absorption (%DA) values as 
provided by EFSA (6) 
ii. implementation not possible: absence of data on the experimentally applied 
concentration as provided by EFSA (57) 
iii. implementation not possible: non-applicability of the DAME model for non-liquid 
experimental items (517) 
3 (sub-versions 
calculated with 
experimental Saq 
values and both 
lag time options) 
Model 3 (calc. S_aq), 
t_lag=0 
OR 
Model 3 (calc. S_aq), 
calculated t_lag 
2 sub-versions (out of 4) calculated with: 
i. experimental Saq values for Jmaxkp conversion 
ii. different tlag assumptions for kp %DA 
transformation (tlag= 0 OR tlag=calculated) 
762 (11.2%) 
i. non-plausible negative experimental % Dermal Absorption (%DA) values as 
provided by EFSA (6) 
ii. implementation not possible: absence of data on the experimentally applied 
concentration as provided by EFSA (57) 
iii. implementation not possible: non-applicability of the DAME model for non-liquid 
experimental items (517) 
iv. additional criterion: absence of experimental data on water solubility (149) 
v. 
mathematically not allowed (33) 
4 (all sub-
versions) 
Model 4, t_lag=0 
OR 
Model 4, calculated t_lag 
Both sub-versions with different tlag assumptions 
for kp %DA transformation (tlag= 0 OR 
tlag=calculated) 
588 (8.6%) 
i. non-plausible negative experimental % Dermal Absorption (%DA) values as 
provided by EFSA (6) 
ii. eHOMO eLUMO values computation not possible (14) 
iii. implementation not possible: absence of data on the experimentally applied 
concentration as provided by EFSA (57) 
iv. implementation not possible: non-applicability of the DAME model for non-liquid 
experimental items (511) 
5 (all sub- Model 5, t_lag=0 Both sub-versions with different tlag assumptions 612 (9.0%) i. non-plausible negative experimental % Dermal Absorption (%DA) values as 
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Model Model sub-version code Model sub-version 
Total excluded 
(percentage of whole 
dataset) 
Exclusion criteria - presented in the order applied 
(no of replicates excluded) 
versions) OR 
Model 5, calculated t_lag 
for kp %DA transformation (tlag= 0 OR 
tlag=calculated) 
provided by EFSA (6) 
ii. eHOMO eLUMO values computation not possible (14) 
iii. Aminopyralid-Olamine excluded (24) 
iv. implementation not possible: absence of data on the experimentally applied 
concentration as provided by EFSA (57) 
v. implementation not possible: non-applicability of the DAME model for non-liquid 
experimental items (511) 
6 (sub-versions 
calculated with 
computed Saq and 
both    and lag 
time options) 
Model 6 (calc.Saq, n.T), 
t_lag=0 
OR 
Model 6 (calc.Saq), 
t_lag=0 
OR 
Model 6 (calc.Saq, n.T), 
calculated t_lag 
OR 
Model 6 (calc.Saq), 
calculated t_lag 
4 subversions (out of 8) calculated with: 
i. calculated Saq values for Jmax kp  conversion 
ii.    for liquids set at 25°C (marked as "nT") 
OR   for liquids set as recorded in the 
database (no additional marking) 
iii. different tlag assumptions for kp %DA 
transformation (tlag= 0 OR tlag=calculated) 
580 (8.5%) 
i. non-plausible negative experimental % Dermal Absorption (%DA) values as 
provided by EFSA (6) 
ii. implementation not possible: absence of data on the experimentally applied 
concentration as provided by EFSA (57) 
iii. implementation not possible: non-applicability of the DAME model for non-liquid 
experimental items (517) 
6 (sub-versions 
calculated with 
experimental Saq 
and both    and 
lag time options) 
Model 6 (exp.Saq, n.T), 
t_lag=0 
OR 
Model 6 (exp.Saq), 
t_lag=0 
OR 
Model 6 (exp.Saq, n.T), 
calculated t_lag 
OR 
Model 6 (exp.Saq), 
calculated t_lag 
4 subversions (out of 8) calculated with: 
i. experimental Saq values for Jmax kp  
conversion 
ii.    for liquids set at 25°C (marked as "nT") 
OR   for liquids set as recorded in the 
database (no additional marking) 
iii. different tlag assumptions for kp %DA 
transformation (tlag= 0 OR tlag=calculated) 
762 (11.2%) 
i. non-plausible negative experimental % Dermal Absorption (%DA) values as 
provided by EFSA (6) 
ii. implementation not possible: absence of data on the experimentally applied 
concentration as provided by EFSA (57) 
iii. implementation not possible: non-applicability of the DAME model for non-liquid 
experimental items (517) 
iv. additional criterion: absence of experimental data on water solubility (149) 
v. 
mathematically not allowed (33) 
7 Model 7 No sub-versions 5250 (77%) Model applied only to a restricted dataset (see 2.7.1.7) 
8 (all sub-
versions) 
Model 8, t_lag=0 
OR 
Model 8, calculated t_lag 
Both sub-versions with different tlag assumptions 
for kp %DA transformation (tlag= 0 OR 
tlag=calculated) 
580 (8.5%) 
i. non-plausible negative experimental % Dermal Absorption (%DA) values as 
provided by EFSA (6) 
ii. implementation not possible: absence of data on the experimentally applied 
concentration as provided by EFSA (57) 
iii. implementation not possible: non-applicability of the DAME model for non-liquid 
experimental items (517) 
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Model Model sub-version code Model sub-version 
Total excluded 
(percentage of whole 
dataset) 
Exclusion criteria - presented in the order applied 
(no of replicates excluded) 
9 (all sub-
versions) 
Model 9, t_lag=0 
OR 
Model 9, calculated t_lag 
Both sub-versions with different tlag assumptions 
for kp %DA transformation (tlag= 0 OR 
tlag=calculated) 
5863 (86%) 
i. implementation not possible: no information on product co-formulants retrievable 
 mixture model not applicable 
ii. implementation not possible: non-applicability of the DAME model for non-liquid 
experimental items 
10 (all sub-
versions) 
Model 10, t_lag=0 
OR 
Model 10, calculated t_lag 
Both sub-versions with different tlag assumptions 
for kp %DA transformation (tlag= 0 OR 
tlag=calculated) 
5863 (86%) 
i. implementation not possible: no information on product co-formulants retrievable 
 mixture model not applicable 
ii. implementation not possible: non-applicability of the DAME model for non-liquid 
experimental items 
11 (all sub-
versions) 
Model 11, t_lag=0 
OR 
Model 11, calculated t_lag 
Both sub-versions with different tlag assumptions 
for kp %DA transformation (tlag= 0 OR 
tlag=calculated) 
5863 (86%) 
i. implementation not possible: no information on product co-formulants retrievable 
 mixture model not applicable 
ii. implementation not possible: non-applicability of the DAME model for non-liquid 
experimental items 
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Appendix H – Adjusted logit 
Many of the plots in the report use either a logarithmic scale or an "adjusted logit scale" on one or 
both axes. This is done always to try to enhance the communication and extraction of information. 
Logarithmic scales are familiar to scientists and need no explanation. The adjusted logit scale used 
here was introduced in the EFSA (2017) guidance on dermal absorption and some support for its use 
may be found in Annex B therein. Some additional description and justification is provide here. 
The logit of a fraction f (or a percentage considered as a number between 0 and 1) is  
logit (f) = log [f/(1-f)].  
Fractions between 0 and 1 are mapped/transformed to numbers which lie anywhere on the real line. 
The fraction 50% = 0.5 is mapped to 0, fractions above 50% to positive numbers and fractions below 
50% to negative numbers. The effect of the transformation is to stretch out the scale near 0 and 1. In 
effect for fractions near 0, the logit is equivalent to the natural logarithm of the fraction and there is a 
similar property near 1. A logit scale is a good choice if one wishes to stretch out fractions near 0 and 
1 in plots of data. It is also a good choice if the precision of measurement is higher near 0 and 1, for 
example if the typical error/variability of measurement of the fraction is proportional to the fraction 
being measured for small fractions. 
The adjusted logit scale used in EFSA (2017) was used to address the fact that some measurements 
of absorption in the database are actually 0% and such measurements would have to be excluded if 
using a pure logit scale. In the adjusted logit scale, fractions are first "shrunk" a little towards 50% 
before calculating the logit, i.e. by calculating 
ℓ = adjusted logit (f) = logit (0.5 + 0.9995(f-0.5)) (1) 
We can invert this, i.e. find f from ℓ, by first undoing the logit: 
fshrunk = e
ℓ / (eℓ + 1)      (2) 
and then undoing the  "shrinking": 
f = 0.5 + (fshrunk – 0.5)/0.9995     (3) 
The corresponding "adjusted logit scale" is used in some figures which follow but the axis tick marks 
show the original percentage absorption to facilitate interpretation of figures. The adjusted logit scale 
is also used for averaging replicates as follows:  
First calculate the adjusted logit of each replicate using equation (1), then calculate the arithmetic 
mean of the adjusted logit values and finally calculate the inverse of the arithmetic mean using (2) 
and (3). The result is an "adjusted-logit mean" in the same sense that using the process with 
logarithms instead of logits gives the geometric mean. 
The key to use of the adjusted logit scale is the precision of measurement of absorption and how it 
depends on the actual magnitude of absorption. This can be assessed, at least partially, by looking at 
the difference between replicate absorption measurement and assessing how the typical magnitude of 
the difference depends on the level of absorption being measured. This is illustrated in the figures 
below: 
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(A)  (B)  
(C)  (D)  
Figure H.1: Illustration of scales used. (A) Untransformed (raw): Dependence of the (absolute) 
magnitude of the difference between two replicate measurements of absorption on the magnitude of 
absorption (B) Relative: Dependence of the (relative) magnitude of the difference between two 
replicate measurements of absorption on the magnitude of absorption (C) Transformed: Dependence 
of the (absolute) magnitude of the difference between two replicate measurements of absorption on 
the magnitude of absorption, with adjusted-logit (replicate/mean) values for %DA (D) the logit (red) 
and adjusted logit (blue) transformations as functions of absorption. 
 
Figure H.1(A) shows that there is a strong relationship between the magnitude of variation between 
replicates and the absorption level and suggests that some alternative scale should be considered 
when analyzing dermal absorption data. A common solution is to use logarithms but Figure H.1 (B) 
shows that the relative magnitude of variation is not constant but decreases near the upper hand of 
the absorption scale. Figure H.1 (C) shows that the adjusted logit is largely successful in making the 
magnitude of variation between replicates homogeneous across the absorption scale. Note that the 
difference of each pair of replicates from the same experiment is shown: this gives more weight to 
experiments having more replicates. Differences between pairs of replicates were used rather than the 
difference between a replicate and the sample mean for the experiment because the difference 
between pairs isolate the intra-experiment variation. 
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Appendix I – Bayesian Random Effects Model (BREM) 
The Bayesian Random Effects model used to analyse the predictive performance of model 7 has a 
simple structure. The adjusted-logit values of absorption measurements are denoted yi and the base 
10 logarithms of model 7 predicted absorptions by xi. Then 
                                  
Here   is the intercept for a linear relationship and   is the slope.        is a random effect for the 
active substance involved for observation   and          is a random effect for the block of replicates to 
which the observation belongs.      is the replicate variation where   controls the scale of the 
variation and    is assumed to be t-distributed with an uncertain number of degrees of freedom, to be 
inferred from the data. Each of the two kinds of random effect is assumed to be normally distributed 
with mean 0 and has its own standard deviation. 
Inference for all parameters is Bayesian using Markov Chain Monte Carlo, implemented using the rjags 
package for R (Plummer, 2016) and using the following approach to specifying prior distributions for 
all models considered: fixed effects were assigned uniform distributions on the range from -20 to 20, 
standard deviations of fixed effects and the scale parameter for replicate variation were assigned 
uniform distributions on the range from 0 to 10 and degrees of freedom parameters were assigned a 
prior which was uniform on the range from 0 to 1 for the reciprocal of the degrees of freedom. The 
ranges for the uniform distributions for fixed effects and standard deviation and scale parameters are 
sufficiently wide that these are effectively flat priors on all possible values. The prior for degrees of 
freedom is  effrey’s prior for a single parameter .The model described above was arrived at following 
the investigation of a number of related similar models: 
 The t-distribution model for replicate variation was selected having considered also three 
other models: a normal error model and two models adding components for within-donor and 
between-donor variability; one with t-distributions for both components and one with a t-
distribution for within-donor variability and a normal distribution for between-donor variability. 
Inference for all models was carried out using rjags and the selected model was chosen on 
the basis of comparison of Deviance Information Criterion values. 
 The choice to include just the linear regression fixed-effect for model 7 and random effects for 
active substance and replicate block was also made on the basis of DIC having considered a 
number of other models. In this case, two other models had very similar DIC value but were 
more complex. The models considered were: 
a) The model above without a random effect for active substance. 
b) The model above with an additional fixed effect depending on formulation group 
c) The model above with an additional fixed effect for concentrate/dilution 
d) Model c)  with an additional per-substance random effect for concentrate/dilution. 
e) Model c)  with an additional fixed effect depending on formulation group. 
f) Model d)  with an additional fixed effect depending on formulation group. 
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Appendix J – Influence of lag time: conversion of kp / Jmax into 
percentage absorption 
In order to convert the predicted permeability constant kp or maximum flux Jmax, selected models were 
combined with DAME as described in 2.7. This applies to all selected models with the exception of 
model 7. Two types of predictions were made for each model, one based on a lag time set to 0 
("worst case"), and one with a calculated lag time, predicted as described in 2.5.1. 
The following plots show the relationship between predictions using the two sub-versions (calculated 
tlag and tlag = 0) of each model or model version. Logarithmic scales are used on both axes in order 
to distinguish between different magnitudes of predicted absorption. A solid line highlights where the 
two versions make exactly the same predictions. 
In the context of the further analyses performed - in particular on the correlation between measured 
and predicted values-, the differences between the two sub-versions of each model were not sufficient 
to merit producing a separate in-depth evaluation for each sub-version. When applicable, the 
calculated tlag sub-versions were used for all models in further assessment. 
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Figure J.1: Relationship between the predicted %DA values of each model (or model version) 
derived by either using tlag=0 or calculated tlag in the kp-%DA transformation formula (Buist 2010 
(DAME)). Model 7 is not depicted here since it directly yields %DA results. For models’ explanations 
please refer to Appendix G. 
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Appendix K – Model predictions vs. average absorption 
measurements 
Below are presented the relationships between averages of replicates within blocks of replicates and 
corresponding average predictions; for models 1, 2, 3, 4, 5, 6, 8, 11 (and their subversions). For all these 
figures the calculated lag time version of the model was used (for explanations refer to 2.5.1 & Appendix 
J). Each figure shows 4 versions of the same relationship but using different scales on the axes. In each 
case the measured absorption is on the vertical axis and the absorption predicted by the model is on the 
horizontal axis. The top-left panel shows the relationship using the unmodified percentage absorbed scale 
for both axes. The bottom-left panel uses the adjusted logit scale for the vertical axis. The bottom-right 
panel uses the adjusted logit scale for both axes. The top-right panel uses a rank scale for both axes. In 
other words, each measurement is replaced by its rank amongst all measurements and each prediction is 
replaced by its rank amongst all the predictions from the model. For models’ explanations please refer to 
Appendix G for explanations on the logit axes transformation please refer to Appendix H. 
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Appendix L – Influence of covariates 
Below, the influence of sub-categorisation by concentration status (Figure L.1) and formulation type 
(Figure L.2) is depicted graphically. Models 7, 9 and 10 are presented in the main document. For 
explanations on the model’s coding refer to Appendix G. 
Concentrates versus in-use dilutions (Concentration status) 
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Figure L.1:Relationships between the averaged experimental % Dermal Absorption (%DA) values 
and the predicted ones divided into concentrates and dilutions. For models’ explanations please refer 
to Appendix G. 
 
 
 
  
In silico tools for prediction of dermal absorption  
 
 
 
www.efsa.europa.eu/publications 152 EFSA Supporting publication 2018:EN-1493 
The present document has been produced and adopted by the bodies identified above as authors. This task has been carried out exclusively by the authors in 
the context of a contract between the European Food Safety Authority and the authors, awarded following a tender procedure. The present document is 
published complying with the transparency principle to which the Authority is subject. It may not be considered as an output adopted by the Authority. The 
European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, 
without prejudice to the rights of the authors. 
 
Merged formulation type and dilution status 
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Figure L.2: Relationships between the averaged experimental % Dermal Absorption (%DA) values 
and the predicted ones divided by formulations groups and into concentrates and dilutions. For 
models’ explanations please refer to Appendix G. 
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Other covariates 
Below is presented the covariate analysis performed for models 7, 9 and 10. The sub-ranges were 
built according to the methodology outlined in 2.8.2.2. Figure L.3 and Figure L.4 provide an overview 
of the rank correlations (Spearman and Kendall tau) inside each model subset. 
Table L.1: Covariates, their 4 sub-ranges and counts of data points per sub-range for model 7. 
covariate MW 
sub-range [112,230] (230,301] (301,377] (377,732] 
n 60 57 59 57 
covariate LogPow 
sub-range [-4.36,0.67] (0.67,2.89] (2.89,3.7] (3.7,8.1] 
n 59 64 59 51 
covariate Saq 
sub-range [0,6.8) [6.8,34.4) [34.4,780) [780,1.44e+08] 
n 56 58 57 62 
covariate pKa 
sub-range [-7.8,1.95] (1.95,3.13] (3.13,9.4] (9.4,17.9] 
n 63 54 59 55 
covariate Charge (QO.N [e]) 
sub-range [0.3,0.64) [0.64,0.83) [0.83,1.2) [1.2,4.56] 
n 52 52 59 70 
covariate HB 
sub-range [1,4) [4,5) [5,7) [7,13] 
n 54 53 55 71 
covariate MP 
sub-range [-170,64.2) [64.2,116) [116,162) [162,360] 
n 55 61 54 63 
covariate Reactivity 
sub-range [6.69,8.55] (8.55,8.97] (8.97,9.44] (9.44,12.2] 
n 61 57 62 53 
covariate Concentration (mg/L) 
sub-range [0.0156,0.52] (0.52,3.24] (3.24,127] (127,800] 
n 59 58 58 58 
covariate Concentrate 
sub-range FALSE TRUE 
n 145 88 
covariate Merged Form 
sub-range Organic Solvent Other Solid Water based 
n 74 12 61 84 
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Figure L.3:  Model 7: Spearman (left) and Kendall tau (right) rank correlations for the subsets 
presented in Table L.1 
 
Table L.2: Covariates, their 4 sub-ranges and counts of data points per sub-range for Models 9 and 
10. 
covariate MW 
sub-range [112,249] (249,330] (330,401] (401,1.63e+03] 
n 41 37 46 31 
covariate LogPow 
sub-range [-1.96,1.25] (1.25,3.2] (3.2,4.11] (4.11,6.2] 
n 40 45 31 39 
covariate Saq 
sub-range [0,1.38] (1.38,7.3] (7.3,200] (200,1.44e+08] 
n 45 34 40 36 
covariate pKa 
sub-range [-7.19,1.07] (1.07,4.17] (4.17,10.9] (10.9,17.3] 
n 39 38 40 34 
covariate Charge (QO.N [e]) 
sub-range [0,0.59] (0.59,0.78] (0.78,1.07] (1.07,1.99] 
n 40 38 41 36 
covariate HB 
sub-range [2,4] (4,5] (5,7] (7,16] 
n 52 35 45 23 
covariate MP 
sub-range [-61.1,76] (76,118] (118,157] (157,298] 
n 41 38 37 39 
covariate Reactivity 
sub-range [7.12,8.31] (8.31,8.66] (8.66,8.97] (8.97,12.2] 
n 39 43 33 39 
covariate Concentration (mg/l) 
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sub-range [0.0156,0.58] (0.58,2.5] (2.5,111] (111,712] 
n 39 39 38 39 
covariate Concentrate 
sub-range FALSE TRUE 
n 99 56 
covariate Merged Form 
sub-range Organic Solvent Other Solid Water based 
n 55 3 23 72 
 
 
  
  
Figure L.4:  Model 9 (top) and model 10 (bottom): Spearman (left) and Kendall tau (right) rank 
correlations for the subsets presented in Table L.2 
